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“When you are a Bear of Very Little Brain, and you Think of Things, you find some-
times that a Thing which seemed very Thingish inside you is quite different when it gets out 
into the open and has other people looking at it.” 
 
A.A. Milne, Winnie-the-Pooh  
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Bioactive Glass Nanoparticles combined with natural 
based polymers for biomedical applications 
Abstract 
 
Bone tissue engineering has assisted in the last decades to an evolution in which 
merely replacement implants gave room to more complex regenerative approaches. Several 
challenges still remain. Although biocompatibility and biodegradability mechanism are now 
reasonably known and controlled, they still need to precisely match the physiological 
rhythm of bone renewal, while maintaining the adequate structural properties to support 
the host tissue growth. These mechanisms are first regulated at the nanoscale through the 
cellular interactions with the materials. Therefore, there is an urge to begin the control of 
materials surface interaction with the environment at the nanoscale and to go up to the 
micro and macro levels that are comprised in the natural bone structure. 
The main goal of this thesis was to give a step further in producing in vitro materials 
able to mimic the structural and chemical environment necessary to bone growth. There-
fore, micro and nanofabrication techniques were used to recapitulate the complex envi-
ronment of mineralized tissues. As bone is based in a mineral/organic natural composite, 
bioactive glass and chitosan were chosen as materials to be combined in order to mimic 
bone structure. Bioactive glass was engineered at the nanoscale, to better follow Nature´s 
path. 
 In a first stage of the work, the production of bioactive glass nanoparticles was stud-
ied and optimized. The influence of changing experimental parameters such as temperature 
and pH were evaluated, as well as the composition of the BG-NPs. All of the considered fac-
tors showed to be important when setting important characteristics of the BG-NPs as size, 
morphology and bioactivity. A ternary and a binary system were compared. The different 
characteristics showed by both systems indicate that in the future, it will be easy to adapt 
the BG-NPs to the environment requirements, namely degradation rate and subsequently 
ionic release to assure efficiently hydroxyapatite layer deposition necessary for bone growth 
while maintaining safe cytotoxicity levels. 
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Following of the BG-NPs evolution in the sol-gel system since the early stages of pro-
duction showed that hollow BG-NPs are easily obtained through Ostwald-ripening. This 
template free route presents a great potential for drug-delivery systems.  
Moreover, the procedure may be simply adapted to produce dense nanospheres 
with controllable sizes, only through the addition of different PEG size chains. 
Chitosan, a natural origin polymer, was then combined with the developed bioactive 
glass nanoparticles to obtain nanocomposites. Two strategies were followed. BG-NPs were 
dispersed in a chitosan solution and then transformed in membranes through a traditional 
solvent casting procedure. Bioactive polymeric nanocomposites were easily obtained by 
using different BG-NPs (from a ternary system based on SiO2-CaO-P2O5 and a quaternary 
system based on SiO2-CaO-P2O5-MgO). Both the bioactivity potential and the osteoblastic 
response in vitro were evaluated.  
A microcontact printing technique was employed to print BG-NPs on the surface of 
the chitosan membranes. Mineralized patterns were obtained and cells showed a tendency 
to attach accordingly to the created pattern. 
Finally, moving up to the 3D level, a novel bottom-up approach was addressed aim-
ing to summarize bone´s natural multihierarchical structure. In this work, it was proved in a 
very simple procedure, how a drop of aqueous suspension of BG-NPs left to dry on a 
superhydrophobic surface leads to the self-assembly of the BG-NPs, creating a bioactive 
glass based aggregate comprising the nano, micro and macro levels. Besides having a hierar-
chical organization, that is known to give mineralized materials their great mechanical prop-
erties, these systems also allow for the inclusion of drugs as was proved by dispersing dye-
ing additives in the macrospheres. Their bioactive character may also be adapted to the host 
tissue requirements by changing the water evaporation ratio only by adjusting the environ-
ment temperature. 
The topics explored in this this thesis contributed for a deeper understanding of the 
BG-NPs production. Moreover, the described research work is based on simple techniques 
highly competitive against other existing technologies for bone´s structure mimicking.  
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Nanopartículas de vidro bioactivo combinadas com 
polímeros de origem natural para aplicações biomédicas 
Resumo 
 
Nas últimas décadas, a Engenharia de Tecidos ósseos, assistiu a uma extraodinária 
evolução. O desenvolvimento de implantes com funções de mero suporte deu lugar a com-
plexas estratégias de regeneração do osso. Apesar dos significativos avanços obtidos nesta 
área, subsistem ainda importantes desafios. Actualmente os mecanismos na base dos con-
ceitos de biocompatibilidade e degradabilidade são já conhecidos e razoavelmente contro-
lados. Persiste no entanto a necessidade de adequar estes conceitos, de um modo efectivo, 
aos ritmos fisiológicos da renovação óssea. Estes mecanismos começam por ser regulados à 
nanoescala através de interacções celulares com a superfície dos materiais e estendem-se 
para aos níveis micro e macrométrico. 
O principal objectivo desta tese prendeu-se com a necessidade de produzir in vitro, 
materiais capazes de mimetizar estrutural e quimicamente o complexo ambiente necessário 
ao crescimento de tecido ósseo saudável. Neste sentido, técnicas de fabricação à escala 
nano e micro foram utilizadas com intenção de reproduzir a estrutura dos tecidos natural-
mente mineralizados. 
Sendo o osso um compósito natural baseado numa fase mineral e orgânica, os mate-
riais escolhidos para reproduzir esta combinação foram o vidro bioactivo e o quitosano. No 
caso do vidro bioactivo, este foi trabalhado à nanoescala, para melhor reproduzir as estra-
tégias encontradas na Natureza. 
Numa primeira fase da investigação, a produção de nanopartículas de vidro bioactivo 
foi estudada e optimizada. A influência de algumas condições experimentais, nomeadamen-
te a temperatura e o pH, foi avaliada, tal como a composição química das nanopartículas. 
Todos os pontos considerados mostraram ser relevantes para definir características impor-
tantes como o tamanho das nanopartículas, a morfologia e a bioactividade. Dois sistemas 
diferentes de vidro bioactivo ternário e binário foram comparados. As diferentes caracterís-
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ticas mostradas por ambos os sistemas, demonstram que no Futuro, as propriedades das 
nanopartículas podem ser facilmente adaptadas aos requisitos do local de implantação.  
O acompanhamento da evolução das nanopartículas de vidro bioactivo no sistema 
sol-gel, desde os seus primeiros momentos de formação, mostra que é possível obter nano-
partículas ocas através do fenómeno de amadurecimento de Ostwald. Este procedimento 
não envolve a necessidade de recorrer a um molde para criar estruturas ocas e oferece um 
grande potencial para sistemas de libertação de fármacos. O procedimento foi ainda adap-
tado de modo a que nanoesferas densas, com tamanhos controláveis, fossem obtidas uni-
camente devido à adição de cadeias PEG com diferentes tamanhos. 
O quitosano, um polímero de origem natural, foi combinado com as nanopartículas 
desenvolvidas de modo a obter nanocompósitos de material orgânico e inorgânico. Para 
este propósito, duas estratégias diferentes foram seguidas. Numa primeira abordagem, as 
nanopartículas de vidro bioactivo foram dispersas numa solução de quitosano e posterior-
mente processadas em membranas por evaporação do solvente. Como resultado, obtive-
ram-se nanocompósitos bioactivos de base polimérica usando diferentes nanopartículas de 
vidro bioactivo (sistema ternário SiO2-CaO-P2O5 e sistema quaternário SiO2-CaO-P2O5-MgO). 
Tanto o potencial bioactivo quanto a resposta osteoblástica foram avaliados in vitro. Numa 
segunda abordagem, a técnica de impressão por microcontacto foi utilizada para criar 
padrões mineralizáveis de nanopartículas de vidro bioactivo na superfície de membranas de 
quitosano. As células cultivadas sobre estes substratos alinharam-se de acordo com o 
padrão previamente formado. 
Finalmente, ao nível 3D, uma nova estratégia foi seguida tendo em vista a obtenção 
de estruturas multihierárquicas semelhantes às encontradas no osso. A deposição de gotas 
de suspensão aquosa de nanopartículas de vidro bioactivo em superfícies superhidrofóbicas 
permitiu, por associação espontânea induzida por evaporação, a obtenção de agregados 
esféricos de nanopartículas, exibindo níveis de organização à escala nano, micro e macro-
métrica. 
Os tópicos explorados nesta tese contribuem para uma melhor compreensão da 
produção de nanopartículas de vidro bioactivo. O trabalho de investigação aqui descrito 
baseou-se em técnicas simples e altamente competitivas em oposição a outras técnicas já 
existentes com vista à mimetização da estrutura óssea. 
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Chapter I  
 
Nanoscale design in biomineralization towards the 
development of new biomaterials for bone tissue en-
gineering * 
 
 
Abstract 
 
New advances in BTE demand the development of materials that not only replace 
bone, but are also able to regenerate the damaged tissue based on external or even internal 
stimulus.  
Researchers are being inspired on bone’s extraordinary hierarchical architecture and 
also in the natural mineralization process, to develop new devices and materials.  
In this chapter, recent advances of nanoscale design in biomineralization towards 
the development of new biomaterials for BTE are presented. The importance of designing 
the materials at the nanoscale is highlighted and justified by the necessary interaction with 
the biological environment occurring at the nanoscale.  
                                         
 
 
 
 
 
 
* This chapter is based on the following publication:  
Luz, Gisela M.; Mano, João F., Nanoscale design in biomineralization towards the develop-
ment of new biomaterials for bone tissue engineering, In Tissue Engineering using ceramics 
and polymers: 2nd Edition, Ed. Boccaccini, Aldo R., Woodhead Publishing, 2013.  
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1. Introduction 
 
The possibility of applying Nanotechnology approaches in biomaterials science is giv-
ing rise to new trends in the orthopedic domain. Specifically, the advent of sensitive tech-
niques and a better understanding of important scientific phenomena, together with the 
motivation of meeting clinicians’ claims, are making BTE a challenge with increasingly inter-
est for  regenerative approaches instead of merely replacement solutions. Several scientific 
fields are being merged in order to fulfill the demanding complexity of such task.  
Being able to design nanostructured materials is of crucial significance, since cell in-
teractions with biomaterials will occur at the nano-level. The challenge of bottom-up ap-
proaches able to mimic nature´s outstanding mineralized structures is facilitated by the ac-
tual nanotechnology tools.  
Advances in nanotechnology also allow the development of novel nanodevices that 
not only have better cytocompatibility and bioactive properties but can also behave as 
unique drug delivery platforms. Moreover, these current approaches allow for the produc-
tion of hierarchical architectures with organized multilevel structures, a key feature of natu-
ral materials. 
Despite the bright future foreshadowed by nanotechnology in BTE, important limita-
tions still need to be overcome regarding the actual methodologies. Cytotoxicity of 
nanomaterials requires careful assessment. Additionally, technical difficulties, as assuring 
proper vascularization of scaffolds also need to be addressed. 
In the following subsections, important concepts regarding the matter of this chap-
ter will be defined. In part 2, several concrete examples of new approaches in BTE are pre-
sented as well as the rational behind them. The aim of this chapter is not to provide in-
depth insights into the different nanoscale designs inspired in the biomineralization process 
but to give an overview of possibilities and limitations when nanodevices are applied in BTE.  
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1.1. The Biomineralization process 
 
Biomineralization is a natural process by which living forms influence the precipita-
tion of mineral materials. By finding ways of mineralizing, living organisms not only devel-
oped an outstanding evolutionary advantage, but they also achieved mobility. [1] The result-
ing highly organized structures fulfill a variety of important functions heading protection and 
mechanical purposes. [1, 2] Some examples are skeleton in mammals, exoskeleton in in-
sects, and shells in mollusks. [3] Usually, biomineralization is an extracellular process were 
inorganic based materials are formed on the outer wall of the cell, within the cell wall, or in 
the immediate surrounding tissue areas. However, intracellular Biomineralization is also 
possible, and in this case, mineral formation will occur within the cell, as it is reported for 
some algae, for instances. [4] 
Biomineralization is a matrix mediated process. An organic template directs the inor-
ganic phase nucleation and growth in a well-ordered manner. The whole process is strictly 
controlled by chemical, physical, morphological and structural mechanisms. [3]  
Biominerals comprise calcium carbonates, like calcite, aragonite and vaterite; Silica, 
like opals; Bioapatites with the general formula Ca10−x+ηXy(PO4)6−x(CO3)x(OH)2−x+ accounting 
for the possible inclusion of ions (x), the substitution of CO3
2− for PO4
3−, and the presence of 
calcium vacancies; and Iron Oxides and Hydroxides as magnetite. [1, 5] 
The intimate association of inorganic and organic phases is a hallmark of 
biomineralization resulting in organic/inorganic hybrid materials with complex shape, hier-
archical organization and superior materials properties as high resistance and lightness. [3, 
6] 
Another exciting characteristic of these natural composites is their ability to respond 
to external stimuli at the cellular level being than able to remodel and self-repair. This char-
acteristic is dependent on several organic molecules. For instances in bone, osteocalcin, the 
most abundant noncollagenous protein [7], will coordinate calcium ions in a spatial orienta-
tion that is complementary to calcium ions in a hydroxyapatite crystal lattice. This protein 
also plays an important role in cell signaling for the recruitment of osteoclasts and osteo-
blasts for bone resorption and deposition, respectively. [8] 
It is of critical importance to unravel the process of biomineralization in order to un-
derstand how both bone and tooth are formed, and therefore to produce biomaterials able 
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to mimic bone structure in the nanoscale details. [9, 10] Moreover, this knowledge would be 
also useful in other areas regarding pathological mineralization, for example in cardiovascu-
lar disease. [11] 
Finally, biomineralization illustrates how nature can design complex, hierarchical, 
and structurally/morphologically controllable materials to be used in BTE based solely in 
weak components such as brittle minerals, soft proteins and water. [2, 12] Moreover, these 
materials are produced at mild temperature and pressure conditions, with relatively low 
energy consumption, making these systems a fascinating natural source of inspiration for 
scientists and engineers. [2] 
 
 
1.2. Bone structure and properties 
 
Bone is a dynamic, highly vascularized tissue that is formed from a composite of 60% 
mineral (mostly nanoscale hydroxyapatite crystals), 30% organics (including collagen, glyco-
proteins, proteoglycans, and sialoproteins) and 10% of water. [13, 14] Its complex cellular 
architecture continues to remodel throughout the lifetime of an individual, giving bone an 
innate ability to regenerate injuries below a critical size, helped by local or recruited stem 
cells. [15, 16] However, some injuries are beyond the limit that the body can self repair, 
namely cases of severe fractures, bone tumor resections, age-related restrictions, scarring 
and inflammation processes. In these cases a human approach is required in order to assure 
proper healing. [15, 16] However, mimicking bone´s natural structure and mechanical pro-
file is still a challenge in BTE. 
High toughness and flaw tolerance are generally associated with natural 
biomineralized composites. They are believed to be intimately related to an advantageous 
hierarchical arrangement of structural motifs at the nanoscale. Bone tissue also presents 
this hierarchical architecture and it is organized in seven different levels. [17] This structure 
is summarized in figure I.1.  
Beginning at the nanoscale, at the order of 1 nm, one will find the aminoacids that 
form the collagen molecules. The collagen molecule or tropocollagen is approximately 
300 nm long and 1.5 nm in diameter and has a 3D polypeptide stranded structure - See fig-
ure I.1 VIIa. The collagen molecules will associate in collagen fibrils with a diameter of 200 
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nm. [18, 19] Together with smaller quantities of various proteoglycans and glycoproteins 
these components represent the organic part of the bone. [20] The organic/inorganic asso-
ciation characteristic of this tissue is due to the presence of hydroxyapatite crystals aligned 
along the type I collagen fibrils c-axis. The dimensions of the crystal will be 50 x 25 nm of 
length and width and with 2-3 nm thickness, presenting plate-shape morphology. The min-
eralized collagen fibrils will be arranged in lamellae (3-7 µm thick) [14] of fibrils arrays each 
one having a different pattern according to the fibrils orientation. The concentric association 
of these fibrils arrays results in a final collagen fiber with a diameter of 2 µm [18]. The rota-
tion of the crystals sub layers, together with the rotation of the collagen ﬁbril bundles 
around their axis, enhance the isotropic properties of bone found at the macroscopic scale, 
giving it its strength. [2, 21] The lamellae are formed by the secondary osteons, interstitial 
lamellae and the inner and outer circumferential lamellae.  
The mineral amount present in the bone tissue is also very important in determining 
its mechanical properties and function. [22] This parameter will be defined by bone´s cells 
activity. Osteoclasts will release an enzyme that destroys the bone tissue, forming tunnels 
along the longitudinal axis of bone. Then, osteoblasts will rebuild the secondary osteons 
cylindrical tubes, by secreting circular rings of lammelae that surround the vascular or 
Haversian canal in the center of the osteon or Haversian system with a diameter of 200 µm 
and 10-20 mm long. [14, 18] - See figure I.1. III. When osteoblasts are trapped in the newly 
synthetized organic osteoid that will soon mineralize, they become osteocytes. Nutrient 
supply will be facilitated to osteocytes through a microcirculating system called canaliculi - 
See Figure I.1. IIb. [14, 17, 23] 
The last and macroscopic level of the hierarchical architecture corresponds to the 
group of closely packed osteons that compose the cortical bone. [17, 23] Figure I.1. summa-
rizes the seven levels of bone hierarchy. 
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Fig. I.  1. Schematics of the seven levels of the bone hierarchy.  
I - Bone; II a - Cancellous bone; II b - Osteon cross section; II c  - Cortical bone showing the densely 
packed osteons; III - Osteon with surrounding lamellae and Haversian canal; IV - Collagen fiber; V - 
Collagen fibril; VI - Mineralized fibrils; VII a - Collagen molecule showing the triple helice; VII b - Plate-
like apatite crystal. 
 
Mechanical support attributed to the skeletal system is essentially provided by corti-
cal bone that, from a biomechanical perspective, behaves like semi brittle, viscoelastic, and 
orientation dependent material. [14, 18] It is the already described lamellar morphology of 
cortical bone that is responsible for the hinder of crack propagation and increase of tough-
ness. [23] 
Cancellous bone - See Figure I.1. II a - is a lighter, less dense form of osseous tissue 
consisting of trabecular plates and bars that are found in the highly vascular inner parts of 
bone where hematopoiesis and ion exchange occur. [18] Regarding cancellous or trabecular 
bone, the stiffness and strength values will depend on if it is a weight or non-weight-bearing 
regions varying greatly depending on location in the body.  Stiffness of cancellous has modu-
lus values in the range of 1-9.7 GPa. Weight-bearing trabecular systems can sustain superi-
or-inferior compression levels of as much as 310 MPa and those from non-weight-bearing 
regions typically fail at stresses from 120 MPa to 150 MPa. [24] 
Cortical bone presents tensile strength of 3.1-180 GPa and modulus of 3.9-71 GPa. 
These values are two to three orders of magnitude greater than that of cancellous bone. 
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[18, 25] The compressive strength (130-180 MPa) and modulus (4.9-34 GPa) of cortical bone 
are also greater than those of cancellous bone. [26]  
 
 
1.3. Bone Tissue Engineering 
 
The term Tissue Engineering is deﬁned by Langer and Vacanti, as ‘‘an interdiscipli-
nary ﬁeld of research that applies the principles of engineering and the life sciences towards 
the development of biological substitutes that restore, maintain, or improve tissue function’’. 
[27]  
Recently, tissue engineering has gained increasing support as a method to treat de-
bilitating musculoskeletal disorders affecting bone, ligament, and cartilage such as osteoar-
thritis and osteoporosis over traditional methods, due to its interdisciplinary approach that 
focus on tissue regeneration rather than on its replacement. [15, 28] Figure I.2. summarizes 
bone replacement and regeneration strategies. 
 
 
 
Fig. I.  2.  Evolution of bone replacement and regeneration strategies. 
(a) First generation implants: M - Metal, FC - Fibrous capsule, B - Bone; (b) Second generation 
implants: M - Metal, HAp - Hydroxiapatite, B - Bone; (c) Bone harvesting; (d) Third generation BTE 
strategies. 
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The so called first generation biomaterials (from the 1960s to early 1980s) were rep-
resented by prostheses, aiming only to match bone physical properties while causing a min-
imal toxic reaction - See figure I.2. (a). They were based on nearly inert materials. This type 
of materials stimulates the host tissue to produce a nonadherent fibrous capsule around 
them with the purpose of isolating the foreign object. With time, this natural protection 
mechanism may cause the deterioration of the implant. These types of materials do not 
regenerate bone, since they do not present specific bioactivity. They are used merely as 
bone replacement devices. Metals, ceramics, and polymers may be included in the nearly 
inert materials group. [29]  
Bioactive materials arrived on the 1980s and initiated the second generation of bio-
materials. Their significance in bone tissue regeneration is related to the strong chemical 
bond between the host tissue and the material will avoid the development of a fibrous cap-
sule that will compromise the fixation of the implant and the success of the intervention 
overtime. [30] See figure I.2. (b). 
Regarding the BTE field, the concept of bioactivity is directly related to the ability of 
a material to bond chemically to the bone, through the formation of an apatitic layer in vivo, 
or to the ability of inducing the precipitation of hydroxyapatite when immersed in simulated 
body fluid (SBF) in vitro. [31-33] The degradation behavior of bioactive materials must be 
synchronized with the cellular events leading to new bone growth. [34]  
Bioactive materials are classified according to the time taken for more than 50% of 
the interface to bond to bone (t0.5bb). The Bioactivity index (IB) is calculated using the formu-
la (1): [33] 
 
IB  = 100/t0.5bb (1) 
 
An IB value greater than 8 (class A), means that the material will bond to both soft 
and hard tissue. Materials with an IB value less than 8 (class B), but greater than 0, will bond 
only to hard tissue. This leads to the distinction of two different classes: Class A comprises 
bioactive glasses which exhibit rapid and strong bonding to bone by means of a series of 
chemical reactions at the bone tissue interface. They are defined as being osteoproductive, 
and osteoconductive. [35] Moreover, bioactive glasses are also able to bond to soft connec-
tive tissue.  On the other hand, Class B relates to materials which bond slowly only to bone, 
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like synthetic hydroxyapatite. They are classified as bioactive ceramics, and only present 
osteoconductive properties. [35] 
When a bioactive material bonds to soft tissue, whether in vitro or in vivo, collagen 
fibers (which are comprised in all soft tissues) become embedded and bonded within the 
growing apatitic layer on the bioactive materials’ surface. [33][36]  
Bioactive materials may be used as coating for prostheses or as scaffolds and fillers - 
see figure I.2. (b). 3D, porous, degradable, polymeric scaffolds provide mechanical support 
while allowing the ingrowth of new bone as the scaffold degrades. The pore size of scaffolds 
needs to be greater than 30 µm to allow bone ingrowth. [25] 
A more recent approach would be the extraction of cells from a patient and later 
transplantation after proper cell culture, or culturing of the cells in a 3D scaffold for implan-
tation in a defect. [37, 38] See figure I.3. (d). With strategies combining both biological sys-
tems and engineered substrates, biomaterials are now on their third generation. The actual 
goal is to elicit specific cellular responses at the level of molecular biology. Such a shift from 
a materials and mechanics approach to biological based tissue repair requires careful under-
standing of the application of molecular biology to bone regeneration. [39] 
Bone repair typically involves the use of autografts, allografts, xenografts, and syn-
thetic materials. [28, 40] These alternatives are depicted in figure I.2. (c). Autologous bone 
grafting is normally the first choice for bone replacement. However the use of autologous 
bone is limited by its short supply and pain resulting from the harvest process. [41] On the 
other hand, obtaining tissue from another biological source implies a certain risk of rejection 
and disease transfer. Tissue engineering may be a suitable solution to the actual limitations. 
[28, 42]  
There are still some important limitations in BTE that need to be overcome, namely 
cell necrosis occurring within the inner core of a mineralized scaffold [37] or the inadequacy 
of its structural properties to the functionality of the tissue. The solutions may lay in a BTE 
nanoscale approach regarding the development of new techniques and materials or combi-
nations of both, in order to obtain the organized structure that gives bone its successful me-
chanical properties and cellular interactions. The design principles employed to develop 
hierarchical approaches aiming to mimic natural materials formation processes, can be ex-
trapolated to the whole class of biomedical materials, including polymers, metals, ceramics 
or hybrid combinations. [43]  
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A BTE biomaterial-based device ideally would present a certain set of characteristics 
related to each one at the macro, micro and nanolevels. Beginning at the macrolevel, bio-
compatibility, biodegradability and mechanical properties are the essential criteria to be 
fulfilled. At the micro level the key features for assuring the biodevice success are deter-
mined by tissue architecture, surface chemistry, surface stiffness, cell migration, nutrient 
delivery and vascularization ability. Ultimately, at the nanolevel, bioactive factors, cell adhe-
sion, mineralization and gene expression will play a valuable role on defining the device fate. 
[44] 
Biomaterials are classified according to their response when implanted in the body. 
Therefore, they are named: bioactive, nearly inert materials and resorbable. While the for-
mer concepts were already described above, resorbability is defined as the ability of a mate-
rial to support the bone growth during the healing process, and later gradually degrade in 
metabolizable residues, being therefore a very desirable feature on a biomaterial. [29] Both 
polymers and ceramics may have adjustable bioresorbability. 
Bioceramics are special compositions of ceramic materials in the form of powders, 
coatings, or bulk devices. They are suitable to repair, augment or replace diseased or dam-
aged bony tissue. [35] Other materials, as metals and polymers are also used in bone repair 
applications. However they are not naturally bioactive, meaning that they will strongly bond 
to bone in vivo or will not develop an apatitic layer when immersed in SBF. [45, 46] Metals, 
as stainless steel (316L), cobalt-based alloys, titanium, and titanium-based alloys are mostly 
used for bone replacement due to their remarkable mechanical properties. [29, 47] 
Both synthetic and natural occurring biodegradable polymers are used for BTE appli-
cations. [48]  
The most common synthetic polymers found in bone regeneration applications are 
aliphatic polyesters, namely poly (glycolic acid) (PGA), the stereoisomers forms of poly (lac-
tic acid) (PLA) [49-52] and their copolymer poly (lactic-co-glycolide) (PLGA) and also the 
poly(ε-caprolactone) (PCL). [53, 54] It is also possible to find applications based on polyes-
ters such as poly(hydroxybutyrate) [55, 56],  poly(propylene fumarate)-diacrylate [57-59] 
and polyurethane [60]. The degradation of these materials occurs by hydrolytic route 
through de-esterification being the resulting products removed by natural excretion path-
ways. [61]  
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Natural-origin polymers are normally based in polysaccharides such as starch, chitin 
or chitosan, or proteins, like silk fibroin and collagen. [53, 54, 62] Also hyaluronan, gelatin 
and alginate have been proposed as natural biopolymers for BTE. [38, 63]  
Chitosan has been widely studied in the biomedical field since its polysaccharide 
backbone is structurally similar to glycosaminoglycans, the major component of the extra-
cellular matrix (ECM) of bone and cartilage. [38] Several chitosan scaffolds were already 
developed for bone tissue engineering applications. However, both mechanical and biologi-
cal properties still need improvements. [38] 
Collagen is another example of a natural polymer with potential use as a material 
device in BTE. It represents 89 % of the organic matrix and 32 % of the volumetric composi-
tion of bone. Because it has ductile properties and excellent biocompatible properties, it is a 
good solution in tissue engineering and repair, since its usage can help to increase the char-
acteristic poor fracture toughness of ceramics. Furthermore, collagen has the advantage of 
being able to self-assemble with hydroxyapatite in a bone-like structure. [63] 
Despite the challenge that relies in creating nanodevices and materials that are able 
to regenerate bone, some special points must be considered. As in every other biomaterial, 
the influence of the topography on the host tissue response is one of the most important 
concerns during the design and manufacture of a biomaterial.[64-66] Moreover, a bio-
material aiming to be applied for bone regeneration must be based on the following im-
portant features: Biocompatibility with bone cells; Bioactivity/Promotion of hydroxyapatite 
mineralization and osseointegration; Suitable mechanical properties/Support of the for-
mation of natural bone; Biodegradability. They need also to provide adequate mechanical 
support regarding the function of the bone and respecting the overall hierarchy, and inter-
actions between the natural stiff inorganic (mineral apatite) crystals and the soft organic 
(collagen) layers. [18, 21, 67, 68]  
Biomimetic mineralization relays on the use of organic molecules to prepare inorgan-
ic crystals with ordered structures seldom found in natural minerals. [69] Some examples of 
minerals synthesized via biomimetic mineralization are: CaCO3, [70] BaSO4, BaCO3, [71] and 
hydroxyapatite. Organic additives are used as templates. They are vital in biomimetic min-
eralization as they determine the morphologies and properties of mineral crystals. [69] 
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In the next section several nanodevices developed for BTE applications, and some-
how inspired by the mineralization process will be presented, as well as the rational behind 
their development.  
 
 
2. Nanoscale-design 
 
2.1. Materials and techniques 
 
Whether a bone defect is going to be repaired with an orthopedic implant or with a 
tissue engineered construct, its success will always be determined by the biomaterial 
choice. This happens because, as was already mentioned, the most important requirement 
on BTE is assuring an immediate interaction between the biomaterial and the host tissue. 
[72] Traditional materials such as ceramics, metals and polymers, already used in BTE, are 
being now reinvented at the nanoscale and adapted to meet specific targets and functionali-
ties, such as delivery systems of drugs and proteins or matrices for bone cells regulation. 
[73] 
Commonly, the concept “nanomaterial” refers to materials with a nano-sized topog-
raphy or composed of nano-sized basic units comprising dimensions in the scale range of 1 
to 100 nm. These will include nanostructured materials, nanocrystals,  nanocoatings, nano-
particles and nanofibers all of them based respectively on basic components, grain sizes, 
individual layers, particles and fibers within the range of 1-100 nm. [72] 
Surface properties such as roughness, charge, chemistry and wettability are crucial 
for healthy functionality of the general cellular system and will influence protein adsorption. 
[72, 74] Since nanoscale protein interactions are essential to control cell functions such as 
proliferation, migration, and ECM production, it is advantageous to optimize these interac-
tions by tailoring the biomaterial´s surface. [72, 75] 
Current techniques for producing hierarchical structures for mineralization at the 
macroscale include electrospinning, [76] directional freezing, [77-79] and biotemplating, 
[80]. However, the majority of these techniques fail to orientate the nucleation of hydroxy-
apatite.  
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New approaches and methodologies aiming to mimic bone are now arising. In the 
production of BTE nanostructures, several techniques are used.  Vapor-liquid-solid method, 
[81] thermal evaporation, [82] controlled precipitation, [83] sol-gel route, microemulsions, 
[84] template and biomimetic synthesis, [85] flame spray, [86] gas aggregation, [87] dip 
coating and spin coating [88]. In the special case of strategies to produce mi-
cro/nanomaterials with multilevel structures, one can find self-assembly, [89] template syn-
thesis, [90] Ostwald ripening or Kirkendall effect, [91] and evaporation induced self-
assembly (EISA) [92]. Other strategies may be used to extend the efficiency of the engi-
neered structures. For instances, layer-by-layer can be used to include functional compo-
nents, such as BMPs, into the developed nanodevices. [93, 94] Furthermore, recreation of 
the cellular microenvironment through the production of ECM by cells seeded on the im-
planted constructs is also possible. [18, 95] 
Sol-gel processing has an inherent flexibility that makes it a proper technique for 
producing nanostructures typically in the order of a few nanometers in size. Besides the 
possibility of setting the desired stoichiometric chemical composition, the obtained com-
pounds will have compositional homogeneity at a molecular level and a sol stability con-
ferred by electrostatic stabilization. [88, 96] Above all, sol-gel processing offers many ad-
vantages for the processing of materials such as organic-inorganic hybrids, nanocomposites, 
and coatings on complex patterned surfaces, making this process very popular for BTE appli-
cations. [88] 
The multitude of properties resulting from the conjugation of the above mentioned 
techniques, result in complex structures that broadens their potential applications and suc-
cessfully address the demanding BTE requirements. 
 
 
2.2. Nanoparticles  
 
Due to their size and easy dispersability, nanoparticles can be applied in a multitude 
of already existing biomedical devices and strategies, enhancing mechanical properties and 
increasing or attributing the bioactive character of the material, or even both. Nanoparticles 
may also work as an independent nanodevice, in applications such as nanocarriers. Moreo-
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ver, the wide variety of core materials available, coupled with tunable surface properties, 
make nanoparticles an excellent platform for a broad range of biomedical applications. [97] 
Bioactive nanoparticles are often based on ceramics, due to the common ability of 
these materials to induce hydroxyapatite precipitation. Several preparation methods are 
commonly followed to synthetize inorganic nanoparticles, namely controlled precipitation, 
sol-gel technique, microemulsions, template synthesis and biomimetic synthesis. [85] Physi-
cal methods as flame spray [86] and gas aggregation source are also used [87].  
It is extremely important that the chosen method allows for composition, shape, 
size, and aggregation control in order to assure that the developed particles meet the appli-
cation requirements. [98] Commonly, solution based synthesis are chosen to synthetize na-
noparticles, since a more accurate control of the stoichiometry is achieved. [85] 
Inorganic nanoparticles have been used in combination with polymeric matrixes to 
develop new biomaterials, that provide a microenvironment that more closely mimics natu-
ral bone tissue physiology, namely nanofiber composites, layer-by-layer coatings, scaffolds, 
injectable materials and imprinting towards the creating of patterned bioactive surfaces. 
[10, 59] The resulting nanodevices are valuable alternatives to the original approach of using 
ceramic blocks to fill bone defects. Moreover, the development of polymer/inorganic hy-
brids has been recognized as a strategy to improve the mechanical behavior of ceramic-
based materials. Compared with microsized bioactive ceramic particles, nanosized particles 
have a larger surface area and can form a tighter interface with polymer matrix in compo-
sites, resulting thus in better mechanical properties. Moreover, the high speciﬁc surface 
area of nanoceramics allows not only for a faster release of ions but also a higher protein 
adsorption and thus bioactivity will also be increased. [99, 100]  
Silica is an abundant biocontaminant with high biocompatibility, commonly designed 
in nanoparticles. For instances, monodispersed, spherical silica nanoparticles may be syn-
thesized at room temperature (RT) by the hydrolysis of tetramethyl orthosilicate (TMOS) in 
alcohol media under catalysis by ammonia. [101] Xu et al prepared polyethylene glycol 
(PEG)-coated silica nanoparticles with sizes ranging from about 50-350 nm in diameter using 
this methodology. These nanoparticles, being able to encapsulate certain reagents in their 
matrixes, were found suitable for biomedical applications, namely in vivo diagnosis, analysis, 
and measurements. [101] 
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Silica nanoparticles were reported as having inhibitory effects on osteoclasts and 
stimulatory effects on osteoblasts, in vitro. [102] The mechanism of bioactivity is a conse-
quence of an intrinsic capacity to antagonize activation of NF-κB, a signal transduction 
pathway required for osteoclastic bone resorption but inhibitory to osteoblastic bone for-
mation. Therefore, it was possible to demonstrate that silica nanoparticles promote a signif-
icant enhancement of bone mineral density in mice in vivo, providing evidences for the po-
tential application of silica nanoparticles as a pharmacological agent to enhance bone min-
eral density and protect against bone fracture. [102] 
One popular example of a material successfully synthetized in the form of nanoparti-
cles, also having a silica base, is bioactive glass. Nanoscale bioactive glasses have been gain-
ing attention due to their superior osteoconductivity and cytocompatibility when compared 
to micro bioactive glass materials. [62, 86] Bioactive glasses are the gold standard material 
for bone regeneration.  It consists of a silicate network incorporating sodium, calcium and 
phosphorus in different relative proportions. [62] It is known that the therapeutic effect of 
bioactive glasses arises from the influence of soluble calcium and silicate species on the ge-
netic expression of osteoprogenitor cells. [103] Bioactive glass can promote the proliferation 
and activity of fibroblasts and accelerate the process of vascularization, facilitating the heal-
ing of skin wounds. [104] Due to their high surface area, bioactive glass nanoparticles (BG-
NPs) have enhanced dissolution. This could cause an undesirable increase in Ca2+ ions in 
culture medium, since the increased intracellular Ca2+ ions level may induce apoptosis of the 
cells. However, this drawback was not reported so far indicating that the BG-NPs are bio-
compatible. [105-107] Preparation methods of nanosized bioactive glasses are similar to the 
ones used for the general inorganic nanoparticles.  
The first work mentioning the preparation of BG-NPs was from Xia and Chang [108] 
in 2007. They developed a quick alkali-mediated sol-gel method to obtain 20-40 nm sized 
particles, being the size in this range controlled through addition of ammonia solution. The 
obtained particles are depicted in figure I.3. The gelation time was around 2 min, and de-
creased with the increase of the concentration of the ammonia solution. Calcination of gel 
powders was done at 600 °C, being the final powder an amorphous glass. [108] 
 
  
 
Chapter I 18 
 
    
 
Fig. I.  3. TEM images of calcinated BG-NPs.  
(A): Nanoparticles prepared using 1 M ammonia solution; (B) Nanoparticles prepared using 2 M 
ammonia solution. Reproduced with permission from [108]. 
 
In the meanwhile Vollenweider et al [109] developed also BG-NPs but this time the 
20 to 50 nm diameter particles were obtained by flame spray synthesis. The authors then 
treated demineralized human dentin with the obtained nanoparticles and compared the 
remineralization potential of the nanosized particles with a micrometer-sized, commercial 
reference material (PerioGlas). The substantially higher remineralization rate induced by 
nanometer-sized vs. micrometric bioactive glass particles confirmed the importance of par-
ticle size in clinical bioglass applications. [109] 
Misra et al [55] performed a study were they also compared the influence of using 
bioactive glass micro particles versus nanoparticles in a composite based on 
poly(3hydroxybutyrate) (P(3HB)). The micro particles were melt-derived while the nanopar-
ticles were ﬂame spray synthesized. Changes on structural, thermal, and mechanical proper-
ties of P(3HB)/bioactive glass composites were investigated and the results conﬁrmed that 
the addition of nanosized bioactive glass particles had a more signiﬁcant beneficial effect on 
the mechanical and structural properties of a composite system in comparison with 
microparticles, as well as enhancing protein adsorption, two desirable effects for the appli-
cation of the composites in tissue engineering. [55] 
In order to develop BG-NPs with improved dispersibility, Hong et al [110] added an 
innovation to the sol-gel synthesis of bioactive-glass nanoparticles. SiO2-CaO-P2O5 ternary 
BG-NPs with 30-100 nm in diameter were obtained via the combination of sol-gel and 
coprecipitation methods. The precursors were hydrolyzed in acidic condition and subse-
quently condensed and precipitated in an alkaline solution. The great advantage of this 
method is that the agglomeration of nanoparticles via the linkage of H2O molecules during 
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the drying process is inhibited by lyophilization of the gel particles. After calcination, a well 
dispersed bioactive glass nanoparticle can be obtained without grinding and sieving, lower-
ing thereby production costs. [110] 
Nanoparticles are often used as nanofillers. However, their shape may influence the 
final mechanical properties of the materials. For instances, it was reported that needle-like 
or short-ﬁber inorganic particles can improve the mechanical performance of polymer-
inorganic composites much more effectively than spherical ﬁllers. [111, 112] Therefore, 
Hong et al [113] developed rice-shaped particle with the composition SiO2 - CaO - P2O5 ≈ 
6:74:20 (mol). The size distribution of the rice-shaped nanoparticles was quite narrow with 
most of the particles having around 70 nm in diameter and 215 nm in length. [113] An in 
vitro investigation with MG-63 osteoblast-like cells revealed a high cytocompatibility of such 
BG-NPs compared with the microsized ones. [86]  
Nanofillers shape is not the only property that needs to be addressed. Several stud-
ies are being conducted in order to better understand the influence of characteristics as 
composition, preparation conditions and size of BG-NPs. 
Luz et al [107] compared the bioactive behavior of BG-NPs from the binary (SiO2-
CaO) and ternary (SiO2-CaO-P2O5) systems. They concluded that the best bioactivity results 
are not only related to the composition but also with the preparation conditions. BG-NPs 
from the ternary system have more bioactive character than BG-NPs from the binary one. 
Moreover, the sol-gel pH also influences the final bioactivity of the particles. Higher prepa-
ration pHs  bioactivity in particles, as well as the heat treatment. This happens due to the 
increasing amorphousness of the samples when submitted to these conditions. On the other 
hand, a higher crystallinity may lower the dissolution rate to ineffective values. [107] Never-
theless, binary bioactive glasses with the composition SiO2-CaO are still bioactive and pos-
sess desirable biological properties. Bioactive glasses offer the possibility of easily adapting 
their composition to meet specific needs. Some works showed that doping bioactive glasses 
with different ions can add value to these materials. [114] For instance, magnesium, one of 
the main substitutes for calcium in biological apatite, [115] when included in the bioactive 
glasses formulation, can enhance osteoblastic adhesion. [116, 117] Other elements were 
also already used to dope bioactive glass, namely Sr, which is known to enhance 
osteoblastic differentiation [118] and Ag2O which confers bacteriostatic and bactericidal 
properties to bioactive glass [119]. Also the processes leading to the formation of different 
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nanoparticles need to be fully understood in order to control their morphology and both 
chemistry and physical behavior. The impact of the nano-size of these inorganic structures is 
also being studied. 
Hong et al studied the effect of bioactive glass on the biomechanical properties of 
various mammalian cells.  By recurring to atomic force microscopy (AFM) for measuring the 
biomechanical properties of mammalian cells, they concluded that binary BG-NPs can 
signiﬁcantly decrease the plasma membrane stiffness of bone marrow stem cells. However, 
when the study was conducted with bovine aortic endothelial cells, the stiffness was in-
creased and the elongation of the cells was stimulated forming endothelial networks. These 
results indicate that the vascularization process may be facilitated due to the implantation 
of BG-NPs. [105] 
Research regarding the optimization of BG-NPs is still being done in order to over-
come some limitations mostly related to morphology control and aggregation issues. For 
instances, BG-NPs (Si:P:Ca = 29:13:58 weight ratio) of about 40 nm diameter were prepared 
via the sol-gel method an then low-molecular-weight PLLA was successfully grafted onto the 
surface of BG-NPs nanoparticles via the coupling of diisocyanate. The aim was to improve 
the phase compatibility between the polymer and the inorganic phase. [51] 
El-Kady et al [50] used a modiﬁed alkali-mediated sol-gel route to obtain BG-NPs. 
The modiﬁed sol-gel method resulted in a reduction of the gelation time to about a minute 
rather than days as in the traditional sol-gel process. Furthermore, fast gelation prevented 
the aggregation and growth of colloidal particles to sizes larger than 100 nm. The proposed 
method is thus capable of delivering nanoparticles of sizes less than 100 nm with minimum 
agglomeration. [50] 
The polyvalence of nanoparticles in BTE was already mentioned. They can be used in 
multitude of applications, and due to their reactivity resulting from the nanoscale dimen-
sions, simple approaches may have great results. 
Recently, Luz et al [92], inspired on colloidal crystals, used BG-NPs as building blocks 
for the construction of hierarchical organized structures by self-assembly. In a very simple 
strategy, drops of BG-NPs aqueous suspensions were left to evaporate on biomimetic 
superhydrophobic surfaces. The crystallization degree of the structures was controlled by 
the evaporation rates taking place at RT or at 4°C. Spherical aggregates were obtained with 
a hierarchical ordered morphology from nano- to micro- and macroscale. The crystallization 
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degree of the structures influenced the Ca/P ratio of the apatitic film formed at their sur-
face, after 7 days of immersion in SBF. This allows the regulation of bioactive properties and 
the ability to release potential additives that could be also incorporated in such particles 
with a high efficiency. The impact of such technology is high, allowing the production of mi-
crospheres with biomedical applications using a highly competitive method against other 
existing technologies until now. [92] 
Metals processed at the nanoscale may also be useful in biomedical applications. 
[97] For instances, silver is known to have an antibacterial action, representing thereby a 
good solution to the infections on the surface of implants, one of the main problems in 
reaching a suitable level of osseointegration. [121] Hydroxyapatite/silver nanocomposites 
have already been designed to accomplish this aim. [121] The combination of the bioactivity 
of the ceramic matrix with the biocide activity of the silver nanoparticles gives these 
nanocomposites an interesting range of applications in BTE. [121] 
Finally, still regarding nanoparticles for BTE, a new class of biomaterials with addi-
tional functionalities targeting the bone must be mentioned. 
Magnetic properties are being included in bone related biomaterials in order to en-
hance the therapeutic potential of novel nanodevices. The combination of magnetic proper-
ties with biocompatible composition is considered to open the door to new biofunctional 
nanomaterials with broaden action on repairing bone injuries while healing it. Magnetic 
nanoparticles, normally iron oxide nanoparticles, are used for in vivo biomedical applica-
tions in areas related to therapeutic (hyperthermia and drug-targeting) and diagnostic appli-
cations (nuclear magnetic resonance imaging). [122-124] A remarkable advantage of this 
type of systems comprising magnetic nanomaterials is the possibility to use external mag-
netic fields to guide the drug carriers to precisely target areas of the body with minimal or 
non-invasive methods. [125] Regarding cancer treatment, hyperthermia consists of heating 
tumors up to temperatures between 43 and 47°C. Within this interval, the malignant cells 
are selectively destroyed whereas the healthy ones only undergo small and/or reversible 
damage. [126] The use of biomaterials as implantable thermoseeds is a very interesting 
methodology to focus the heat into the target region without overheating the surrounding 
healthy tissues. [126] 
Specifically for bone repair and related cancer therapy, the materials and carriers 
should be biocompatible with bone, such as the cases of hydroxyapatite and bioactive glass-
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es. Ruiz-Hernandez et al [126] were the first to run hyperthermia heating experiments as 
well as preliminary biocompatibility assays for bioactive glass implantable thermoseeds. 
They concluded that the presence of sol-gel glass modiﬁes the magnetic properties, improv-
ing the heating power. The ability to reach hyperthermic temperature range together with 
the bioactive behavior makes bioactive glass a very promising candidate for bone cancer 
treatment. [126] 
Either based on ceramic, polymeric or metallic compositions, nanoparticles play an 
increasingly important role in nanomedicine and in BTE in particular. Efforts are already be-
ing made in order to move a step further regarding the optimization of these polyvalent 
nanodevices. 
Nanoparticles surfaces are now being engineered in a mimicking strategy aiming to 
overcome the body´s physiological barriers. Nanoparticles used for multimodal diagnostics 
and for target-specific drug/gene delivery applications are covered with biomolecules that 
mimic the ones present on the cell membrane, such as proteins, peptides, and carbohy-
drates. These strategies assure that upon injection in the blood stream or following oral 
administration, the nanoparticles will reach the intended target. [127] 
Clinically, the use of nanoparticles in vivo is mainly related to bioimaging and thera-
py. In order for BTE nanodevices to be successfully implanted in vivo, aspects such as 
bioconjugation and nanotoxicity need to be explored. [128]. Nanoparticles can offer a multi-
tude of functionalities due to the possibility of controlling their dimensions, morphology and 
composition. Hence, they are good candidates for a promising avenue in BTE research. 
 
 
2.3. Nanofibers and Nanotubes 
 
Nanofibers are often used in the preparation of scaffolds for BTE. The rationale for 
using nanoﬁbers is related to the theory that cells attach and organize well around ﬁbers 
with diameters smaller than the diameter of the cells. [28] In fact, it has been reported that 
cells might migrate through fibrous matrices by pushing the fibers aside. [72] Therefore, 
materials offering low resistance to the amoeboid movement of the cells, such as nanoscale 
fibers are more suitable for promoting cell migration. [129] Moreover, nanofibers can mimic 
the physical structure of the major constructive elements in the native ECM. [130, 131] 
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Nanofibers are normally produced by electrospinning. Briefly, a high voltage is ap-
plied to the polymer solution to draw out nanofibers that are then collected on a ground 
plate in the form of a mesh. Nanofibers can be cross-linked in order to adjust solubility or 
mechanical properties. They can also be modified in order to increase their biocompatibility 
or bioactivity. Nanofibers may be also produced by self-assembly. Collagen fibrils of bone 
itself are formed by self-assembly of the collagen triple helices and the hydroxyapatite crys-
tals. The hydroxyapatite crystals grow within these fibrils in such a way that their c axes are 
oriented along the long axes of the fibrils. [132] 
There are several examples in the literature of the application of self-assembly phe-
nomena to the production of nanofibers resembling the ones existing in ECM. 
Fischer et al [133] chose collagen and hyaluronic acid as polymers for constructing a 
nanofiber mesh based scaffold because they are the main components of the ECM and have 
been utilized in electrospinning. The collagen/hyaluronic acid meshes were cross-linked to 
render them insoluble and conjugated with gold nanoparticles to promote biocompatibility. 
The results showed that the produced scaffolds were successful in promoting cellular at-
tachment, being thereby a suitable choice for a tissue engineered solution to promote cell 
growth. [133] 
Hartgerink et al.  [134] described a self-assembly based method for producing a 
nanostructured ﬁbrous scaffold resembling the ECM. The work was based on the self-
assembly of a peptide-amphiphile via a pH-controlled and reversible mechanism. The design 
of this peptide-amphiphile allows the nanofibers to be reversibly cross-linked to enhance or 
decrease their structural integrity. After cross-linking, they are capable of nucleating hy-
droxyapatite in an alignment similar to that observed at the lowest level of hierarchical or-
ganization of bone in that the crystallographic c axis of hydroxyapatite is oriented along the 
long axis of the organic fibers.  [134] Figure I.4. shows the evidences of mineralization of the 
fibers. 
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Fig. I.  4. TEM micrographs of the cross-linked peptide-amphiphile fibers. 
(a) Incubated for 10 min in CaCl2 and Na2HPO4 solution. (b) After 20 min, forming hydroxyapatite 
crystals (red arrows) are observed in parallel arrays on some of the peptide-amphiphile fibers. (c) 
After 30 min, mature hydroxyapatite crystals (red arrows) completely cover the peptide-amphiphile 
fibers. Reproduced with permission from [134]. 
 
Also, injectable scaffolds with controllable release are possible. Hosseinkhani et al 
[135] produced a 3D scaffold by mixing a peptide-amphiphile aqueous solution with BMP-2 
suspension. A 3D network of nanofibers was formed with an extremely high aspect ratio and 
high surface areas. In vivo release profile of BMP-2 from 3D network of nanofibers was in-
vestigated. It was demonstrated that the subcutaneous injection of an aqueous solution of 
peptide-amphiphile together with BMP-2 in rats, resulted in the formation of a transparent 
3D hydrogel at the injected site and induced significant homogeneous ectopic bone for-
mation around that area in marked contrast to BMP-2 injection alone or peptide-amphiphile 
injection alone. This kind of strategy represents a promising procedure to improve tissue 
regeneration. [135] 
Electrospinning is also an effective way of producing controllable nanofibers for BTE. 
[136] By adjusting both concentration and feeding rate, it is possible to influence bioactivity. 
[137] This technique may be applied not only to pure polymeric solutions, but also to pro-
duce inorganic based nanofibers. [137] 
Chen et al [137] used electrospinning method to prepare bioactive TiO2 fibers films. 
An acetic acid/ethanol/tetrabutyltitanate/polyvinylpyrrolidone solvent system was used as 
precursor for the electrospinning. The TiO2 fiber structures (including its fiber diameter, 
morphology, and phase composition) could be controlled by changing feeding rate, precur-
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sor concentration and sintering temperature, proving that the electrospinning method is an 
effective way to prepare bioactive TiO2 fiber films. [137] 
Nanotubes may also be prepared by electrospinning using a polymeric sacrificial 
template that will be later sacrificed by a heat-treatment after proper cover of the desired 
material. Mi-Kyung et al [138] used a nanofiber mesh of a polymer (polycaprolactone) as a 
template that was mineralized within solutions via a biomimetic process. A subsequent 
heat-treatment (over 500 °C) completely eliminated the inner polymer, resulting in preserv-
ing the surface mineral phase in the form of nanotubes with diameters of hundreds of na-
nometers with nonwoven mesh, replicating the initial nanofiber template. [138]  
Also, polycaprolactone nanowires were synthesized through template synthesis. The 
in vitro tests showed enhanced biological response. [90] 
Researchers are now exploring nanofibers in a multitude of forms that can be used in 
bone related applications. For instances, magnetic properties were attributed to hydroxyap-
atite nanotubes by embedding magnetic nanoparticles within the inorganic tubes. [73] The 
magnetic hydroxyapatite nanotubes were produced using a template made of magnetite 
nanoparticles/ polycaprolactone and later they underwent surface mineralization and ther-
mal treatment.  
Also, Zhao et al, [139] used single-walled carbon nanotubes as a scaffold for the 
growth of artificial bone material. The tubes were chemically functionalized with 
phosphonates and poly(aminobenzene sulfonic acid). The negatively charged functional 
groups on the nanotubes attracted the calcium cations and lead to self-assembly of hydrox-
yapatite and well-aligned plate-shaped hydroxyapatite crystals with 3nm thickness were 
obtained after 14 days of mineralization. [139] 
As already mentioned, at the smallest length scale of bone, collagen triple helices 
spontaneously form nanoscale bundles, which act as a template for the crystallization of 
hydroxyapatite nanocrystals. Researchers are making an effort to produce nanofibers able 
to mimic bone structure while maintaining the ability of inducing crystal nucleation and 
growth of hydroxyapatite. Although this strategy represents a good approach to follow, and 
despite the good results already obtained, there are still good opportunities for optimiza-
tion.  
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2.4. Nanopatterns 
 
At the nanolevel, every aspect of the biointerface of the biomaterial surface will have 
a considerable effect on the desired cellular response. Therefore, it would be of great value 
if researchers could control the chemical and physical characteristics at the material´s sur-
face.  Nanopatterns have been created in order to control cell interactions with surface by 
means of an imposed pattern with controlled geometry and periodicity. Specific cellular 
responses may then be targeted. [43] 
Despite its significance, just a few works regarding mineralized patterns have been 
produced till the date.  
Ozawa and Yao [140] were the first to create mineralizable patterns at the 
microscale. They presented two different methods for the formation of an apatite 
micropattern by a combination of a biomimetic process and transcription of a resist pattern. 
These two kinds of strategies for forming apatite micropatterns are applicable for the de-
velopment of various smart biomaterials, such as cellular biosensing devices, by combining 
the bioaffinity of apatite with properties of other functional materials at the microscale. 
However, one can go even further and produce micropatterns based on bioactive nanopar-
ticles. 
Tan et al [43] inspired by natural mineralization process created a material with a 
complex structural form in which a nanometer scale mineral phase is organized in a con-
trolled fashion on a micrometer scale template that is preset by a controllable 
microfabrication process. The micrometer scale structures were created using photolithog-
raphy and reactive ion etching techniques. Acidic moieties were generated on the surface 
through silanization and succinylation. Later, a layer of nanostructured calcium phosphate 
was formed on the patterned surface in supersaturated calcium phosphate solution. The 
developed materials were biocompatible with bone cells, inducing a range of desirable cellu-
lar responses. [43] 
Shi et al [41] produced smart surfaces capable of controlling and triggering the oc-
currence of biomineralization in biodegradable substrates. The bioactive substrates were 
prepared from poly(L-lactic acid) and reinforced with Bioglass®. A hollowed polycarbonate 
mask was used to expose only certain regions of the substrate surface to plasma treatment, 
allowing for the insertion of poly(N-isopropylacrylamide) (PNIPAAm) into specifically desig-
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nated areas creating therefore a mineralizable pattern. It is found that such treatment, to-
gether with temperature, could trigger the formation of apatite on the biodegradable sub-
strate upon immersion in SBF above the PNIPAAm lower critical solution temperature. On 
the other hand, no apatite is formed at RT. A control experiment on a material that is not 
subjected to surface treatment does not show any evidence of mineral deposition at the 
two analyzed temperatures. By patterning the surface, it was possible to merge the temper-
ature switching and spatial control of biomimetic apatite formation. This concept could also 
extend to the biomimetic production of other minerals, where it would be triggered by an-
other kind of stimulus (e.g., pH or ionic strength) in substrates with more complex geome-
tries. [12] 
Luz et al [141] showed how bioactive nanoparticles may be easily patterned on a sur-
face by micro contact printing. This technique allowed the creation of a mineralizable pat-
tern on a chitosan membrane using a poly(dimethylsiloxane) (PDMS) stamp inked in a BG-
NPs pad. [141] This membrane was then immersed in SBF and an apatitic pattern was creat-
ed. Cells were also cultured on these membranes and results showed that L929 cells repli-
cated the initial inorganic pattern preferring the environment created by the BG-NPs ionic 
release rather than migrating to chitosan. Depending on the nanoparticles chemistry and on 
the pattern created, cellular response can be directed and studied at the nanoscale. In addi-
tion to the opportunity to study cell behavior when exposed to mineralizable nanoparticles, 
this work opens new possibilities of potential applications, not only in BTE, but also in guid-
ed tissue regeneration for skin and osteochondral areas and also in angiogenesis. [141] 
It is already known that nanometer features tightly control osteoblast behavior. 
[142] Therefore, it would be also desirable that non mineralizable substrates could be also 
successfully patterned at the nanoscale for BTE applications. 
Lamers et al [142] evaluated the role of different nanometer features, like 
(an)isotropy, pattern depth, width and spacing on (initial) cellular behavior by using a very 
high throughput biochip. They observed that isotropic nanosquares do not induce morpho-
logical changes on osteoblasts, but they specifically enhance motility up to a maximum at a 
pattern spacing of 400 nm. These results are summarized on figure I.5. 
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Fig. I.  5. Immunofluorescence micrograph of osteoblast-like cells cultured on nanogrooved substrates.  
Focal adhesions (α-vinculin, green) on a groove width of (a) 500 nm (153 nm depth) were mostly 
aligned with the groove direction, whereas alignment of focal adhesions to a groove width of (b) 
150 nm (120 nm depth) had diminished and was random on a groove width of (c) 50 nm (17 nm 
depth). (d) An overlay of a fluorescent micrograph with a light micrograph. α-Vinculin staining on a 
width of 300 nm (158 nm depth) shows that focal adhesions mainly reside on top of the ridges. Green, 
vinculin; red, F-actin; blue, nuclei. Bars: 10 μm. Reproduced with permission from [142]. 
 
Puckett et al [143, 144] were also able to control the osteoblastic alignment on 
nanopatterned titanium. They showed that the orientation of the nanosurface coating of 
metal implants is also an important parameter when trying to enhance the osteoblastic ad-
hesion. Osteoblast functions where studied on nanopatterned titanium substrates created 
by electron beam evaporation as a means to control the direction of bone growth. These 
patterns appear to better promote bone cell functions more similar to long bones of the 
body. As a result of mimicking the structure and properties of bone, initial formation of ani-
sotropic bone upon implantation could occur. [144] 
Other works show that the grafting of titanium bone implants with nanoparticles 
containing Arg-Gly-Asp-Cys peptide (RGDC) improves the adhesion behavior of cells seeded 
on these materials. [145] 
Li et al [146] developed a novel method that allows the easy deposition of a wide va-
riety of predetermined topographical geometries of nanoparticles of a bioactive material on 
both metallic and non-metallic surfaces. Using different mesh sizes and geometries of a gold 
template, hydroxyapatite nanoparticles suspended in ethanol have been 
electrohydrodynamically sprayed on titanium and glass substrates under carefully designed 
electric field conditions. Thus, different topographies, e.g. hexagonal, line and square, from 
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hydroxyapatite nanoparticles were created on these substrates. The thickness of the topog-
raphy could be controlled by varying the spraying time. [146] 
By precisely controlling material structures on both micrometer and nanometer 
length scale by using patterning techniques, researchers have proved that it is possible to 
create new materials with direct application in BTE. Moreover, the developed techniques 
can be extrapolated to all the classes of biomedical materials, namely polymers, metals, 
ceramics or hybrid combinations. 
The obtained knowledge can aid the further development of smart surfaces that con-
trol cell behavior and account for improved osseointegration around orthopedic and dental 
implants. [142] 
 
 
2.5. Drug delivery systems 
 
Bacterial infection commonly occurs after orthopedic surgeries. The administration 
of antibiotics by oral or intravenous via presents several drawbacks, such as systemic toxici-
ty and limited bioavailability. Targeted drug delivery systems for local delivery at the site of 
the implantation offer great advantage in the orthopedic field. [147] 
Nanostructures, in particular nanoparticles may act as suitable and promising drug 
delivery systems due to their ability of enhancing endocytosis of drugs by targeting cells and 
also by facilitating capillary penetration. [97, 148]  
The efficacy of drug delivery systems based on nanostructures may address some is-
sues related to the properties of currently used drugs, namely solubility, in vivo stability, 
pharmacokinetics, and biodistribution. [97] Nevertheless, drug delivery systems are experi-
encing great progresses in the past few years. Researchers are developing ways to use in-
ternal stimuli to control drug release instead of external ones in order to avoid cell damage. 
[149-153] For instances, these kind of systems allow the release of drugs when exposed to 
the acidic pHs of cancer cells lysosomes, integrating targeted drug delivery with internal 
stimulus induced self-release.   
Although drug delivery has been a polymer-dominated field, the blossoming of nano-
technology means that ceramic materials are now showing much promise for numerous 
drug delivery applications. [148] 
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Ceramic nanodevices present some useful characteristics not shared by their poly-
mer-based homologous. First, they usually have longer biodegradation times and are slowly 
degradable, meaning that it is easier to control drug release kinetics and also to retain drugs 
for longer times after administration. Also, the small swelling ratios of ceramics prevent the 
release of a high amount of drugs as is commonly seen in polymeric hydrogels, such as 
poly(2-hydroxyethyl methacrylate) drug-delivery systems. [148] Since ceramics are normally 
bioactive, they can be of an extraordinary value when approaching drug delivery especially 
targeted for bone. 
Merging drug delivery science with BTE may bring outstanding results for this field. 
Mineralization at the nanoscale can be used as an ingenious way to control both particles 
structure by reinforcement and the drug release by controlling the dissolution. Some exam-
ples found in the literature indicate that drug delivery is being associated with mineraliza-
tion and bone regeneration. 
Min et al [154] developed micelles with a core-shell-corona structure that in the 
aqueous phase provided the three distinct functional domains: an hydrated poly(ethylene 
glycol) outer corona for prolonged circulation, the anionic poly(L-aspartic acid) middle shell 
for calcium phosphate mineralization, and the hydrophobic poly(L-phenylalanine) inner core 
for doxorubicin loading. The doxorubicin release from the doxorubicin-loaded mineralized 
micelles at physiological pH was efficiently inhibited, whereas at an endosomal pH (pH 4.5), 
doxorubicin release was facilitated due to the rapid dissolution of the calcium phosphate 
mineral layers in the middle shell domains. The calcium phosphate mineralization on as-
sembled nanoparticles may serve as a useful guide for enhancing the antitumor therapeutic 
efficacy of various polymer micelles and nanoaggregates. [154] 
Another in-situ biomineralization approach leads to the production of poly(N-
isopropylacrylamide) and calcium phosphates hybrid nanocomposites. [155] Biomimetic 
self-assembly enabled the interaction between PAA and Ca2+ leading to the formation of a 
homogeneous and robust nanocomposite. Smart drug release was possible since the 
nanocomposites were pH- and thermal-responsive. The introduction of calcium phosphates 
nanocrystallines decreases the permeation of the encapsulated drug effectively. [155] 
In another work, [156] titanium was anodized to possess nanotubular surface struc-
tures suitable for drug delivery. The nanotubes were 200 nm deep and had 80 nm of inner 
diameter. These surfaces were able to promote bone cell functions (such as adhesion and 
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differentiation) in vitro and in vivo compared with unanodized titanium. In order to test local 
drug delivery, anodized titanium with nanotubular structures were loaded with penicillin-
based antibiotics using a co-precipitation method in which drug molecules were mixed in 
SBF to collectively precipitate with calcium phosphate crystals. Results showed for the first 
time that such co-precipitated coatings on anodized nanotubular titanium could release 
drug molecules for up to three weeks whereas previous studies have demonstrated only a 
150 min release of antibiotics through simple physical adsorption. These findings represent 
a promising surface treatment for titanium that could be used for local drug delivery for 
improving orthopedic applications. [156]  
Also, TiO2 nanotubes filled with gentamicin were able to reduce bacterial adhesion 
on their surface while still being able to enhance osteoblast differentiation. [147] The results 
related to this experiment are presented on figure I.6. 
 
 
 
Fig. I.  6. SEM images of titania nanotubular surfaces and fluorescence images of bacterias cultured on 
titanium surfaces.  
(a) cross-sectional view of mechanically fractured sample showing that the length of the tubes is 
approximately 400 nm; (b) Top view of nanotubular surface; (c) High magnification top view of 
nanotubular surface showing the tube diameter of approximately 80 nm. Figures (d), (e) and (f) 
show fluorescence microscope images of bacteria stained with Syto 9 after 1 h of culture on 
titanium (d), nanotubes (e) and nanotubes filled with gentamicin (f). Reproduced with permission 
from [147]. 
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 A plethora of nanodevices may be used for drug delivery systems in BTE, namely na-
noparticles, nanofibers, nanoscaffolds, liposomes, dendrimers and nanogels. 
For instances, a nanogel of cholesterol-bearing pullulan in combination with prosta-
glandin E2 showed efficacy in inducing new bone formation. [157]  
Nanodevices have become excellent platforms to design targeted drug delivery sys-
tems for biomedical applications in general. For BTE in particular when bioactive materials 
like ceramics are chosen, several advantages may be numbered, such as their ability to 
modulate drug release kinetics, incorporate multifunctional molecules and target specific 
focus sites. Furthermore, the potential and development of hybrid or composite ceramic-
polymer drug delivery systems that incorporate the benefits from other types of materials 
should not be neglected. [148] 
Although some challenges remain, mostly regarding toxicity issues, [158] it is im-
portant to continue the effort of understanding the metabolism and elimination routes from 
the body of drug delivery nanoplatforms in order to guarantee promising avenues to diag-
nose, understand and treat numerous bone diseases through drug delivery while regenerat-
ing the tissue. 
 
 
2.6. Nanocomposites 
 
Natural mineralized composites, such as bone, tooth and shells, result from the mix-
ture of two or more phases, where at least one of them is in the nanometer size range. They 
exhibit ordered, complex, hierarchical microstructures that current man-made composite 
materials cannot achieve. [2, 159] 
Experiments show that the improved strength and toughness of natural 
biocomposites is caused by a structural and functional organization at different length 
scales, including a nanometer scale. [160, 161] These characteristics should be taken into 
account when fabricating bioinspired advanced materials. [79] 
It was already shown that ceramics at the nanoscale stimulate the interactions be-
tween materials and cells. [105] Inorganic biomaterials present high brittleness. It is there-
fore difficult to obtain porous scaffolds based solely on pure inorganic materials (such as 
bioceramics or bioglasses). However, the combination of inorganic nanoparticles or 
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nanoﬁbers with polymeric systems enables the reinforcement of nanocomposites improving 
their mechanical properties. Hence, these systems possess the potential to be used in a se-
ries of orthopedic applications, including BTE and regeneration. [62] Biopolymers are biode-
gradable and also contain structural groups similar to natural extracellular components, 
being thus suitable for implantation in living bodies. [38]  
Besides the biodegradability and biocompatibility, nanocomposites for BTE also re-
quire an appropriate porous structure and also the ability to induce hydroxyapatite precipi-
tation in SBF solution in order to obtain tissue regeneration from both a chemical and a bio-
logical activity. [60] 
The choice of the technique used in the production process of the BTE device will be 
important to direct the final characteristics of the nanocomposites. Techniques such as 
thermally induced phase-separation method, [49] sol-gel, solvent casting, electrospinning or 
combinations of more than one technique, such as solid-liquid phase separation method 
combined with solvent extraction [50]  are normally used to produce BTE nanocomposites.  
Through freeze-drying, adequate microporosity is assured for cellular migration. 
[105, 162, 163]  Cross-linking can be also used to combine different materials and improve 
their mechanical properties. For instances, Wang et al [164] synthesized a sol-gel derived 
bioactive nanocomposite containing BG-NPs and phosphatidylserine through cross-linking of 
collagen and hyaluronic acid by using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and 
N-hydroxysuccinimide. [164] 
Self-assembly technique is a very suitable technique for BTE, since bone itself is 
based on self-assembly of hierarchical structures in collagen matrix, and involves the spon-
taneous nucleation of Ca/P ions and the oriented array of formed hydroxyapatite crystals on 
collagen template. [63] 
Collagen allows the most successful mimicking approaches. It has been shown to 
align hydroxyapatite in vitro on the nanoscale [165] and has been recently mineralized with 
macroscopic domains of oriented hydroxyapatite by utilizing its liquid-crystalline behavior. 
[166] 
Recently, Wang et al [63] produced a hydroxyapatite/collagen biomimetic 
nanocomposite prepared through self-assembly. Hydroxyapatite nanocrystals formed as 
preferentially oriented needles with 50 - 100 nm in length on the collagen fibers matrix. The 
obtained nanocomposite is analogous in both composition and nanostructured architecture 
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to native bone. Longer aging time promotes the growth and puriﬁcation of nano-
hydroxyapatite on collagen based on a chemical bonding. [63] 
In such a biomimetic physiological environment, calcium phosphates mineralize and 
nucleate directly on the collagen molecules templates through self-assembly. Hydroxyap-
atite crystals are oriented in the c-axis direction parallel to the long axis of the collagen ﬁbril 
via electrostatic interactions between the lateral COO- in the triple helix structure of colla-
gen and Ca2+ in the surface of hydroxyapatite. [63] 
Inorganic materials used to reinforce nanocomposites are normally: hydroxyapatite, 
β-tricalcium phosphate, calcium phosphate and montmorillonite. [38] These materials will 
also give a bioactive character to the nanocomposites. 
A popular nanofiller is BG-NPs. To avoid the possible aggregation of nanoparticles in 
polymeric matrix due to incompatibility, and negative consequences for the mechanical 
properties, surface modification of the particles can be done. For instances, low-molecular-
weight PLLA was grafted onto the surface of the sol-gel-derived BG-NPs by diisocyanate and 
the ring-opening polymerization of the L-lactide. [52] By grafting organic molecules on BG-
NPs, their dispersion is improved on the polymeric matrix and thereby the mechanical prop-
erties did not decrease. [52] 
In general, the inclusion of ceramic nanoparticles in a polymeric matrix has positive 
consequences, namely: alteration of the water uptake and consequently the degradation 
rate and increasing of the biocompatibility, bioactivity and cytocompatibility. Furthermore, 
the induction of a nanostructured topography on the surface of the composites improves 
protein adsorption in comparison to the unfilled polymer and the composites containing 
micron-sized bioactive glass particles. [55] 
Besides 3D porous scaffolds structures, nanocomposites membranes have been also 
applied in the field of bone tissue regeneration. Specifically, in guided tissue/bone regenera-
tion, membranes are used as barriers to prevent the faster growing soft tissue cells from 
entering the defect space and to regenerate periodontal ligament, cementum, and bone. 
Membranes are important for guided tissue regeneration since they can improve healing of 
surrounding tissues.  By directing soft tissue growth, infection will be prevented and repair 
will be facilitated. [18] 
Chitosan/BG-NP composite membranes were developed to be used as barrier mem-
branes to soft tissues with possible applications in periodontal regeneration. [167] It is pos-
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sible to target the nanocomposites properties by adjusting the formulations of the inorganic 
part. Luz et al [117] showed this by preparing chitosan nanocomposite membranes using 
two distinct BG-NPs systems, namely SiO2:CaO:P2O5(mol.%)=55:40:5 and 
SiO2:CaO:P2O5:MgO(mol.%)=64:26:5:5. [117] The chitosan/Magnesium based nanoparticles 
composite presented moderate bioactive character. Also, their higher hydrophilicity was 
found to stimulate a better osteoblastic response towards cellular differentiation and min-
eralization. 
Finally, nanofibers dispersed on a biodegradable polymeric matrix have been also 
used to reinforce BTE composites. [168] 
Regarding the multitude of works that develop nanocomposites for BTE, some con-
clusions can be drawn. In general, the addition of nanoparticles has a signiﬁcant stiffening 
effect on the composite modulus. Surface modification is also useful to establish a deeper 
bonding between inorganic and organic material, which will also improve the 
nanocomposite mechanical properties. [51, 52, 55, 169] Interconnected pores [56] with 
pore sizes in the range 150-500 µm [162] have been obtained. In BTE applications, intercon-
nected pores with interconnection sizes above 300 µm are reported to be necessary to 
avoid hypoxic conditions and favor osteogenesis. [170] 
Nanocomposites represent a viable solution in BTE strategies. By varying parameters 
such as the polymer cross-link or the size and composition of the nanofillers, it is possible to 
adapt the composite chemical and physical characteristics to a specific clinical need. 
 
 
2.7. Nanogels and Injectable Systems 
 
Nanomedicine devices and techniques allow the improvement of minimally invasive 
procedures that can bring great benefit for the orthopaedic field. Injectable matrixes may 
also deliver encapsulated cells and bioactive agents.  
Particularly targeting the orthopaedic reconstructive and regenerative medicine, Chi-
tosan-β-glycerophosphate salt formulations were mixed with BG-NPs in order to conceive 
injectable thermo-responsive hydrogels with rheological properties and gelation points ade-
quate for intracorporal injection. In vitro bioactivity tests, using incubation protocols in SBF, 
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allowed the observation of bone-like apatite formation in the hydrogel formulations con-
taining bioactive nanoparticles. [171] 
Besides the inclusion of nanoparticles in organic/inorganic nanocomposites, nano-
particles can also work as fillers in a variety of moldable and injectable systems, as bone 
cements. Calcium phosphate cements possess the advantage of self-hardening to form hy-
droxyapatite in the bone cavity, avoiding thereby the problem of sintered hydroxyapatite 
implants that require a perfect match between implant shape and bone defect. [28, 172] 
Although calcium phosphate based cements present very high osteoconductivity, their brit-
tleness and low strength limit their use to only non-stress bearing locations. [173] 
Nanoscaled fillers inclusion on these systems may help to improve the composites strength 
until they match the ones of cortical bone. 
Since bone cements under stress can develop cracks, some modifications may be 
performed in order to precisely tune the mechanical properties of the bone cements. For 
instances, Xu et al [174] fused silica particles with silicon carbide whiskers to roughen the 
whisker surfaces for enhanced retention in the resin matrix. [173] The strength of the 
nanocomposites was three times higher than the strength achieved in previous studies for 
conventional bioactive composites containing hydroxyapatite particles in this type of resins. 
The mechanical properties of the final composite nearly matched those of cortical bone and 
trabecular bone. [173] 
Stevens et al [41] injected calcium-cross-linked alginate gels or modified hyaluronic 
acid gels into an artificial space between the tibia and the periosteum in rabbit. This stimu-
lated bone and cartilage formation from resident progenitor cells in the inner layer of the 
periosteum. Injectable systems show that complex tissues can be generated from relatively 
simple materials by using the body as a bioreactor. [41] 
BTE approaches using injectable systems have been developed as a good scaffolding 
solution for irregularly shaped bone defects or with difficult access. Besides, the advantage 
of being minimally invasive injectable systems also offers the possibility of being combined 
with living cells or therapeutic drugs. Hence, they represent a very complete tissue engi-
neering solution. 
The development of targeted gels is also important for tissue regeneration because 
matrix elasticity is sufficient to induce lineage-specific differentiation of progenitor cells. 
[175] For instances, Discher et al [175, 176] showed that the differentiation of human 
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mesenchymal stem cells is dependent on the 2D matrix elasticity of collagen-coated poly-
acrylamide substrates on which they were cultured. The cells grown on moderately firm 
substrates, with E of 10 kPa, similar to that of muscle, exhibited upregulated myogenic 
markers, whereas the others proceeded down an osteogenic pathway when cultured on a 
stiffer substrate (E of 35 kPa, similar to that of crosslinked collagen of osteoids).  
Owing to their tissue-like elasticity, PEG-based hydrogels are highly desirable as 3D 
scaffolds for tissue regeneration. Also, their high permeability can mimic the native ECM. 
However, their applications are limited by their poor mechanical properties and bioinert 
nature, which restrict cell adhesion and spreading. To overcome these limitations, a novel 
hierarchical nanocomposite hydrogel composed of PEG diacrylate and hydroxyl mesoporous 
silica nanoparticles was developed via in situ free-radical polymerization. Structural and 
physicochemical characterization shows that hydroxyl mesoporous silica nanoparticles act 
as both reinforcing agents and adhesion sites in the hydrogel system, which significantly 
enhances mechanical properties and cellular affinity. Due to the anchoring effect of the hy-
droxyl mesoporous silica nanoparticles, the hybrid hydrogels possessed greatly enhanced 
mechanical properties as compared to the pure PEG hydrogels. Furthermore, the introduc-
tion of hydroxyl mesoporous silica nanoparticles into hydrogel systems may be beneficial for 
osteogenesis, making these nanocomposite hydrogel a promise scaffold for BTE. [177] 
By recurring to injectable systems cells, drugs and molecular signals can be delivered 
to irregularly shaped bone defects in a minimally invasive manner. These injectable materi-
als can also work as a scaffold especially in locations that are not easily accessible. 
  
 
2.8. Surfaces functionalization and templating 
 
Many studies claim that the processes of biomineralization initiation and control are 
based on collagen templates and on the recognition of Ca2+ by a variety of noncollagenous 
biomolecules, [178] such as acidic proteins rich in aspartate, glutamate and its derivative γ-
carboxyglutamate, phosphorylated residues such as phosphoserine, [179] and also acidic 
glycosaminoglycans (GAGs) and other polysaccharides, which are significant bone constitu-
ents. [180, 181] Soluble macromolecules interact with the matrix to control mineral deposi-
tion, crystal habit, and orientation within a structural framework that acts a template for 
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nucleation and growth of hydroxyapatite. [182, 183] While biopolymers provide a base for 
the initial organization of mineral ions into a crystallographic layer, biomolecules are also 
presumed to play an inhibitory role in mineralization by binding to specific crystal surfaces, 
thus preventing further growth of that surface. [181, 184] In face of this knowledge, con-
trolled organization of well-defined, bioinspired architectures based on organic-inorganic 
hybrid materials is of great interest for applications in tissue regeneration. [182] 
In an effort to mimic the composition of mineralized tissue in artificial systems, sev-
eral organic templates have been investigated for their ability to nucleate biological miner-
als on the nanoscale, including self-assembled monolayers, [11] biopolymers, phospholipids 
[185] and poly(amino acids). [181] Most of these systems fail to mimic the hierarchical 
structure of bone, since they are not able to induce the nanoscale crystallographic align-
ment of hydroxyapatite.  
Medical devices able to induce osseointegration regardless of the implantation site, 
or both bone quantity or quality need to exhibit the right functional groups for apatite nu-
cleation on their surfaces. [10] Some functional groups have been shown to induce bone-
like apatite formation, namely Ti-OH, Zr-OH, Nb-OH, Ta-OH, -COOH, Si-OH and PO4H2. [10] 
These groups have in common a negatively charged character, given by the neutral isoelec-
tric points at pH values much lower than 7. They will attract Ca2+, PO4
3- and CO3
2− from the 
environment forming an amorphous layer that will later crystalize in hydroxyl carbonate 
apatite with oriented apatite crystals. [11, 186] 
Since the ECM, which is responsible for templating hydroxyapatite in mineralized tis-
sues, contains 1D, fiber-like nanostructures, nanodevices mimicking these structures are 
gathering researcher’s attention. For instances, peptide amphiphiles containing a hydro-
phobic alkyl tail covalently attached to a peptide sequence were recently used to study bi-
omimetic mineralization. [182] In this study the authors showed that the ability to nucleate 
oriented hydroxyapatite using a fibrous supramolecular template depends strongly on the 
details of its nanoscale architecture. Mineral oriented relative to the principal axis of the 
fibers, as it occurs in mammalian bone, were only nucleated on calcium binding nanostruc-
tures with curved, cylindrical architectures, and not on chemically similar ones with flat sur-
faces. When cylindrical nanostructures were part of a hierarchically aligned monodomain 
gel containing bundles of nanofibers, the ability to nucleate oriented crystals over multiple 
length scales was maintained. The templates described in this study may also be interesting 
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to investigate the role of alignment in cell signaling and preparation of therapeutic con-
structs to promote in vivo regeneration of mineralized tissues. [182]  
Besides the peptide-based self-assembly approach for designing templates for 
biomineralization, cylindrical assemblies of filamentous bacteriophage bearing acidic coat 
proteins have already demonstrated oriented hydroxyapatite mineralization. [187, 188] 
Surfaces can also be functionalized targeting the control of cell behavior, and indi-
rectly the cellular mineralization process. Rezania and Healy [189] functionalized solid mate-
rials surfaces with peptide sequences incorporating both cell- and heparin-adhesive motifs. 
They were able to enhance the degree of cell surface interactions and hence, influence the 
long-term formation of mineralized ECM in vitro. [189] 
In order to design new BTE devices regarding biomineralization at the nanoscale, it is 
important to understand the main mechanisms responsible for apatite induction. Surface 
functionalization may be a very useful tool to attribute bioactivity to materials not able to 
induce apatitic deposition for themselves. Moreover, mimicking nature´s organic templates 
towards the biomineralization process initiation may be the key to obtain hierarchical orga-
nized nanostructures similar to the ones that can be found in bone. 
 
 
3. Final remarks 
 
BTE field is evolving and presents a plethora of innovative features aiming to meet 
the challenging demands of clinicians. Materials for bone replacement are no longer re-
quired to be inert. Nowadays the challenge of BTE is the design of a matrix that mimics the 
natural properties of bone while providing a temporary scaffold for tissue regeneration, still 
maintaining the resorbable, bioactive and biocompatible characteristics. A new class of 
smart materials is being created not only to replace bone, but also to regenerate the dam-
aged tissue based on external or even internal stimulus.  
Bone has been an inspirational source for tissue engineering, since it presents an ex-
traordinary hierarchical architecture with notable biological and mechanical properties. It is 
known that its structure is based on aligned collagen bundles embedded with nanometer-
sized inorganic hydroxyapatite crystals, however, the relationship between morphology of 
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the organic matrix and orientation of mineral is poorly understood. Unraveling the underly-
ing mineralization process and how that knowledge can lead to the development of new 
devices and materials sharing the same remarkable mechanical properties of this natural 
nanocomposite is the main goal of BTE.  
The central goal of this chapter was to bring forward some of the recent advances of 
nanoscale design in biomineralization towards the development of new biomaterials for BTE 
in the field of Nanomedicine applied to the bone. In section 1, some important concepts 
related to the issues being discussed were presented, as well as a brief review of the physio-
logical and anatomical characteristics of bone tissue. Section 2 described the latest nano-
technology trends applied to the physical and chemical mimicking of bone environment us-
ing synthetic materials. 
Hybrid organic-inorganic structures mimicking the composition of mineralized tissue 
for functional bone scaffolds were analyzed. The combination of biodegradable polymers 
(synthetic and natural) with nanoscale bioactive ceramics or ﬁbers is emerging as a powerful 
approach toward third generation bioactive materials comprising injectable 
osteoconductive biomaterials, thin coatings and ﬁlms or self-assembling osteoconductive 
nanobiomaterials. The impressive possibilities are closely linked to the broad range of prop-
erties they offer. 
The nanostructures were recognized as being a key point for the successful achieve-
ment of bone regeneration. These devices must possess the ability of sensing biological de-
mands and also to adapt to the mutability of the biological environment. In order to mimic 
the complex hierarchical structure of bone new methodologies are arising or being adapted 
to meet nanoscale design challenges. Modern materials and devices are being created, 
based on a dynamic interaction with the biological environment starting at the nanoscale 
allowing bone tissue regeneration to be targeted at the cellular signals level. These materi-
als need to be able to communicate with cells and direct them to adhere, proliferate mi-
grate or differentiate.  
A number of open issues still need to be addressed. Some parameters of modern 
BTE devices lack optimization. Namely, degradation rate and mechanical properties are re-
quired to match with new bone formation and also bone vascularization needs to be im-
proved in order to avoid necrosis of the host tissue surrounding the implant. This is an im-
portant point limiting the upscale of bioartificial devices. On the other hand, long-term 
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health effects of nanomaterials are still not fully understood. The development of scalable 
and reproducible manufacturing methods is also important. In the future, polyvalent devices 
comprising abilities as support, therapeutics and bioactivity will be implanted in bone tis-
sues able to respond perfectly to the demanding in vivo environment. These materials will 
be able to release drugs to specific organs. Efficient combination of growth factors with the 
materials will also improve their efficacy in regenerating healthy bone. However, this in-
creasingly complexity of nanodevices may compromise their financial viability regarding 
translation to clinical due to the level of chemical and physical complexity required for these 
materials to be able to influence cell behavior.  
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Chapter II  
 
Mineralized structures in nature: Examples and inspi-
rations for the design of new composites * 
 
Abstract 
 
Through the natural evolutionary process, organisms have been improving amazing 
mineralized materials for a series of functions using a relatively few constituent elements. 
Biomineralization has been widely studied in the last years. It is important to understand 
how minerals are produced by organisms and also their structure and the corresponding 
relationship with the properties and function. Moreover, one can look at minerals as a tool 
that could be used to develop high performance materials, through design inspiration and 
to find novel processing routes functioning at mild conditions of temperature, pressure and 
solvent type. As important as the molecular constituents are structural factors, which in-
clude the existence of different levels of organization and controlled orientation. Moreover, 
the way how the hierarchical levels are linked and the interfacial features play also a major 
role in the final behavior of the biogenic composite. The main aim of this work is to review 
the latest contributions that have been reported on composite materials produced in na-
ture, and to relate their structures at different length scales to their main functions and 
properties. There is also an interest in developing new biomimetic procedures that could 
induce the production of calcium phosphate coatings, similar to bone apatite in substrates 
for biomedical applications, namely in orthopedic implants and scaffolds for tissue engineer-
ing and regenerative medicine; this topic will be also addressed. Finally, the latest proposed 
approaches to develop novel synthetic materials and coatings inspired from natural-based 
nanocomposites are also reviewed. 
 
* This chapter is based on the following publication:  
Luz, Gisela M.; Mano, João F., Mineralized structures in nature: Examples and inspirations for the design 
of new composite materials and biomaterials, Composites Science and Technology, 2010, 70 (13), pp: 
1777-1788,   DOI: 10.1016/j.compscitech.2010.05.013. 
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1. Introduction 
 
Nature, through the evolutionary process, has been able to design and produce high-
ly sophisticated materials, used for a variety of functions, including for structural purposes 
[1] and [2]. The physical properties of biological systems, such as the mechanical perfor-
mance, are typically far better than that of the equivalent synthetic materials, with similar 
compositions and processed with present technologies. Moreover, these materials are pro-
duced at mild temperature and pressure conditions, with relatively low energy consump-
tion. Finally, such systems are made with significant weak components such as brittle min-
erals, soft proteins and water. Therefore, nature has been a fascinating source of inspiration 
for scientists and engineers. Biomimetics is an emerging field of science that includes the 
study of how nature designs, processes and assembles/disassembles molecular building 
blocks to fabricate high performance hard polymer-based composites (e.g., mollusk shells, 
bone, tooth) and/or soft materials (e.g., skin, cartilage, tendons), and then applies these 
designs and processes to engineer new molecules and materials with unique properties. [3-
5] 
Biologically inspired design or adaptation or derivation from nature is referred to as 
‘biomimetics’. It means mimicking biology or nature. The field of biomimetics is highly inter-
disciplinary. It involves the understanding of biological functions, structures and principles 
of various objects found in nature by biologists, physicists, chemists and material scientists, 
and the design and fabrication of various materials and devices of commercial interest by 
engineers, material scientists, chemists and others. [6] 
Mineralized biological materials are a subgroup of this immense world that has fas-
cinating many researchers due to their unique structure and performance. Despite the large 
variety of existing biocomposites, only about 60 minerals are used by organisms, approxi-
mately half of them containing calcium. [7-8]. It has been recognized that some constitu-
ents, such as calcium carbonate or silica, exist recurrently in very different mineralized or-
ganizations and processed by completely diverse living organisms. As important as the mo-
lecular constituents are structural factors, which include the existence of different levels of 
organization and controlled orientation. Moreover, the way how the hierarchical levels are 
connected also plays a major role in the final behavior of the biogenic composite. The main 
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aim of this work is to review the latest contributions that have been reported on natural 
mineralized materials, and to relate their structures at different length scales (molecular, 
nanometric, micrometric and macroscopic levels) to their main functions and properties. An 
emphasis will be done on discussing topics that include how the different hierarchical levels 
are organized and what would be the contribution of both the organic fraction and water 
that existing within such structures. A series of examples of mineralized structures will be 
presented, including the fracture surface of shells, bone and teeth. The study of the struc-
ture–function relationships in bone has been particularly investigated, together with studies 
in the area of calcium phosphates, as hydroxyapatite constitutes the inorganic component 
in this tissue. In this context, much work has been done in the development of new proce-
dures that could induce the production of calcium phosphate coatings in substrates for bio-
medical applications, namely in orthopedic implants and tissue engineering scaffolds; this 
topic will be also reviewed. Finally, the latest proposed approaches to develop novel syn-
thetic materials and coatings inspired from natural-based composites are also reviewed. The 
difficulties associated with such biomimetic routes will be pointed out, related to the com-
plex architecture found in the biogenic composites and with interfacial arguments. In fact, 
many aspects of biomineralization are far from being clearly understood and suggestions on 
how such fundamental knowledge could be transposed to useful synthetic strategies for 
developing completely new materials offers a series of stimulating research opportunities 
for researchers. 
 
 
2. Structure of mineralized biocomposites and properties relationships 
 
2.1. General considerations 
 
It has been recognized that biological composites exhibit a series of organized struc-
tures on discrete scale levels, ranging from the molecular to the macroscopic. [9, 10] The 
components at each level are interrelated with each other such that the performance for 
the required functions can be optimized. The different levels are assembled through a bot-
tom-up approach using nanofabrication methodologies, mediated by cellular signals. It is 
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interesting to notice that the hard mineral component in natural composites exhibit 
nanometric sizes, at least in one direction, displays an anisotropic geometry and is im-
mersed in a soft organic matrix. For example (see more details later), enamel is composed 
by 15–20 nm thick and 1000 nm long crystals, with low soft protein matrix content; dentin 
and bone contains plate-like crystals (2–4 nm thick) and double the quantity of protein ma-
trix; nacre is made of plate-like crystals (200–500 nm thick) and contains a very small 
amount of soft matrix. In a pure fracture-mechanics perspective Gao and co-workers 
showed that nanometer scale plays a key role in allowing these biological systems to 
achieve their superior mechanical properties. [11, 12] Below a critical size on the nanometer 
length scale, the mineral crystals fail no longer by propagation of pre-existing cracks, but by 
uniform rupture near their limiting strength. This increase of robustness is also achieved 
through the hierarchical organization, as studied by modeling self-similar composite struc-
tures mimicking the nanostructure of bone. Such mechanistic analysis also allowed the un-
derstanding the importance of the anisotropic structure of the mineral crystals that can ex-
plain how nature can produce stiff composites with low mineral content (e.g., bone): it was 
shown that the large aspect ratio of mineral crystals in bone can fully for the softness of the 
matrix. [12] 
Another important aspect in the common structure of many mineralized biological 
materials, namely the ones that were produced to fulfill a multipurpose function (e.g., mol-
lusk shells, skeleton of sea urchins, lamellar bone and biogenic silica) is that they seem to be 
designed to reduce the extent of mechanical anisotropy. [13] Here, the idea of multipurpose 
material is related to material produced by a variety of different organisms of the same tax-
on, and used in anatomically different environment. Therefore, they should function under 
many different situations and should respond mechanically more or less equally from all 
different directions. In these systems one may observe highly anisotropic structures at some 
hierarchical level (for example, the mineralized fibrils within the layers of lamellar bone), but 
it seems that the design strategy throughout the entire levels of structure is to enhance, as 
much as possible, the isotropic character of the material. [13] 
An interesting example of structural hierarchy was reported for a silica-based miner-
alized skeleton of a sponge, providing a unique example of how glass, a classic brittle mate-
rial, can be used as a structural element in the biological world. [14] The assembly towards 
the glassy cage of this organism involves at least seven hierarchical levels, all contributing to 
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mechanical performance. Silica nanospheres are arranged into concentric layers, held to-
gether by organic layers, to yield lamellar fibers. Those are organized in bundles to produce 
flexural rigid composite microscopic beams. The beams are arranged in a rectangular lattice 
that, together with other structural motifs, provides adequate mechanical features of the 
glass skeletal system at the macroscopic scale. Some more examples of mineralized 
biocomposites will be given, where the relationship between structure and performance or 
function will be highlighted. As the main applications of nature inspired synthetic materials 
that were intended to be focused are in the biomedical field, a special attention will be giv-
en to human mineralized tissues (bone and teeth). Shells will be also discussed as calcium 
carbonate-rich nanocomposites as they also exhibit particular structural features and prop-
erties that can also be interesting in the orthopedic field. 
 
 
2.2. Bone 
 
Bone refers to a family of materials that all have the mineralized collagen fibril as 
their basic building block. [15] The general structure of bone is summarized in Fig. II.1.A. 
Plate-shaped crystals, with 50 × 25 nm of length and width and with 2–3 nm thickness, of 
carbonated hydroxyapatite, with crystals aligned along their c-axis, are embedded in a type-I 
collagen framework. The fibrils consist of triple-helix collagen chains with 1.5 nm diameter 
and 300 nm length. Their ends are separated by holes of ca. 35 nm and the neighboring 
molecules are vertically offset by 68 nm. The apatite crystals are nucleated at specific re-
gions on or within the collagen fibrils. They grow in the hole zones that exists between 
neighboring collagen molecules. For the particular case of lamellar bone the fibrils are then 
arranged in parallel arrays, with crystals aligned (sub-layers). The consecutive sub-layers 
rotate through the lamellar plane by an average of 30°, forming a so-called plywood-like 
structure. As each lamella is composed of five sub-layers, the total rotation is 150°, thus 
forming an asymmetric structure. Moreover, the collagen fibril bundles rotate around their 
axis within the five sub-layers. Both facts enhance the isotropic properties of bone found at 
the macroscopic scale, as previously reported. Moreover, this type of architecture hinders 
crack propagation and increases toughness. Fig. II.1.B displays a typical lamellar morphology 
found in cortical bone, showing a cryogenic fracture surface of a bovine femur. The layered 
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texture reveals the complex and periodic structure of the lamellar bone, being in agreement 
of the plywood-like structure. The lamellae that form cortical bone have three forms of ap-
pearance: the secondary osteons, interstitial lamellae and the inner and outer circumferen-
tial lamellae. The secondary osteons are cylindrical tubes, which are permanently re-built by 
the remodeling process. The remodeling is regulated by the mineral metabolism and the 
appearance of microcracks caused by fatigue. Osteoblasts destroy the bone tissue, forming 
a tunnel along the longitudinal axis of bone. The tunnel is then filled up by circular rings of 
lamellae surrounding the vascular canal, both of them forming together the so called 
haversian system or osteon, a cylindrical motif, formed by concentric layers of lamellae and 
are usually oriented in the longitudinal direction of bone. [16] The micrograph in Fig. II.1.B 
also reveals the existence of an Haversian canal, found in the in central region of the osteon. 
For further details read. [15] 
 
 
 
Fig. II. 1.   Bone structure and morphology.  
(a) The general structure of bone, showing its hierarchical organization; (b) fracture surface of a 
bovine cortical bone revealing a lamellar morphology. 
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Comparing different types of bone, it can be concluded that the main determinant of 
mechanical properties is the amount of mineral in the tissue. [17] A clear trend between 
stiffness and mineral content is found when various types of bone are compared. The stiff-
ness and strength values in the cancellous bone, varies depending on the weight or non-
weight-bearing regions. Stiffness has modulus values in the range of 1–9.7 GPa. Weight-
bearing trabecular systems can sustain superior–inferior compression levels of as much as 
310 MPa and those from non-weight-bearing regions typically fail at stresses of from 
120 MPa to 150 MPa. [18] The near-linear relationship found in this trend shows that the 
failure of bone in bending is determined by the strain to which it is subjected. [17] Concomi-
tantly, the increase in the Young’s modulus is associated with a decrease in the strain at 
failure. Despite the importance of the mineral content, the organic matrix plays a major role 
in the mechanical performance of bone, contributing for its plastic deformation, and the 
overall hierarchical microstructure is essential for its toughness. [19] Experiments on bone 
fracture showed that crack propagation is prevented by various complex ways, discussed by 
Nalla et al [20] In that study it was possible to experimentally demonstrate that local criteri-
on for fracture in human cortical bone is consistent with a strain-based criterion, rather than 
being stress-controlled. More correlations between mechanical properties and structure 
found not only in bone but in a vast number of natural materials were excellently reviewed 
by Meyers et al [21] 
 
 
2.3. Teeth 
 
Mammalian tooth is a structural and functional gradient composite consisting of a 
hard, inert, component, the enamel, supported by the less mineralized, more resilient, and 
vital hard connective tissue, dentin, which is formed from and supported by the dental pulp 
- See Fig. II.2.A. Tooth is an engineering tool performing daily functions of mastication: teeth 
are subjected to stresses of about 20 MPa, 3000 times a day but their fracture is rare. It is 
hypothesized that this is partly due to the hardness and stiffness of enamel and partly to the 
toughness and relative compliance of dentin. [2] 
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Fig. II. 2 Mineralized structure of tooth.  
(a) Schematic drawing showing the enamel and dentin regions; (b) SEM micrograph of enamel and (c) 
SEM micrograph of dentin, showing the tubular morphology, surrounded by dense peritubular dentin 
– the longitudinal cut along the tubules is seen in the inset image. 
 
Enamel is the most highly mineralized tissue found in the vertebrate body and also 
the hardest, being constituted by approximately 97% mineral (w/w), 1% organic material 
and 2% water. The basic structure is the nanosized fibril-like carbonate apatite crystals, 
much larger than the apatite crystals found in bone: in newborn mammals, they can be at 
least 100 μm long and 50 nm diameter [2]. The crystals are bound together, forming rods, or 
prisms, which are in turn arranged in a decussating, plywood-like structure. [17] Fig. 2B 
shows a SEM picture of a fracture surface of enamel of a 6 years old infant tooth. The topog-
raphy reveals the formation of unique structures consisting of aligned prisms or rods with 
∼5 μm diameter, which run approximately perpendicular from the dentin–enamel junction 
towards the tooth surface. Each rod consists of tightly packed carbonated hydroxyapatite 
crystals, with very high aspect ratio. More details in the microstructure, detected, for exam-
ple using atomic force microscopy can be found elsewhere. [22] In that work it was found, 
for nano-indentation experiments, that the stiffness is different in the two main direction of 
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the rods orientation. However, Fig. II. 2.B shows that, at a micron-level, different fiber orien-
tations exist that could allow the enhancement of the isotropic behavior of the material, as 
discussed previously for other mineralized tissues. 
Dentin has a similar composition to that of bone, its crystals being much thinner than 
those in enamel (ca. 2 × 50 × 25 nm) [2]. The tissue comprises a network formed by random-
ly intertwined mineralized collagen fibrils. Dentin is permeated by tubules, as shown in Fig. 
2C that radiate from the pulp cavity towards the dentin-enamel junction. The mechanical 
performance in the region of such junction was analyzed by Imbeni et al in order to under-
stand the mechanism that provides a crack-arrest barrier for flaw formed in the brittle 
enamel [23]: it was suggested that the interface never debonds but rather the crack pene-
trates and stop after a short travel through dentin. 
 
 
2.4. Mollusk shells and nacre 
 
Shells mainly consist of calcium carbonate (calcite or aragonite) forming multilayered 
microstructures, and a small amount of organic component (1–5 wt.%), mainly located with-
in the inter-crystalline boundaries. Despite this composition, and owing to the special com-
posite microstructure, mollusk shells present an enhancement in toughness by three orders 
of magnitude with respect to non-biogenic calcium carbonate. [24, 25] In fact, the arrange-
ment of the crystals forces the deflection of a crack to a direction with an unfavorable stress 
state and prolongs the crack propagation, enhancing the energy absorption in the direction 
of crack travel. [26] However, as it will be seen later, other mechanisms should be taken into 
account to explain the amazing mechanical features of mollusk shells. 
In some organisms the two calcium carbonate polymorphs may be found, but sepa-
rated in different layers. [7, 27] A typical example is the shell of mussel (Mytilus sp.), where 
two layers can be found: an inner nacreous layer, a ‘brick-and-mortar’ of plate-like aragonite 
crystals (Fig. 3A), and an outer prismatic layer, with a honeycomb-like network structure of a 
polygonal prism formed by large crystals of calcite (Fig. II.3.B). During the growth of shells, 
the prismatic layer is first deposited and the nacre is added as the shell thickness increases 
with time. [8] These animal’s shells have both calcite (90%) and aragonite (10%). The pris-
matic layer is based on long calcite crystals (rhombohedral) that are produced in a space 
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between a closely packed sheet of epithelial cells and a highly insoluble protein layer called 
the periostracum (covering the external surface of the shell). The nacreous layer is based on 
aragonite crystals (orthorhombic) deposited after the calcite layer so the mineralization is 
confined to the space between the cell layer and the growth front of the mineralization 
structure. [8] The crystallographic texture of aragonite is characterized by a nearly perfect c-
axis alignment normal to the plane of the tiles. As in the prismatic layer, nucleation of arag-
onite tiles involves the induction of a single crystal in each nucleation site, with the particu-
larity that in this case the orientation of the crystal is controlled in all three-dimensions rela-
tive to the structure of the organic matrix substrate. [7] Nucleation of the aragonite crystals 
takes place at a specific site on the surface which is known to have unique calcium-binding 
properties and to be rich in sulphur, presumably in the form of sulphate. [7] 
 
 
 
Fig. II. 3.  SEM micrograph showing the fracture surface of the nacre (a) and prismatic (b) structure of mussel 
shell. 
 
The nacreous layer is a laminate, with a thickness of about 0.5 μm, consisting of 
aragonite polygonal tablets between thin sheets of organic matrix. This matrix is formed by 
a protein-polysaccharide and limits the thickness of the crystals and is structurally important 
in the mechanical design of the shell. [7, 8] It reduces the number of voids in the wall, inhib-
iting crack propagation by dissipating energy related to an expanding defect along the or-
ganic layers rather than through the inorganic crystals. The organization and composition of 
the organic matrix in nacreous system was very well described by Addadi and Weiner [7], 
and reviewed later by the same group [28]. The mineral component is formed within an 
organic matrix composed of by β-chitin, silk-like proteins, and acidic glycoproteins rich in 
aspartic acid. It was hypothesized that the beta-chitin would be organized in aligned fibrils in 
the interlamellar sheets of the organic matrix, whereas the silk would be placed within the 
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sheets. [28] Nacre is stiff (E = 60-80 GPa) while maintaining a relatively high toughness 
(JIC = 1.5 kJ/m
2, this is about 1000 times the toughness of aragonite). [29] Other mechanisms 
have been also proposed to explain the remarkable mechanical performance of nacre. A 
strength anisotropy perpendicular to the layers of 5 MPa vs. 540 MPa [21, 25, 30] and a rel-
atively small difference in tensile and compressive strength of 170 MPa vs. 230 MPa [31], 
justifies the high toughness, possibly attributed to the existence of intertile mineral bridges 
in combination to the organic “glue”. Fig. II. 4. summarizes the strength of nacre with re-
spect to various loading directions. 
 
 
 
Fig. II. 4. Compressive and ultimate tensile strengths of nacre under different loading direction. 
 
Wang et al examined the inelastic deformation of nacre, and conclude that this 
would involve interlamellae shearing [32]; moreover, these authors reported the existence 
of nano-asperities onto the aragonite tablets, which could provide resistance to interfacial 
sliding. Based on atomic force microscopy (AFM) and scanning ion conductance, Schaffer et 
al [33] suggested that mineral bridges could exist between the successive aragonite tablets, 
which were confirmed by Song et al, using TEM. [34] This particular nanostructure signifi-
cantly influences the mechanical performance of the organic matrix layers of nacre, helping 
to arrest crack propagation. [35] Moreover, it was found that the individual aragonite plate-
lets in nacre consist of the assembly of cobble-like polygonal nanosized grains (with sizes of 
about 32 nm) providing a ductile nature to such microstructures. [33] Such deformability of 
the aragonite platelets is relevant for the nacre’s fracture toughness. A more recent work 
reports in situ AFM observations of the nanogranular texture of the aragonite platelets dur-
ing mechanical deformation. [36] Under this process nanograin rotation and deformation 
occur, facilitated by the existence of the biopolymer spacing between the nanograins, which 
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will contribute to energy dissipation in nacre. The water present at the nanograin interfaces 
also contributes for the viscoelastic features in nacre. In fact, it was found that water has a 
significant positive effect on the macroscopic mechanical properties of mollusk shells. 
[37, 38] 
Other morphologies, different from the prismatic and nacreous ones can be found in 
seashells. Fig. II.5. A shows the typical crystalline arrangement in an oyster shell, where it is 
clear a non-uniform arrangement of the elongated crystals. One can find then an additional 
upper level in the hierarchical organization of the shell in a cross-lamellar like organization, 
which will have a role in crack deflection during the fracture process. Similar microstructures 
were analyzed in another seashell. [39, 40] The cross-lamellar structure is a three-
dimensional array of closely packed aragonite crystals, which are packed together tightly 
with their long axes and straight sides all aligned to form a sheet or lamella tens of microns 
wide and thick. [41] As previously mentioned in Section 2.1, this kind of morphology will 
enhance the isotropy of the macroscopic material. 
Cross-lamellar morphologies can also be detected in gastropods. The shells of a 
conch (Muricopsis sp.) and of a terrestrial snail (Helix sp.) observed in the present work ex-
hibit principally a cross-lamellar structure – see Fig. II. 5. B and C, respectively. 
 
 
 
Fig. II. 5.   Fracture surface of the cross-lamellar structure of different shells. 
(a) Oyster shell; (b) Conch shell (Muricopsis sp.); (c) and a snail shell (Helix sp.). 
 
The micro-architecture of nacre (mother of pearl) has been classically illustrated as a 
‘brick-and-mortar’ arrangement. It is clear now that hierarchical organization and other 
structural features play an important role in the amazing mechanical properties of this natu-
ral nanocomposite. The more important structural characteristics and mechanical properties 
of nacre are exposed as a base that has inspired scientists and engineers to develop biomi-
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metic strategies that could be useful in areas such as materials science, biomaterials devel-
opment and nanotechnology. [42] 
 
 
3. The importance of the interface in biogenic composites 
 
Although presenting a hierarchical organization, any biocomposite is a complete 
structural system in itself, composed by different levels that are held together by specific 
interactions between the components. Therefore, the final mechanical and functional per-
formance will be highly influence by the surface-to-surface interactions, including the inter-
actions between the organic and inorganic components. Whatever the nature of the bond-
ing between levels, adequate adhesion is required for system structural integrity. For exam-
ple, it was suggested that one of the mechanisms associated with the good toughness of 
bone is that cracks propagation is prevented by unbroken collagen fibrils that bridges the 
crack. [20] In another study the total deformation of bone was studied together with the 
local deformation of the fibrils and mineral particles, by combining in situ tensile testing 
with high brilliance synchrotron X-ray diffraction and scattering. [43] The results were con-
sistent with a hierarchical and coupled deformation mechanism starting from the nanoscale, 
where the organic matrix is relevant in the amount of strain transferred to the mineral 
platelets. This is a clear indication of the importance of the organic component, and its good 
liaison with the apatitic phase, on the mechanical performance of a mineralized tissue. The 
importance of the nano microstructure of the inorganic component in nacre for its mechan-
ical properties has been referred to in Section 2.4. The particular interactions existing be-
tween the organic and aragonitic components also play an important role in the toughness 
of nacre. The inorganic insoluble layer between the nacre tablets can be seen as an adhesive 
that holds the tablets together. Smith et al used AFM to perform force-extension experi-
ments in single-molecules of the organic material that was exposed on a freshly cleaved 
nacre surface. [44] The curves obtained did not exhibited a smooth and continuous shape as 
usually found in soft materials; instead, the individual fibers elongate in a stepwise manner, 
producing a series of saw tooth jumps, as folded domains or loops are pulled open. Such 
“sacrificial” (either intra- or interchain) bonds existing within the structure of the organic 
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molecules are believed to be in the origin of such peculiar behavior found on the nano-
mechanical features of such macromolecules and will provide high energy of break. 
The same kind of sacrificial bond and hidden length mechanism contributes to the 
mechanical properties of the bone composite. [45] In this case it was suggested that bone 
consists of mineralized collagen fibrils that are glued together by a non-fibrillar organic ma-
trix. AFM measurements were also performed to get nano-mechanics information, where 
two pieces of bone are put in contact in solution, one on the AFM cantilever and one as a 
sample; the pieces were pressed together and pulled apart during which the forces were 
measured. It was seen that when the glue between the two pieces is stretched, energy is 
dissipated through rupturing of sacrificial bonds and the stretching of hidden length. This 
mechanism will contribute to the toughness of bone by increasing the amount of energy 
necessary for a crack to propagate. It was also suggested that specific interactions between 
the collagen-rich organic matrix and the ceramic nanoparticles could be on the origin of the 
minimum in the loss factor observed at 37 °C when on perform viscoelastic measurements 
as a function of temperature. [4] Such finding could be assigned to the fact that the molecu-
lar motions associated to damping may damage the bone structure. The minimization of 
damping at meaningfully temperatures and frequencies may then reduce this harmful pro-
cess. 
 
 
4. Biomimetic calcium phosphate coatings in the biomedical area 
 
One of the most important applications that can arise from the study of 
biomineralization is in the treatment of medical pathologies or injuries in calcified tissues. In 
orthopedic applications the surface properties of implants play a fundamental role for the 
fixation to the bone tissue, in order to assure their long term function. However, artificial 
materials implanted into bone defects are usually encapsulated by a fibrous tissue, isolating 
it to the surrounding bone and thus compromising their use in bone repair. This tendency 
has been overcome by using or coating the implant with bioactive ceramics or glasses that 
spontaneously integrate with bone in vivo. [41] Among these materials, Bioglass®, BG, in the 
Na2O–CaO–SiO2–P2O5 system, was found to exhibit excellent bone bonding capability and 
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has been used clinically since 1985. [46] Upon implantation, bioactive ceramics and glasses 
produce a layer of apatite at the interface with bone, consisting of nanocrystals of car-
bonate-ion-containing apatite that has a defective structure and low crystallinity (see [41] 
and references cited therein). Much work has been developed to enhance the bioactivity of 
materials. They may involve procedures such as the introduction of bioactive particles of 
ceramics or glasses into the polymer (bioactive composites) or over its surface, or by chemi-
cally modifying the surface of the polymeric material, with groups that enhance the nuclea-
tion and growth of apatite. The so-called biomimetic preparation of calcium phosphate 
coatings on implant materials has emerged as a new concept and several methodologies 
have been proposed, especially implemented in polymeric-based systems, as it can be car-
ried out at low temperatures. [47, 48] 
An essential question is to assess the bioactive performance of materials in vitro. It 
was proposed that the formation of bone-like apatite in vivo could be reproduced in a simu-
lated body fluid (SBF) with ion concentrations nearly equal to those of human blood plasma. 
Therefore, in vivo bone bioactivity of a material can be predicted from the apatite formation 
on its surface upon immersion in SBF. [49, 50, 51] 
An example is given in Fig. II.6. where one can see the formation of a calcium phos-
phate layer in constructs for bone tissue engineering applications. Such kind of biodegrada-
ble porous structures can be seeded with the patient’s own cells and differentiated into os-
teoblasts; when enough tissue is formed in vitro within the material, the hybrid construct is 
implanted in the bone defect in order to promote the formation of new bone. In a particular 
study PLLA/Bioglass® were prepared by compression molding followed by salt leaching. This 
allows for the production of porous structures with smooth surfaces (see Fig. II.6.A-left). 
Upon immersion in SBF an apatite layer is formed exhibiting a typical cauliflower morpholo-
gy, which is composed by nano-sized carbonated hydroxyapatite crystals, i.e. very similar to 
the ceramic component found in bones (Fig. II.6.A-right). The combination of salt and an-
other polymeric water soluble porogen, such as poly(ethylene oxide), PEO, permits the for-
mation of pores with a textured surface due to the fingerprint left by PEO spherulites that 
are leached out during the scaffold processing [52] – see Fig. II.6.B-left. It was found that 
when Bioglass® is present in such textured scaffolds the ceramic formed upon immersion in 
SBF has a completely different nature that could lead to a different biological performance 
of the implant – see Fig. II.6.B-right [53]. This result demonstrates the relevance of surface 
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topography in the morphology of the calcium phosphate coating that is developed during 
immersion in SBF. 
 
 
 
Fig. II. 6 . SEM images of the PLLA/Bioglass® scaffold. 
(a) (left) Smooth surface of the scaffold and (right) after one day of immersion in SBF, where the 
typical cauliflower-like morphology of the apatite layer is observed. (b) (left) Rough patterned 
surface of the porous scaffold where also PEO was used as a porogen and (right) after 1 day of 
immersion in SBF, where a completely different calcium phosphate coating was formed. Data based 
on results from [53]. 
 
Calcium phosphate coatings can also be used as reservoirs for the release of relevant 
therapeutic agents. An interesting concept is the inclusion of cytokines or morphogenetic 
factors, such as BMP-2, into biomimetic calcium phosphate coatings [54], which enhance 
the performance of the scaffold. 
There is a strong interest in developing “smart” materials for a range of biomedical 
applications, which are able to respond to the trigger of different external variables, such as 
temperature, pH or ionic strength. [55] Such devices can be used in controlled drug delivery, 
cell culture substrates or sensors/actuators. In this context it would be interesting if one 
could trigger the onset of mineralization onto the surface of a biomaterial when immersed 
in SBF upon some change of an external variable, such as temperature, pH, light or salt con-
centration. For example, “smart” surfaces were produced in poly(l-lactic acid)/Bioglass® 
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composites where a temperature-responsive polymer was grafted onto the surface: the 
precipitation of bone-like apatite occurred at physiological temperature, but was prevented 
at RT. [56] Such concept was extended to pH-responsive systems, where chitosan was graft-
ed onto such composites [57]: in this case calcification occurred just at physiological pH and 
was prevented in acidic media, where the surface is more hydrophilic. Calcified responsive 
particles were also prepared where the release profile of a previously encapsulated drug 
could be dependent on both temperature and pH. [58] 
Mimicking biomineralization under microgravity was performed by Sinha et al. [59] 
The authors carried out on-board during the flight of first recoverable space capsule (SRE-1) 
launched by Indian Space Research Organization, a polymer matrix mediated synthesis of 
hydroxyapatite nanoparticles under microgravity. In contrast, of a defect free large crystal 
formation under microgravity in solution crystallization, the present study revealed an order 
of magnitude reduction in the dimensions of hydroxyapatite nanoparticles synthesized by a 
biomimetic process with respect to its 1 g counterpart. 
 
 
5. Biomimetic nacre-inspired nano/micro laminated materials and biomaterials 
 
Biomimetic strategies should not attempt to copy directly the structures or functions 
of biological composites but rather gather key concepts from these systems that can be 
somewhat adapted within a synthetic concept. Therefore, as commented by Green et al, 
biomimetic composites should be habitually less complex than their biological counterparts 
and, to date, hierarchical architectures as observed in biological composites, remain outside 
the current technologies. [60] Advances in polymer technology have permitted to produce 
hierarchical structures in plastic pieces, using, for example, semi-crystalline or liquid–
crystalline polymers. [61] 
Much effort has been made to mimic the general structure and properties of natural 
composites, especially the synthetic production of nacre-like materials. Here are presented 
the latest advances on the synthetic design and production of nacre-inspired materials, in 
particular to be used in biomedical applications. The basic structural motif in nacre is the 
assembly of oriented plate-like aragonite crystals with a ‘brick’ (CaCO3 crystals) and ‘mortar’ 
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(macromolecular component) organization. Many works recognized that such structure 
would be associated with the excellent mechanical properties of nacre, and biomimetic 
strategies have been proposed to produce new layered nanocomposites. [42] 
A simple example of nacre mimicking was the production of laminated a Si3N4/BN 
composite, using a roll compaction technique, imitating the layered microstructure found in 
nacre [62]. The fracture surface of this material exhibits clear crack deflection and the frac-
ture toughness was 28 MPa m1/2 and works of fracture more than 4000 J/m2. It would be 
much more interesting to fabricate nanolaminate structures at mild conditions, i.e. aqueous 
solutions and environmental temperatures and pressures. Moreover, it would be also im-
portant to have a good control of the organic/inorganic interface. Manne and Aksay re-
viewed some methodologies of producing nanolaminates [63], based on the use of inorganic 
particles. Four categories are addressed and discussed, namely Langmuir–Blodgett deposi-
tion, covalent self-assembly, alternating sequential adsorption and intercalation of organics 
into layered inorganic structures. Another approach proposed by Sellinger et al was based 
on a self-assembly process. [64] The process starts with a solution of silicates, coupling 
agents, surfactant, organic monomers and initiators in a water/ethanol mixture; during dip-
coating micellar structures are formed and assemble into interfacially organized liquid–
crystalline mesophases, thereby simultaneously organizing both the inorganic and organic 
precursors into the desired laminated structure. Organic polymerization, combined with 
continuous inorganic polymerization, lock-in the nanocomposite morphology through cova-
lent bonds within the organic–inorganic interface. Note that most of the approaches pre-
sented do not enable the production of thick nanocomposites with pre-defined complex 
geometries. Thick hybrid films, based on nanocomposites containing clay with layered struc-
ture were produced by Bonderer et al, exhibiting excellent stiffness and strength. [65] 
Nanostructured organic–inorganic films were produced by Tang et al, also based on the lay-
er-by-layer method, in which layers with more than 5 μm could be obtained. [66] The multi-
layered films were produce by sequential immersion of a glass slide in solutions of a 
polycation and anionic montmorillonite clay. The tensile strength of the prepared multi-
layers approached that of nacre, whereas their ultimate Young modulus was similar to that 
of lamellar bone. In another work the layer-by-layer technique was combined with chemical 
bath deposition to prepare TiO2/organic polymer multilayered films with a nacre-like archi-
tecture. [67] Osteoconductive glass–ceramic nanoparticles were produced by a sol–gel 
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methodology and showed to be bioactive when combined with polymers. [68, 69] Layer-by-
layer nanostructured hybrid coatings were also obtained by the sequential deposition of a 
substrate in a suspension of such bioactive glass–ceramic nanoparticles (exhibiting a nega-
tively charged surface) and a solution of a positively charged polymer (chitosan) [70] – see 
Fig. II.7. Such biodegradable coatings were found to promote the deposition of apatite upon 
immersion in SBF (Fig. II.7) and are believed to have potential to be used in a series of or-
thopedic applications. 
 
 
 
Fig. II. 7. Layer-by-layer with BG-NPs and Chitosan. 
Bioactive nanoparticles (AFM image in a) were used to produce multilayered coatings (b) by alternate 
dipping a substrate in a chitosan solution, water and nanoparticles suspension (c). Upon immersion in 
SBF an apatite layer could be detected onto the surface (d). Data based on results from [70]. 
 
During the formation of sea ice the solutes present in sea water are expelled from 
the forming ice and entrapped within channels between the ice crystals; such principle was 
applied by Deville et al to ceramic particles dispersed in water to build nacre-like architec-
tures. [71] First, layered materials are prepared through a freeze-casting method; the po-
rous scaffolds are then filled with a second phase, e.g., an organic component, in order to 
produce a dense composite. Such simple methods should allow the production of layered 
composites with complex shapes and very interesting mechanical properties. 
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We refereed before to the fact that the formation of nacre involves the use of organ-
ic macromolecules as templates for the nucleation of the minerals and the control of the 
final material’s shape. It was shown that a nacre-mimetic architecture could be synthetically 
reproduced through an appropriate combination of inorganic crystals and organic polymers 
[72, 73]. The specific interactions existing between the two components during crystalliza-
tion of K2SO4 in the presence of poly(acrylic acid) generate the nanoscopic architecture 
(20 nm diameter blocks), and the switching between the modes of growth explains the for-
mation of the macroscopic structure (microscopic nacre-like layered structure). [72] Similar 
experiments were carried out with CaCO3 and poly(acrylic acid), where it was seen that, as 
in real biominerals, the synthetic mineral was generated from bridged nanocrystals with 
incorporated organic polymer. [73] Such bottom-up approaches may be useful to the design 
and synthesis of biomaterials for hard tissues, such as scaffolds for bone replacement or 
regeneration. [74] 
Other bottom-up approaches are based on self-assembling. Also inspired by this 
natural material, Launey et al demonstrated that the concept of hierarchical design can be 
applied to conventional compounds such as alumina and poly(methyl methacrylate) 
(PMMA) by using ice-templated structures. With a flexible approach (that can be extended 
to other materials) they produced bulk hybrid materials with exceptional toughness that can 
be nearly 300 times higher (in energy terms) than either of their constituents. Like in nacre, 
the best synthetic materials reflect the natural concept of a hard ceramic phase providing 
for material strength, separated by a softer ‘‘lubricant” phase to relieve stresses in order to 
enhance toughness. The result is a high toughness ceramic, with strength of 200 MPa and a 
fracture toughness that is ≈300 times (in J-terms) larger than the main constituent, Al2O3, 
and exceeds values of 30 MPa m1/2 (Jc ≈ 8000 J m
−2). Future work is being directed towards 
the formation of hybrid materials with much higher inorganic contents, the manipulation of 
the properties of the soft lubricating phase and extending this concept to other material 
combinations. In particular, the authors are attempting to process ceramic scaffolds infil-
trated with higher melting point metals with the objective of developing strong and tough 
ceramic-based materials that can operate at elevated temperatures. [75] Lin et al reported a 
simple electrodeposition technology that enabled the creation of an inorganic–organic 
nanocomposites assembling gibbsite (Al(OH)3) nanoplatelets/polyvinyl alcohol in a single 
step. The oriented layered nanostructures mimic the ordered brick-and-mortar nanostruc-
  
 
Chapter II 77 
 
ture found in the nacreous layer of mollusk shells. The electrodeposited inorganic/organic 
nanocomposite films are obtained by applying direct-current electric field that enables the 
preferential alignment of gibbsite nanoplatelets and the co-deposition of non-ionic-type 
polymer between the inorganic nanosheets. The resulting self-standing nanocomposite films 
are optically transparent and flexible, even though the weight fraction of the brittle inorgan-
ic phase is higher than 80%. [76] 
Tseng et al, fabricated a nacre like ZnO structure with three levels of hierarchy by a 
biomimetic method under mild conditions where the biopolymer gelatin was used as struc-
ture directing agent. The gelatine contains many polar amino acids, as surface protecting 
agent for the polar surfaces of ZnO. They found that the ZnO–gelatin microcrystal with well-
defined hexagonal twin plate shape is built by the stacking of nanoplates. The irregularly 
edged nanoplates can adjust themselves to each other throughout the microcrystal, result-
ing in a roughly hexagonal edge. Similar to nacreous architecture, the nanoplate of ZnO was 
constructed from the oriented attachment of ZnO nanoparticles. The synthesis of the hier-
archical ZnO structure in this paper could lead to new approaches to control the crystal size, 
orientation, and spatial patterning. [77] 
Ekiz et al [78] used a novel technique called Hot-press Assisted Slip Casting (HASC) to 
produce artificial nacre-like laminar composites. This method combines hot-pressing and 
slip-casting to improve alignment and volume fraction of the reinforcement, allowing the 
production of Bulk nano-laminar composites. Alumina flakes were used as filler in an epoxy 
matrix. Flexural tests on Chevron notched specimens revealed a high work-of-fracture in the 
case of the fabricated composites reaching to 254 J/m2. Main fracture mechanism is 
debonding of flakes from the matrix. With its high volume fraction (60%) of reinforcement 
phase and high degree of flake alignment, a nacre-like microstructure was achieved with a 
relatively efficient, cost effective and simple hybrid conventional method. The authors be-
lieve that with suitable raw materials HASC can be a very promising means to fabricate bulk 
biomimetic high work of fracture nano-laminar composites that can be used in numerous 
applications, increasing volume fraction of the filler and decreasing porosity that can lead to 
maximized mechanical performance. 
Cai and Tang [79] suggested a new model of ‘‘bricks and mortar’’ based on the bio-
logical aggregation of apatite nanoparticles. An inorganic phase, amorphous calcium phos-
phate, acts as ‘‘mortar’’ to cement the crystallized ‘‘bricks’’ of nano-hydroxyapatite. Mean-
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while, biological molecules control the nano-construction. By using hydroxyapatite 
nanospheres as the building blocks, highly ordered enamel like and bone-like apatite are 
hierarchically constructed in the presence of glycine (Gly) and glutamate (Glu), respectively. 
 
 
6. Tissue engineering of mineralized structures 
 
The overall goal of tissue engineering is to create functional tissue grafts that can re-
generate or replace defective or worn out tissues and organs. [80] Tissue engineering strat-
egies combines cells, biodegradable scaffolds, and bioactive molecules to recapitulate natu-
ral processes of tissue regeneration and development. The scaffold is basically an artificially 
substrate that will support cell proliferation and differentiation while maintaining its stabil-
ity. Along the development of new tissue, the scaffold must degrade. These processed ma-
terials are viable under in vitro and in vivo conditions, allowing the integration of the scaf-
fold with the living tissues. [81] Material choices are guided by the need to restore cell sig-
naling and to match the mechanical behavior of the tissue being engineered. [82] An ideal 
scaffold needs to accomplish certain requirements to be able to stimulate the body’s repair 
mechanisms. These include having a pore network large and open enough for cells and 
blood vessels to penetrate and the ability to bond to bone. [83] In the orthopedic area, the 
ideal scaffold should promote early mineralization and support new bone formation while at 
the same time allowing for replacement by new bone. Osteoconductive scaffolds may be 
readily prepared by including bioactive ceramic or glasses within the polymeric matrix. [84] 
When studying biomineralization processes, calcium phosphates are of special im-
portance because they are the most important inorganic constituents of biological hard tis-
sues in vertebrates. They consist of the same ions as the mineral in natural bones. [85] Bio-
logically formed calcium phosphates are often nanocrystals that are precipitated under mild 
conditions. They are disposed in complicated hierarchical structures, always based in small 
blocks of nanometer size scale. Mimicking the formation of natural calcium phosphate hard 
tissues contributes significantly to the biological function of engineered materials. Many 
advances have been made in biomaterials with the rapid growth of nanotechnology, allow-
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ing the possibility of applying nano-calcium phosphates three-dimensional scaffolds in the 
repair of hard and soft skeletal tissues. [81, 86, 87]. 
Cai and Tang [79] present an interesting reflection over nano-calcium phosphates, 
showing that the capability of synthesizing and processing nano-calcium phosphates with 
controlled structures and topographies, in an attempt to simulate the basic nano-units of 
natural materials, provides the possibility of designing novel proactive bioceramics neces-
sary for enhanced repair efficacy. Specifically, nano-hydroxyapatite can be seen as an ideal 
biomaterial able to mimic the building units of biological tissues such as bone, dentin, and 
enamel being of an extreme importance in hard tissue engineering due to its good biocom-
patibility and bone/enamel integration. The various primary positive results, regarding the 
biocompatibility and biomimicity of novel nanostructured bioceramics to natural bone, mer-
it further confirmation (as a deep study of how these materials interact with cells) and also 
express a concern with the biological security of using nano particles, due to the danger of 
reaching the circulatory system by penetration into blood vessels. As bone biogenesis is 
thought to occur by templated mineralization of hard apatite crystals by an elastic protein 
scaffold, Song et al [75] attempted to recapitulate this process with synthetic biomimetic 
hydrogels (cross-linked polymethacrylamide and polymethacrylate polymers) functionalized 
to mimic the mineral nucleating proteins of bone. Strong adhesion between the organic and 
inorganic materials was achieved for hydrogels functionalized with either carboxylate or 
hydroxyl ligands. They investigated the integration of biomimetic mineral-nucleating ligands 
with calcium phosphates using a mineralization approach described elsewhere [88], discov-
ering that the morphology and crystallinity of the mineral, as well as the binding strength at 
the polymer–mineral interface, were governed by the structure and density of the 
templating ligands. These results provide a framework for generating synthetic composites 
with defined organic/inorganic interfaces similar to natural bone. 
The current challenge in bone tissue engineering is to fabricate a bioartificial bone 
graft mimicking the extracellular matrix (ECM) with effective bone mineralization, resulting 
in the regeneration of fractured or diseased bones. [89] In order to evaluate the potential of 
using nanostructured substrates for bone tissue regeneration, Prabhakaran et al [89] used 
electrospinning to prepare biocomposite polymeric nanofibers blending poly-l-lactide 
(PLLA), collagen and nano-hydroxyapatite. Osteoblasts grown on 
PLLA/collagen/hydroxyapatite nanofibrous scaffolds showed higher cell proliferation, and 
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increased ALP activity and mineralization, than the PLLA and PLLA/hydroxyapatite scaffolds. 
Hence the obtained biocomposite PLLA/collagen/hydroxyapatite nanofibers revealed to be 
promising structural scaffolds with suitable cell recognition sites, biocompatibility, 
osteoconductivity and sufficient mechanical strength for bone tissue engineering. Also 
based on this principle, nano-hydroxyapatite/collagen based composites, inspired from re-
search on natural bone, have received great attention. The composites are prepared by di-
rectly mixing the nano-hydroxyapatite and collagen. Nano-hydroxyapatite is produced using 
modern ceramic technologies, while collagen is purified from animal tissue as fixing agent 
for hydroxyapatite. The weak binding between hydroxyapatite and collagen make them no 
cooperation effect in vivo for bone defects repair. The collagen degrades fast, but hydroxy-
apatite ceramic remains in the original form which do not attend the remodeling progress of 
bone. Researchers have also tried to develop mimetic methods to prepare nano-
hydroxyapatite/collagen composites. One method involves the immersion in a simulated 
body fluid (SBF), used to improve the biocompatibility of conventional metal, alloy and pol-
ymer implants. Another method involves co-precipitation of collagen fibrils and nano-
hydroxyapatite spontaneously, and is a promising route for achieving the same hierarchical 
structure in synthetic materials as in bone. [90] Cui et al [90] present a review on self-
assembly of mineralized collagen composites including recent work involving biomimetic 
synthesis of new materials with the structure of mineralized collagen, focusing mainly on 
materials containing type-I collagen, with mineralization by Ca–P crystals. 
A new class of biomimetic molecules that can form gels from aqueous solutions was 
proposed by Stupp and co-workers. [91, 92]. They introduced the concept of amphiphilic 
peptide, consisting of a peptide sequence covalently bonded to a very hydrophobic segment 
that is stable and neutral in aqueous solution. By changing the pH or the electrolyte envi-
ronment (e.g., put the molecules in contact with physiological fluids) the molecules self-
assemble giving rise to a complex 3D network of nanofibers and to mechanically consistent 
gels with very high water contents, being adequate to act as a synthetic extracellular matrix 
to be used in different applications in the field of regenerative medicine. By designing the 
peptides sequences appropriately it is possible to induce the precipitation of bone-like apa-
tite onto such nanofibers [91], indicating that they could find applications in the orthopedic 
area. 
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Sol-gel derived bioactive glasses are also relevant on mineralized structures tissue 
engineering because they have a nanoporosity that can control degradation rate [87]. They 
can be foamed to produce scaffolds that mimic cancellous bone macrostructure. Bioactive 
glass foams with optimized nanoporosity are strong in compression; however, they have 
low toughness and pore strength when loaded in tension. Therefore an ideal scaffold would 
have all the properties of the glasses with enhanced toughness. This can only be achieved by 
creating new nanoscale composites. Resorbable polymers must interact with the silica 
based inorganic network at the nanoscale to maintain bioactivity and controlled resorption. 
A scaffold like this would regenerate diseased or damaged bone to its original healthy state. 
[83] 
In order to understand the complex mineralization processes involved in bone-
matrix mineralization, and adapt these strategies to the design of materials, Spoerke et al 
[93] developed an artificial, in vitro biomineralization process that utilizes a nanofiber gel as 
a substrate for biomimetic hydroxyapatite mineralization in three-dimensions. The system 
employs alkaline phosphatase (a natural enzyme secreted by osteoblasts, which liberates 
phosphates necessary for HA mineralization from organic phosphates) and a phosphory-
lated, anionic nanofiber gel matrix to template HA nanocrystals with size, shape, and crystal-
lographic orientation resembling natural bone mineral. Although the authors do not intend 
to mimic, functionally or structurally, any single bone protein, they believe that the assem-
bly of peptide amphiphile nanofibers into a scaffolding framework could lead to biomimetic 
materials to promote bone regeneration, or the synthesis of hybrid materials with 
crystallographically defined structures. Data suggested that neither a nanofiber matrix 
alone, nor calcium enrichment alone will promote the ALP-mediated template mineraliza-
tion observed in the PA gels, both spatial and temporal elements are necessary to achieve 
biomimetic mineralization in synthetic materials. 
A high degree of hierarchy, gives bone its optimal bio-physical response. The current 
inorganic scaffold production processes do not allow the generation of a biomimetic orga-
nized hierarchical structure, due to the consistent limitations in the current chemical pro-
cessing technology for biomaterials. The development of hierarchically organized bone scaf-
folds would surpass the current solutions in the synthetic bone substitutes matter. 
Some authors [94-97] were inspired by nature. Tampieri et al [94] was specifically in-
spired by natural wood templates, in the development of hierarchically structured bio-
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materials. Wood exhibits a remarkable combination of high strength, stiffness and tough-
ness at low density due to the unique hierarchical architecture of the cellular microstruc-
ture. Hence, the alternation of fiber bundles and channel-like porous areas makes wood an 
elective material to be used as a template in starting the preparation of a new bone substi-
tute characterized by a biomimetic hierarchical structure. In their work, the authors devel-
oped a new biomimetic hydroxyapatite bone scaffold having highly organized micro- and 
macro-porosity, by implementing a multi-step procedure involving chemical–physical trans-
formations of a natural wood template: pyrolysis of ligneous raw materials to produce car-
bon templates; vapor or liquid calcium infiltration to transform carbon into calcium carbide; 
oxidation process to yield calcium oxide; carbonation by hydrothermal autoclave treatments 
in controlled environment for further conversion to calcium carbonate and, finally, 
phosphatization through a hydrothermal process. This complex chemical process leads to 
the synthesis of biomimetic hydroxyapatite hierarchically organized scaffolds. Such synthe-
sized structures maintain the 3D porous morphology of the starting native wood, thus allow-
ing cell in-growth and reorganization and consequently providing the necessary space for 
vascularization due to the unidirectional oriented pore structures on the micrometer scale. 
The hierarchical architecture of the wood cellular microstructure and the hydroxyapatite 
constituting phase allow this new biomimetic material to be considered as an innovative 
charming inorganic scaffold for bone regeneration and engineering. 
 
 
7. Concluding remarks 
 
Nature offers a variety of hard materials exhibiting different hierarchical and orient-
ed structures using a limited source of minerals and organic molecules. Such systems are 
produced in a bottom-up fashion under mild and aqueous solution conditions. These mate-
rials are designed to fulfill their structural and functional requirements. The lessons taken 
from the study of the structure–properties relationships of biocomposites and the mecha-
nisms of biogenic composite formation can inspire the development of new concepts both 
for the design and the processing of man-made materials. The field of biomimetics has been 
developed faster in the last years, due to the recent developments of: (i) biology applied to 
materials science, including the use of biomaterials in tissue engineering and regenerative 
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medicine; (ii) nanoscience and nanotechnology and (iii) supramolecular chemistry. Such 
tools will enable the translation the enormous amount of work that has been accumulated 
from the observation of nature, namely the structure–properties/functions relationships 
found in natural nanocomposites, into useful devices. 
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Abstract 
 
The aim of this chapter is to present, in a more comprehensive manner, the details 
concerning both the materials and techniques used throughout the thesis to complement 
the information given in each chapter.  
The materials studied in this thesis were chitosan and bioactive glass. Different 
methodologies were approached to process the referred materials, resulting in distinct ex-
perimental procedures that required different characterization techniques. 
Keeping in mind that the ultimate purpose of doing research on the BTE is the suc-
cessful translation to clinic, it is demanding to simulate as close as possible the in vivo condi-
tions. Therefore, several tests were run in vitro to validate the future applicability of the 
developed materials in vivo. 
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1. Materials and processing 
 
1.1. Bioactive glass 
 
In opposition to some of the greatest scientific findings, bioactive glasses were not 
discovered by accident. Their discovery was the result of the pioneer investigation of several 
researchers, such as Larry Hench and colleagues who worked, between 1969 and 1971, to-
wards the concretization of one apparently complex task: To develop a material that would 
not be rejected upon implantation in the human body. [1] This goal was achieved when they 
developed what is nowadays termed Bioglass®. This melt-obtained glass, comprising 45% of 
SiO2, 24.5% of Na2O, 24.5% of CaO and 6% of P2O5, known as 45S5, was successfully bonded 
to bone in in vivo tests. A series of further studies regarding a deeper understanding of the 
biological and chemical phenomena behind the bonding mechanism between bone and 
Bioglass® followed. Several clinical applications were also developed in the meanwhile 
based on its potential for bone regeneration. [1] 
Despite the promising beginning of Bioglass®, a few limitations, inherent to the bio-
active glass properties, prevent this material to be widespread in actual clinical use. Some 
comprehensive examples of the reasons behind these drawbacks follow. 
45S5 Bioglass® monolithic devices were successfully implanted for replacing hearing 
related bones [2], tooth roots [3] and orbital floors [4]. The results were quite impressing 
and the implants were able to restore the previous damaged functions. Nevertheless, as in 
each case the implant had to be custom designed for each patient, the commercial viability 
was compromised, because pre-set sizes could not be adapted in situ, since the surgeons 
were not able to cut or remodel the material.  
Another pointed out disadvantage of 45S5 Bioglass® and bioactive glasses of similar 
composition is the fact that they cannot be designed into amorphous bioactive glass scaf-
folds because they crystallize during sintering. Therefore, commercially, other bioceramics 
are preferred. [5] Regarding bioactive glass coatings used to improve metallic implants, they 
are also not the first commercial choice when the composition is very bioactive, because 
quick degradation times will compromise the stability of the implant in the long term. [5] 
Moreover, bioactive glass particulates compositions with actual regulatory approval for 
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bone synthetic materials are also not suitable for being processed as fibers, scaffolds or 
coatings. [5] 
Concerning the described drawbacks, it is comprehensible that the commercial use 
of the bioactive glass is mostly restricted to the dental area, where they are usually used as 
granules. [5] 
In the meanwhile researchers have found several solutions to overcome this prob-
lem; however, the new developments on bioactive glasses did not reach clinical trials yet. 
[5] 
One of the most fundamental changes in producing bioactive glasses was the use of 
sol-gel procedures instead of melt-quench. Although all the commercially available bioactive 
glasses are produced by traditional melt-quenching, [5] sol-gel route offers a considerable 
number of advantages when processing this material [6-8]:  The processing temperatures 
are much lower than the traditional ones; A wider range of bioactive compositions allows 
for a better response to specific clinical applications; Easier control of the final form (pow-
ders, monoliths, nanoparticles, gels…); High purity of the products; High specific area; High 
osteoconductive properties; Higher degradability. 
Nevertheless, because melting is a low cost procedure and not as time consuming as 
sol-gel route, it will continue to dominate the commercial production of bioactive glass. [7] 
Bioactive glasses obtained by the sol-gel method, do not need to include Na2O in 
their composition, since the role of this component is related to final material processing, 
namely the lowering of the melting-point.  
The structure of bioactive glasses is based on an amorphous network having SiO4
4- 
tetrahedrons as basic unit. Normally, these tetrahedrons are linked together by oxygen ions 
located at their corners. In amorphous silica based networks, the existence of non-bridging 
oxygen ions balanced by ions such as Na+, K+, Ca2+ (called network modifiers) prevent the 
regular arrangement that is attributed to crystalline silica. The level of bioactivity of a glass 
may be related to the mean number of non-bridging oxygen ions in the silica tetrahedron, 
since it will dictate the instability of the network when in contact with an aqueous solution, 
defining thereby its reactivity and solubility. [9]  
In order to be considered bioactive, the number of non-bridging oxygen ions per tet-
rahedron must be greater than 2.6, where 0 non-bridging oxygen correspond to a crystalline 
silica network or quartz glass and 4 non-bridging oxygen are attributed to dissolve SiO4
4- ion. 
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[10] Figure III.1. depicts the evolution of silica tetrahedral network towards the formation of 
a particle during sol-gel synthesis. [9] 
 
 
 
Fig. III. 1. Reactions occurring during the sol-gel process: formation of silica tetrahedra and nanoparticles at RT. 
Network modifiers are not represented for simplification purposes. Reproduced with permission 
from [5].  
 
The proper chemical characterization of the produced bioactive glasses is very im-
portant, since variations in the oxide compositions will influence the chemical properties 
that control the bonding to the host tissues. [11] Characterization techniques applied to the 
study of the BG-NPs are presented in section 3 of the present chapter. 
 
 
1.1.1. BG-NPs production 
 
BG-NPs were prepared in different conditions and compositions throughout the ex-
periments carried out in the research work herein reported. In Chapter IV, the influence of 
the reaction pH value (9 or 11.5) as well as the temperature of calcination (0 or 700°C), were 
evaluated regarding both a binary (SiO2:CaO (mol.%) = 70:30) and a ternary system 
(SiO2:CaO:P2O5 (mol.%) = 55:40:5). In chapter V the structural evolution of the same BG-NPs 
systems were studied in detail within the sol-gel reaction system. Also the influence of dif-
ferent molecular weight PEG was investigated for the ternary system developed at pH 11.5 
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and calcinated at 700°C. Chapter VI studied both the bioactivity and osteoblastic response of 
chitosan-based nanocomposites comprising BG-NPs from the ternary (SiO2:CaO:P2O5 
(mol.%) = 55:40:5) and quaternary compositions (SiO2:CaO:P2O5:MgO (mol.%) = 64:26:5:5). 
They were both produced at pH 11.5 and calcinated at 700°C. In Chapter VII, BG-NPs from 
the ternary composition SiO2:CaO:P2O5 (mol.%) = 55:40:5 and also produced at pH 11.5 and 
calcinated at 700°C were printed on the surface of chitosan membranes in order to produce 
micro-scale bioactive features over such films. BG-NPs-based macrospheres from Chapter 
VIII were developed with a binary composition of SiO2:CaO (mol.%) = 35:65. Table III.1. 
summarizes all the conditions and compositions of BG-NPs produced during this PhD. 
 
 
Table III.  1. BG-NPs compositions prepared in this work. 
 
 Conditions Composition (% mol) 
Chapter pH T (°C) PEG (g/mol) SiO2 CaO P2O5 MgO 
IV 
9 
0 
20000 
70 30 - - 
55 40 5 - 
700 
70 30 - - 
55 40 5 - 
11.5 
0 
70 30 - - 
55 40 5 - 
700 
70 30 - - 
55 40 5 - 
V 
9 
0 
20 000 
70 30 - - 
55 40 5 - 
700 
70 30 - - 
55 40 5 - 
11.5 
0 
70 30 - - 
55 40 5 - 
700 
20 000 70 30 - - 
0; 1500; 8000;  
10 000; 20 000. 
55 40 5 - 
VI 11.5 700 20 000 
55 40 5 - 
64 26 5 5 
VII 11.5 700 20 000 55 40 5 - 
VIII 11.5 700 - 35 65 - - 
 
 
The general procedure for obtaining the BG-NPs through sol-gel route is herein de-
scribed as follows:  In a washed beaker (300 mL) equipped with a magnetic stirrer, the ade-
quate proportion of calcium nitrate was dissolved in distilled water at RT. TEOS together 
with ethanol were added to the above that solution. The pH value of the resultant solution 
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was adjusted to 2 with citric acid (10%) under stirring.  The reaction mixture was kept stir-
ring for 3h to obtain solution A.  
In the case of the binary system, 1500 mL of distilled water were poured in 2000 mL 
beaker and under stirring the pH value was adjusted to 11.5 with ammonia water to obtain 
solution B. For the ternary and quaternary systems, (NH4)2HPO4 was added to this solution, 
and for the quaternary system, also Mg(NO3)2.6H2O was included in solution B. Solution A 
was then slowly added drop-by-drop to solution B (1 drop/sec), through a separating funnel. 
During this step, pH value of solution B was kept around pH value of 9 or 11.5, according to 
the experimental conditions, by continuous supplement of ammonia water. After all the 
solution A content was added to solution B, this reaction mixture was kept stirring for 48 
hours. The reaction system was kept still for 24h.  After this gelation period, the supernatant 
was poured away and the precipitate was washed 3 times with 500 mL of distilled water. 
200 mL distilled water were added to the white precipitation slurry, and then 2 g PEG was 
dissolved in this suspension with stirring. This suspension was kept still overnight, and then 
the supernatant was discarded and the precipitation slurry was moved to a plastic box that 
was frozen at -80°C. Freeze-drying followed for 7-10 days. The white powder obtained was 
calcinated at 700°C for 3h-5h. Figure III.2. presents a diagram comprising the experiment 
steps necessary for obtaining the BG-NPs through sol-gel route. 
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Fig. III. 2.  Experimental steps to obtain the BG-NPs through sol-gel procedure. 
 
 
1.2. Chitosan 
 
Chitin is a highly insoluble natural polysaccharide found in the outer structures of 
crustaceans, insects and also on the cell walls of algae and fungi. The product of its N-
deacetylation is chitosan, although the degree of deacetylation defining both is still not 
clear. [12, 13] The result is a linear polysaccharide, composed of glucosamine and N-acetyl 
glucosamine linked in a β(1–4) manner. [13] 
The molecular weight of chitosan may vary from 300 to over 1000 kD according to its 
source and preparation conditions. The degree of deacetylation may also range from 30% to 
95%. Crystalline chitosan is insoluble in aqueous solutions with pH value above 7. Its solubil-
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ity may be facilitated in acidic mediums (pH<6.0), since the free amino groups on glucosa-
mine become protonated. [13, 14] See figure III.3. 
 
 
Fig. III. 3. Representation of the pH dependent protonation/deprotonation of the chitosan molecule. 
Adapted from [15]. 
 
Chitosan is a good candidate for biomaterial, because it has excellent properties such 
as biocompatibility, biodegradability, non-toxicity, adsorption properties. [12] When im-
planted in the body, it evokes a minimal foreign body reaction, with little or no fibrous en-
capsulation while stimulating the integration of the implanted material by the host. [16, 17] 
Nevertheless, some of its properties deserve some concern in order to achieve the best 
physiological results. For instances, chitosan’s degree of acetylation influences inversely its 
degradation rate and on the other hand is directly correlated to cell attachment. [13, 18] 
Chitosan is primarily degraded through a hydrolysis mechanism resulting from the lysozyme 
action. [13] 
From the processing point of view, chitosan is moldable in a wide range of forms 
such as membranes, fibers, blocks, granules and nanoparticles. Its porosity is also easily con-
trolled by simple techniques as freeze-casting. [13] 
Chitosan has a cationic nature that has been associated to important electrostatic in-
teractions with negatively charged molecules, namely with anionic GAGs. Since a large 
number of cytokines/growth factors are linked to GAGs (mostly with heparin and heparan 
sulphate), chitosan may useful in retaining and concentrate growth factors secreted by col-
onizing cells. [14]  
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1.2.1. Chitosan processing 
 
1.2.1.1. Chitosan purification 
 
Prior to any use, commercial chitosan of medium molecular weight was purified. In-
soluble contaminants particles were removed by dispersing chitosan in distilled water and 
then solubilizing it by adding acetic acid to a concentration of 1% (w/v) chitosan in 1% (v/v) 
acetic acid. Filtering of the solution was performed first with a nylon filter followed by two 
filtrations with paper filter. 
After filtering, chitosan was precipitated from the solution by titration with 2M 
NaOH until pH value of 8 was reached. The chitosan flakes were then washed with distilled 
water until pH value of 7 was reached and dehydrated with water/ethanol solutions with 
percentages of 80/20, 50/50 and 10/90. Finally, the chitosan flakes were frozen, freeze-
dried and triturated till a fine powder was obtained.  
 
1.2.1.2. Solvent casting of chitosan membranes  
 
Chitosan membranes were produced by a casting solvent evaporation technique. In 
the case of the BG-NPs/chitosan composites, the membranes were obtained dissolving chi-
tosan (0.7 % w/v) and BG-NPs (0.3 % w/v) in 2 % v/v acetic acid. The control membranes 
contain 1 % w/v of chitosan. 80 mL of the polymeric solution was poured on a square Petri 
dish and left to dry at RT. After evaporation for several days, the membranes were neutral-
ized in NaOH 0.1 M, and left to dry. Figure III.4. illustrates the steps of casting, drying after 
neutralization and final cut with a 1.5 cm diameter punch. 
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Fig. III. 4 Preparation of the chitosan membranes. 
(a) Casting of the membrane in the squared Petri-dish; (b) Dried membrane after casting; (c) Drying of 
the  chitosan membrane in a frame after proper neutralization; (d) Final cut of the membranes with a 
diameter of 1.5 cm. 
 
In order to assure proper reproducibility of the results, the same surface area of the 
samples was used, for both cell seeding and mineralization tests in Chapters IV, VI and VII. 
When working with chitosan membranes in wet conditions one common problem, especial-
ly when the chitosan membranes have small dimensions as was the case of the samples 
used in this work is the rolling of the membrane over itself, preventing the homogenous 
wetting of the surface targeted to the study. To avoid this, the circular membranes were 
clipped in eppendorf tops - See figure III.5. - which besides being easily sterilized and inert, 
facilitated the handling of the samples in each step of the experiments and also assured that 
the same surface area was in contact either with the cells or with the SBF. 
 
 
 
Fig. III. 5. Eppendorf frame used to handle the samples during the biological and mineralization assays. 
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2. Specific processing techniques 
 
2.1. Microcontact printing 
 
2.1.1. PDMS stamps production 
 
In Chapter VII, a microcontact printing (μCP) technique allowed the production of 
BG-NPs micropatterns on chitosan. µCP is a soft lithography technique that uses the relief 
pattern on a PDMS stamp to form patterns on the surfaces of substrates by contact. [19] 
PDMS polymer was chosen to produce the stamps since it has enough rigidity to 
support the topographic microstructure and also the required flexibility to adapt to the sub-
strate and revert back to its original shape. Moreover, it is non-toxic and do not swell in the 
presence of water or ethanol. [20-24] 
The master used to emboss the PDMS stamp was obtained by photolithography us-
ing SU-8 photolack. [25] In photolithography, a photoresist layer is spin-coated on a silicon 
wafer. Then a mask is placed in contact with the layer of the photoresist that will be illumi-
nated with ultraviolet (UV) light through the mask. An organic solvent is used to dissolve and 
remove photoresist that is not crosslinked. After obtaining the patterned master, the PDMS 
stamp was prepared by casting a 10:1 mixture of Sylgard 184 (Dow Corning) prepolymer and 
cross-linker. The mixture was poured over the master and cured at 90 °C for 3 h in a vacuum 
oven. After cooling, the PDMS was peeled off from the lithographic template and cut to 
suitable sizes. Fig. III.6. summarizes the process. 
 
 
 
Fig. III. 6. Steps for the production of (a) The master and the (b) PDMS stamp. Adapted from [26]. 
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The initial master contained three different patterned regions that were transferred 
to the PDMS stamp. The geometries were 50 μm diameter cylindrical pillars arranged in a 
square pattern with 50 μm spacing, 50 μm diameter cylindrical pillars arranged in a hexago-
nal pattern with 40 μm spacing, and ellipsoidal pillars (50 μm long axes and 30 μm short 
axes) arranged in a hexagonal pattern with 40 μm spacing. Each field was an 8 mm2 square. 
The height of the final PDMS was controlled by the thickness of the layer of photoresist that 
was spread on the surface of the wafer. On the other hand, the mask controlled the shape 
and lateral dimensions. [27] 
The aim of this experiment was to use a self-assembly or “stick-and-place” approach 
to retrieve BG-NPs from a donor substrate (glass slide) onto a PDMS stamp by van der Walls 
interaction. In a following step, the nanoparticles should be printed onto the receiving sub-
strate, the chitosan membrane. 
Regarding the preparation of the BG-NPs pad, a 549 μL amount of BG-NPs dispersion 
with different nanoparticles concentrations in ethanol (between 0.003% and 0.05%) was 
poured on the surface of a glass slide (9° inclination) in a small area of 1 cm × 1.5 cm limited 
with a hollow rectangular piece fixed to the glass slide with dental wax. The dispersion was 
left to evaporate for 48 h inside a chamber saturated with ethanol. Pictures related to the 
production of the BG-NPs pad can be seen on figure III.7. 
 
 
 
Fig. III. 7. Homogenous BG-NPs pad. 
 
A special device was developed to facilitate the µCP process on the chitosan mem-
branes. It was composed by two main axes. One of the axes was fixed to the base of the 
device and its function was to guide a central piece that established the connection be-
tween the fixed axe and the movable axe where the weights were applied. The fixed axe 
provided stability during the printing process. Recurring to two screws located at the central 
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piece, the printing axe position could be fixed or moved. Different weights (50g, 100g, 
150g), having a hole in the middle, were easily fit in the movable axe where the PDMS 
stamp could be glued at its bottom with a double-sided adhesive tape. 
The lift-off was made by pressing the PDMS stamp against the dried membrane of 
BG-NPs that remained in the glass slide (donor substrate) for 10 min at 7 kPa and RT. Before 
the “printing” step, the chitosan membrane was treated with a drop of acetic acid (0.1 M) 
spread on its surface with a brush. μCP of the nanoparticles was achieved by pressing the 
BG-NPs-loaded stamp on the chitosan membrane for 30 s under 30 kPa at RT. After remov-
ing the PDMS, the membrane was washed with ethanol and dried in a vacuum oven for 2 h 
at 40 °C followed by 24 h at 10–2 bar. Figure III.8. summarizes the steps involved in the µCP 
technique. 
 
 
Fig. III. 8.  Procedure for obtaining the µCP printed membranes.  
(a) Preparation of the BG-NPs pad in the evaporation chamber. (b) Inking of the PDMS stamp in the 
BG-NPs pad; (c) Wetting of the chitosan membrane with acetic acid; (d) and (e) Pressing of the 
PDMS stamp in the chitosan membrane’s surface and printing of BG-NPs. (f) Drying in the vacuum 
oven at 40°C. 
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2.2. Production of BG-NPs macrospheres on superhydrophobic surfaces 
 
Superhydrophobic surfaces combined with controlled evaporation were successfully 
used in chapter VIII to produce BG-NPs-based macrospheres. The rational behind this exper-
iment was the fact that, on superhydrophobic surfaces, the contact angle of a water droplet 
is so high that a BG-NPs suspension droplet is able to maintain a spherical shape while 
evaporating. EISA occurred during this process, resulting in BG-NPs-based macrospheres 
with ordered nanoparticles domains. 
To prepare artificial superhydrophobic surfaces some techniques are used, namely 
the generation of rough surfaces coated with low surface energy molecules, roughening the 
surface of hydrophobic materials, and creation of well-ordered structures using microm-
achining and etching methods. [28] 
The superhydrophobic surfaces were prepared through a chemical-based deposition 
procedure using commercial plates of copper (Cu). [29] The Cu substrate was immersed in 
distilled-water and the pH was adjusted to 9-10 with ammonium hydroxide. After 5 days at 
4 °C the surfaces were collected, washed with distilled-water and left to dry on air. Finally, 
the Cu plates were immersed in a 1H, 1H, 2H, 2H - perfluorodecyltriethoxysilane (PFDTS) 
solution (1% v/v in ethanol) during at least 24 h and then dried in air.   
 
 
3. Morphological characterization 
 
3.1. Fluorescence microscopy 
 
Fluorescence microscopy was used in Chapter VII and VIII were different samples 
were observed under a standard inverted-light microscope.  
In Chapter VII, the obtained cell patterns were studied by this technique in order to 
gather visual information concerning the living cells. Calcein acetoxymethyl esther (calcein-
AM) was chosen as a fluorescent cell viability marker. [30] By itself, calcein-AM is not fluo-
rescent. However, after crossing living cell’s membrane, an enzyme will remove the AM por-
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tion. Within the cell, the calcein will bind to its calcium content, emitting thereby a green 
fluorescence under UV light. 
In Chapter VIII, calcein-AM was also used to test the homogeneity and distribution of 
an additive in the BG-NPs macrospheres. In this case, no enzymatic reaction was involved to 
turn the calcein-AM in a fluorescent compose, since no cells were present. The staining was 
possible because a fluorescent complex between the calcium comprised in the BG-NPs and 
calcein occur at a strongly alkaline pH, as is the case of BG-NPs suspensions. [31, 32] 
In both cases, staining was obtaining by addition of 2 mg of calcein-AM per mL of cell 
medium or BG-NPs suspension. After 10 min of incubation period, fluorescent images were 
obtained with the corresponding filters under an inverted microscope (Imager-Z1M).  
 
 
3.2. Scanning electron microscopy  
 
Due to the fact that almost all the samples analyzed in this work exhibited nanoscale 
phases, it was necessary to use scanning electron microscopy (SEM) to perform a morpho-
logical evaluation. SEM micrographs can be found in all chapters of part 4. 
For imaging the samples, the scanning electron microscope uses secondary electrons 
for showing morphology and topography of the samples surfaces and backscattered elec-
trons to achieve phase discrimination. 
A NanoSEM-FEI Nova 200 (FEG/SEM) scanning electron microscope was used. It was 
necessary to sputter coat the samples with a thin gold layer, because the observed sub-
strates were not naturally conductive, minimizing thereby charge accumulation.  The sput-
tered conductive gold coating had between 10-20 nm in thickness. 
An accelerating voltage of 15 kV was used to obtain the micrographs at different 
magnifications.  
 
 
3.3. Scanning - Transmission electron microscopy 
 
Scanning - Transmission electron microscopy (S-TEM) was used in Chapter V to fol-
low the formation of the particles. While SEM retrieves 3D micrographs of the samples sur-
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face, with S-TEM it is possible to obtain 2D structural images that allow one to distinguish 
hollow or dense structures. 
S-TEM combines the principles of transmission electron microscopy and SEM pre-
senting an improved spatial resolution. S-TEM was performed in the NanoSEM-FEI Nova 200 
(FEG/SEM) scanning electron microscope. 
In general, S-TEM requires sectioning of samples in very thin cuts. In the case of the 
BG-NPs observation, due to their reduced size, no further processing was necessary besides 
the particles dispersion in propanol by ultrasonic bath for 15 min and then transfer to a thin 
carbon ﬁlm supported on TEM copper grids. 
 
 
4. Chemical Characterization  
 
4.1. Energy dispersive x-ray spectroscopy 
 
SEM images are obtained by backscattered electrons. The atomic characteristics of 
each element will influence the final contrast on the image. By recurring to Energy Disper-
sive x-ray Spectroscopy (EDS or EDX) it is possible to identify those elements and also their 
relative proportions.  
The data resulting from the EDX analysis are based on an X-ray spectrum obtained 
from a scan area of the SEM. A typical graph depicts on the Y-axis, the counts received by 
the detector, and on the X-axis it is represented the respective energy level of those counts.  
EDX was used in chapter IV and V for characterization of the particles composition. 
At% was reported. In chapter VI, VII and VIII, EDX analysis were targeted for bioactivity 
characterization, since, with this technique, one can easily obtain the Ca/P ratio from the 
apatitic layer formed.  
A Pegasus X4M instrument was used to perform the EDX experiments at low vacuum 
and without any coating. The measures were preformed at least in three different areas of 
each sample. 
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4.2. Zeta potential and particles size 
 
In the hereby reported work, a Malvern Zetasizer device, model Nano ZS, was used 
to measure the Zeta potential of particles in a liquid medium. Their size was also measured.  
Particle size measurements were performed in Chapter V. In solution, particles pre-
sent a random movement due to the action of the molecules that surround them. The parti-
cles size is obtained by measuring this movement, called the Brownian motion of the parti-
cles, by a Dynamic Light Scattering (DLS) and establishing a relation with theoretical con-
cepts based on the possible speed of movements associated with each particle size. 
The zeta potential was measured to obtain information about the particles stability. 
In Chapter V, the zeta potential of both the binary and ternary systems was analyzed 
throughout the particles evolution regarding the sol-gel route. In Chapter VI, both the BG-
NPs (from ternary and quaternary compositions) and the chitosan zeta potential were ana-
lyzed. 
The zeta potential concept may be explained as follows: A particle in solution has an 
inherent electric charge and is thereby surrounded by a layer of oppositely charged and 
strongly bound ions that is called Stern layer.  The Stern layer by its turn is neighbored by a 
diffuse layer of ions of different polarities. Within this diffuse layer there is a hypothetical 
location about 2 nm from the surface of the particle inside which the ions act as a single 
entity, that is defined as the shear level or slip plane. The zeta potential is measured at this 
frontier, establishing the electrical potential difference between the dispersion medium and 
the stationary layer of fluid attached to the dispersed particle. Zeta potential decreases ex-
ponentially approaching to zero when increasing the distance from the particle surface.  [33-
35] These concepts are represented in figure III.9. for a more comprehensive understanding. 
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Fig. III. 9. Zeta potential and schematic of liquid layers surrounding the particle.  
Reproduced with permission from [35]. 
 
Zeta potential can be used as an indicator of the tendency of aggregation between 
similarly charged particles. A value of 30 mV (rather positive or negative) indicates particle 
stability. A zeta potential value, lower than 30 mV, indicates that the attraction forces are 
stronger than the repulsion ones, leading to the formation of aggregates. [33, 36] 
Zeta potential is calculated through theoretical models, namely the Smoluchowski 
model. [33] The Malvern Zetasizer device uses a combination of the Electrophoresis and 
Laser Doppler Velocimetry techniques to measure the zeta potential. A relation is estab-
lished between the speed of a particle movement in a liquid and the applied electrical field. 
These properties will be related to two other known constants of the sample, the viscosity 
and dielectric constant to determine the final zeta potential of the particles. 
The samples were prepared by dispersing 3 mg of sample in 5 mL of filtered ul-
trapure water. The pH of the solutions was adjusted to 7.4 to mimic the physiological condi-
tions. The particles in solution were further dispersed for 15 min in the ultrasound equip-
ment. Each sample was analyzed at 25°C after 120s of equilibration time. 3 measurements 
were preformed and the Smoluchowski model was used. 
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4.3. Fourier Transformed Infrared Spectroscopy  
 
In Fourier transform infrared spectroscopy (FTIR), infrared radiation will be applied 
to a sample. The information resulting from the radiation absorption or transmitted will give 
one details about the molecular structures present in the sample, since only specific mo-
lecular vibrations can be excited. 
In the initial stage of the work presented in this thesis, FTIR analyses were applied to 
the study of the BG-NPs composition. The analyses were performed in an IR Prestige 21 
Shimadzu spectrometer. The samples were prepared by pressing the particles with KBr into 
a small disc. The FTIR spectra were recorded from 400 to 4400 cm−1 with the resolution of 4 
cm−1. Results can be found on Chapter IV. 
 
 
4.4. X-ray diffraction  
 
X-ray diffraction (XRD) is a technique based on the observation of the scattered in-
tensity of an X-ray beam applied to a sample. It reveals detailed information about the 
chemical composition and crystallographic structure of the materials. 
X-ray diffraction characterization of the BG-NPs was performed in Chapter IV. A 
Bruker D8 Discover model was used and operated at 40 kV and 40 mA using Cu Kα radiation. 
The detector was scanned over a range of 2θ angles from 15° to 60° at a step size of 0.04° 
and dwell time of 1 s per step. 
 
 
5. Physical evaluations 
 
5.1. Contact angle 
 
The angle formed between the drop of a liquid and a solid substrate is defined as 
contact angle. Contact angle measurement gives one an indication of the affinity of a liquid 
to a solid surface. Surfaces may thereby be classified as hydrophobic if the referred angle is 
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higher than 90° or hydrophilic if the angle is lower. Contact angle is therefore useful in 
providing information related to the interactions between a surface and a liquid, namely the 
wetting ability and the surface energy. 
There are several methods to obtain a contact angle measurement based on wheth-
er the data are collected on a dynamic or static mode. 
In chapter VI of the present thesis, the wettability of the membranes was evaluated 
through the sessile drop method. In this method, an optical system captures the profile of a 
selected liquid drop on the substrate in study.  
The volume of the applied droplets of glycerol was 3 μl. The mean value was calcu-
lated from at least four individual measurements on different areas of the surfaces. An 
OCA15+ goniometer (DataPhysics, Germany) was used.  
 
 
6. In vitro Mineralization tests 
 
In the work herein reported, the testing of the bioactive character of the materials 
was exclusively performed in vitro.  
The essential requirement for establishing a bond between a biomaterial and bone is 
the formation of an apatitic layer on its surface when immersed on physiological fluids or 
simulated physiological fluids. [37] Therefore, it is widely accepted that in vivo bioactivity 
can be predicted by immersing the material to be tested in an SBF. SBF is prepared in order 
to reproduce approximately the ion concentrations found in human blood plasma. Table 
III.2. compares the ion concentrations of SBF and human blood plasma. [38] 
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Table III.  2. Comparison between ion concentrations in SBF and in human blood plasma. 
 
 
 
 
 
 
 
 
 
 
 
Using SBF as an in vitro indication of the materials’ behavior upon implantation pre-
sents several advantages over the in vivo studies. It is a good ethical practice since it avoids 
sacrifice of animals in preliminary studies. Moreover, the costs associated with this type of 
tests are reduced and the reproducibility is more reliable since it is easier to control the 
conditions than in the physiological environment. 
Whether in vivo or in vitro, Hench explained the glasses bioactivity mechanisms with 
five initial stages of inorganic reaction. [1] These stages are summarized in Fig. III.10. 
In stage I a rapid exchange of cations such as Na+ or Ca2+ occur with H+ or H3O
+ from 
solution. In the following stage, soluble silica in the form of Si(OH)4 is lost to the solution 
resulting from breakage of Si-O-Si bonds and formation of SiO-OH (silanols) at the 
glass/solution interface. In the third stage condensation and repolymerization of a SiO2-rich 
layer on the surface presenting a significant Ca and P loss. The fourth stage comprises mi-
gration of Ca2+ and PO4
3- group to the surface forming CaO-PO4
3- clusters on the top of the 
silica rich layer, followed by growth of the amorphous CaP. Finally, in stage V, Crystallization 
of the amorphous CaP occurs by incorporation of OH-, CO3
2- anions from solution to form a 
hydroxyl-carbonate apatite layer. 
 
Ion 
Ion concentrations (mM) 
Blood plasma SBF 
Na
+
 142.0 142.0 
K
+
 5.0 5.0 
Mg
2+
 1.5 1.5 
Ca
2+
 2.5 2.5 
Cl
-
 103.0 147.8 
HCO3
-
 27.0 4.2 
HPO4
2-
 1.0 1.0 
SO4
2-
 0.5 0.5 
pH 7.2-7.4 7.4 
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Fig. III. 10. Ionic exchanges at the glass/solution interface, leading to the formation of an HAp layer in vitro. 
 
In vivo, the following stages would comprise the adsorption and desorption of 
growth factors and preparation of the implant site for tissue repair by the macrophages, 
followed by attachment, proliferation and differentiation of the osteoblasts. After 6-12 days, 
in the last in vivo stage, mineralization of the matrix occurs followed by maturation of the 
encased osteocytes. [1]  
The bioactive character of the tested materials was assessed exhaustively in chapter 
IV by SEM, EDX and XRD.  In chapter VI, VII and VIII only SEM and EDX were used, since the 
formulations studied were mostly based on the results from chapter IV, which could be ex-
tended for the new developed applications. Furthermore, EDX analysis was performed in a 
quantifying mode that allowed the calculation of Ca/P ratio and later comparison with the 
HAp Ca/P ratio. 
 
 
7. Biological studies 
 
Analysis of cells metabolic activity, morphology, proliferation and activity were per-
formed with the aim of evaluating the in vitro biological performance of the developed ma-
terial. 
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7.1. The cells 
 
Prior to any in vivo assessment, it is important to run preliminary studies that will 
discard or not a certain material for biomedical applications. For this purpose, cell lines are 
frequently used. 
Cell lines are immortalized cultures of cells, able to proliferate indefinitely, being 
thereby very useful to study a number of biological responses in vitro. Such cell sources of-
fer the advantage of being more homogeneous and standardized than primary cultures. 
L929 fibrosarcoma mouse cell line (European collection of cell culture-ECACC, UK) 
was derived in March of 1948 and is suitable for toxicity testing. It was used in chapter IV 
and VII for preliminary biological response assessment to the materials therein reported, 
namely BG-NPs and BG-NPs patterned chitosan membranes. 
SaOs-2 (European collection of cell culture-ECACC, UK) is a human osteosarcoma cell 
line usually used to study bone-applications biomaterials, since it possess several 
osteoblastic features. In Chapter VI, SaOs-2 cells were seeded on the different 
nanocomposites of BG-NPs and chitosan produced.   
 
 
7.2. Preparation of the cell culture 
 
In Chapter IV an indirect assessment of the BG-NPs cytotoxicity was performed using 
L929 cells. Materials leachables were obtained by placing in a falcon tube 200 mg of BG-NPs 
per mL of culture medium. The particles were previously sterilized by autoclaving. After 24 h 
under stirring at 37 °C, the media containing the BG-NPs extracts, was filtered and applied, 
as nourishment medium, to the plates containing cells previously seeded on a multi-well 
plate and cultured at 37 °C with 5% CO2 and nourished with Dulbecco’s modified minimum 
essential medium (D-MEM) supplemented with 1% antibiotic and 10% FBS. The cultures 
were then incubated at 37 °C for one, three and seven days. The culture media was replaced 
on the third day. 
Regarding the biological tests that were ran in chapter VI and VII, the procedure had 
slight modifications. In this case, direct contact assessment was chosen since the cells could 
be efficiently seeded on the membranes surface. 
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L929 cells and SaOS-2 cells, respectively in Chapter VI and VII were cultured at 37 °C 
with 5% CO2 and nourished with Dulbecco’s modified minimum essential medium (D-MEM) 
supplemented with 1% antibiotic and 10% FBS. The medium was refreshed every three days 
until confluence, when the cells were tripsinized. In both cases, the samples were previously 
sterilized by immersion in 70% (v/v) ethanol overnight and then washed twice with sterile 
phosphate buffered saline (PBS). The cells were then seeded on the samples (n = 3) at a 
density of 65 000 cells/cm2, and then the cultures were incubated at 37 °C also for one, 
three and seven days with a culture media renewal at the third day. 
In chapter VI, for both DNA proliferation assay and for ALP activity quantification, 
samples were collected on days 1, 3 and 7 after seeding. Samples removed from culture 
were rinsed twice in PBS solution and transferred into 1.5 mL microtubes containing 1 mL of 
ultra-pure water. In order to assure cell lysis, samples were incubated for 1 h at 37 °C in a 
water bath and stored for at least 1 h in a -80 °C freezer. After thawing, samples were 
sonicated for 15 min. 
 
 
7.3.  The assays 
 
7.3.1. MTS assay 
 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium) assays were conducted in chapter IV, VI and VII. Regarding chapter IV and VII, 
the assay was applied with the purpose of obtaining an indication of the cellular toxicity. In 
chapter VI, MTS was a complement of other biological assays also performed. 
MTS assay is based on the fact that only metabolic active cells are able to reduce 
tetrazolium products. A colored formazan product will be obtained as a result of that reduc-
tion that can be correlated to the number of viable cells in culture. 
The MTS test (Promega) was done after each time point (1, 3 and 7 days of culture).  
The relative cellular viability (%) was obtained and compared with tissue culture pol-
ystyrene (positive control of cell viability). Latex was used as negative control of cellular via-
bility. For this assay, an MTS solution was prepared by using 1:5 ratio of MTS reagent and D-
MEM culture medium without phenol red or FBS, followed by a 3 h incubation period at 37 
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°C. All cytotoxicity tests were conducted by using three replicates. Finally, the optical density 
(OD) was read at 490 nm on a multiwell microplate reader (Synergy HT, Bio-Tek Instru-
ments). 
 
 
7.3.2. DNA assay  
 
To assess cell proliferation on the developed nanocomposites of Chapter VI, by dou-
ble-stranded DNA (dsDNA) content analysis, an Invitrogen/Molecular Probes PicoGreen 
dsDNA Quantification Kit was used.  
The basic principle of this assay is the measurement of the fluorescence produced 
when PicoGreen dye is excited by UV light while bounded to dsDNA.  
Triplicates were made both for samples and dsDNA standards (0-2 µg/ml), followed 
by incubation of the 96-well white plate (Costar; Becton-Dickinson) for 10 min in the dark. 
Fluorescence was read using a microplate ELISA reader (BioTek, USA) at an excitation of 485 
nm (excitation of the dye) and an emission of 528 nm (when the dye is bounded to the 
dsDNA) with bandwidth of 20 nm. DNA concentration values were obtained from a standard 
curve. 
 
 
7.3.3. ALP quantification 
 
Bone-type alkaline phosphatase (ALP), a tetrameric glycoprotein that is attached to 
the osteoblast cell membrane by a carboxy-terminal glycan-phosphatidyl-inositol anchor, is 
frequently related to bone formation and calcification, although there are still some ques-
tions regarding its relevance and specific functions in the mineralization process. [39-41] For 
instances, it is known that the enzymatic hydrolysis activity of ALP is necessary to form min-
eralized tissue. However, the anchoring of ALP to the cell membrane is not always necessary 
for mineralization, but influences the nodule formation in vitro. [39] 
When bone ALP is released from the plasma membrane by the action of a phospho-
lipase (phosphatidylinositol-specific phospholipase C), it will stay in circulation for 1-2 days 
being after that period cleared from circulation by the liver. [39, 41]  
  
 
Chapter III 118 
 
Since the increase of osteoblastic differentiation in bone tissue can be correlated 
with the increase of the released ALP activity, ALPase enzymatic activity is widely used in 
vitro as a marker of osteoblast phenotype and differentiation.  [39] 
Bessey et al [42] developed a method for rapid determination of alkaline phospha-
tase in human serum that can be extrapolated for in vitro assays. The assay is based in a 
colorless substrate, p-nitrophenyl phosphate. In the presence of ALP, a yellow salt of p-
nitrophenol is released when the phosphate group is lost, indicating thereby the phospha-
tase activity. 
ALP quantification was performed in chapter 6, because the aim of the experimental 
work thereby reported was to study the osteoblastic response upon seeding in chitosan/BG-
NPs films. 
In detail, to quantify ALP activity, each well of a 96-well plate (Costar; Becton-
Dickinson) received 20 μl of the sample to be analyzed and 60 μl substrate solution consist-
ing of 0.2% (wt v-1) p-nytrophenyl phosphate (Sigma) in a substrate buffer with 1 M 
diethanolamine HCl (Merck, Germany), pH 9.8. After an incubation period of 60 min at 37 
°C, 80 μl stop solution (2M NaOH (Panreac, Spain) plus 0.2mM EDTA (Sigma)) was added to 
each well. Standards were then prepared with p-nytrophenol (10 μM ml-1; Sigma) in order to 
achieve final concentrations in the range 0-0.3 μM ml-1. Samples and standards were pre-
pared in triplicate. Absorbance was read at 405 nm and sample concentrations were read 
from the standard graph. ALP enzymatic activity was normalized to total DNA content. 
 
 
7.3.4. SEM observations 
 
In chapter VI and VII, SEM observation of the seeded cells was carried out as a means 
to evaluate the effect of each sample on the morphology of the cells. 
After 1, 3 and 7 days of culture, the samples were rinsed twice with PBS to remove 
non-adherent or loosely adherent cells and fixed with a solution of 2.5% (v/v) 
glutaraldehyde in 0.1M PBS, for 1h at 4˚C. After removing the fixative, the cells were rinsed 
in PBS and distilled water and dehydrated in a graded series of ethanol solution (50%, 70%, 
90% and 100%) each one repeated twice for 15 min. They were left to dry at air at RT, and 
sputter-coated with gold before SEM observation.  
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8. Statistical analysis 
 
In the analysis performed in this work, 3 to 5 replicates were used for each condi-
tion; therefore, Student's t-test was chosen to run the statistical analysis, since it is suitable 
for being applied on small groups of samples independently collected.  
In Student's t-test the means of two samples are compared. It is assumed that the 
samples follow a t-distribution where   is the sample mean,   the population mean, s the 
estimator for population standard deviation, and N the set of the independent measure-
ments   . 
 
  
   
    
    
 
   
 
   
       
  
      
 
 A null hypothesis is formulated, stating that there is no significant difference be-
tween the means of the two data sets. The level of significance chosen in this work was 
α = 0.05. This means that the confidence level by which one can reject the null hypothesis is 
95%, which is a reasonable level of significance in biological studies. 
Statistical analysis was performed using Excel Software and all the data were report-
ed as a mean ± standard deviation. P-values lower than α (rejecting the null hypothesis) 
were considered statistically significant in all the analysis.   
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Brief notes on the Part 3 structure 
 
When doing research on BTE the ultimate goal is to develop bioactive structures able 
to mimic bone’s natural architecture. The herein reported work focused on three main 
points: The multiscale levels of bone’s architecture – from nano to macro scale; the need for 
a bioactive material; and the importance of the assembly of an organic and inorganic phase 
in the osseous tissue. 
The starting point of this thesis was the production and optimization of BG-NPs. The-
se materials represent the basic units for the artificial bone construction; therefore, it was 
of great importance to deeply understand the processes leading to BG-NPs formation. This 
aim was pursued in Chapter IV and V. 
Chapter VI and VII introduce chitosan as the natural polymer intended to mimic 
bone’s organic phase, represented in Nature mainly by collagen. In Chapter VI, bioactive 
nanocomposites are developed comprising chitosan and different BG-NPs compositions. The 
aim of this work was to prove how the BG-NPs composition may be easily adapted to clinical 
needs. The osteoblastic response to the developed nanocomposites is presented. Chapter 
VII, on the other hand, presents the use of a mCP technique to spatially control mineraliza-
tion, in order to assure a wider range of applications of the bioactive nanocomposites. 
Finally, Chapter VIII presents an important step on mimicking bone’s natural struc-
ture. A simple but effective approach allowed the induction of BG-NPs self-assembly into 
ordered structures, comprising the nano, micro and macrolevels.  
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PART 3 - Results 
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Preparation and characterization of bioactive glass 
nanoparticles prepared by sol-gel for biomedical ap-
plications 
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Wettable arrays onto superhydrophobic surfaces for 
bioactivity testing of inorganic nanoparticles 
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Nanoengineering of bioactive glass: From hollow to 
dense nanospheres 
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Chitosan/bioactive glass nanoparticles composites for 
biomedical applications 
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Micropatterning of bioactive glass nanoparticles on 
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Nanotectonics approach to produce hierarchically or-
ganized bioactive glass nanoparticles-based 
macrospheres 
  
  
 
Chapter IV 129 
 
Chapter IV 
 
Preparation and characterization of bioactive glass 
nanoparticles prepared by sol-gel for biomedical ap-
plications 
 
 
Abstract 
 
Bioactive glass nanoparticles (BG-NPs), based on both ternary (SiO2-CaO-P2O5) and 
binary (SiO2-CaO) systems, were prepared via an optimized sol-gel method. The pH of prep-
aration and the effect of heat treatment temperature were evaluated, as well as the effect 
of suppressing P in the bioactivity ability of the materials. The morphology and composition 
of the BG-NPs were studied using FTIR, XRD and SEM. The bioactive character of these ma-
terials was assessed in vitro by analyzing the ability for apatite formation onto the surface 
after being immersed in simulated body fluid (SBF). XRD, EDX and SEM were used to confirm 
the bioactivity of the materials. The BG-NP effect on cell metabolic activity was assessed by 
seeding L929 cells with their leachables, proving the non-cytotoxicity of the materials. Final-
ly the most bioactive BG-NPs developed (ternary system prepared at pH 11.5 and treated at 
700 °C) were successfully combined with chitosan in the production of biomimetic 
nanocomposite osteoconductive membranes that could have the potential to be used in 
guided tissue regeneration. 
 
 
 
* This chapter is based on the following publication:  
Luz, Gisela M.; Mano, João F., Preparation and characterization of bioactive glass nanopar-
ticles prepared by sol-gel for biomedical applications, Nanotechnology, 2011, 22 (49), nr: 
494014,   DOI: 10.1088/0957-4484/22/49/494014. 
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1. Introduction 
 
When bioactive glasses were discovered, they radically changed the biomaterials 
field. For the first time, a chemical bond between implants and host tissue was possible, 
leaving behind a first generation of bioinert devices. This was the beginning of a second 
generation of bioactive materials capable of inducing a cellular response at their surface. 
These materials were able to bond not only to bone, but to soft tissue as well, avoiding fi-
brous encapsulation. [1, 2] Moreover, the broad scope of the possible compositions leads to 
different chemical properties and rate of bonding with tissues, allowing more specific clini-
cal applications. [3] 
The first bioactive glass developed by Hench in 1971 was composed of SiO2, CaO, 
Na2O and P2O5 (Bioglass®). [2] The first bioactive glasses were produced by melting the re-
quired materials and casting of the bulk or quenching of powders. [2] In 1991, Li et al pro-
duced bioactive glasses by sol–gel processing. [4] Sol–gel is a wet-chemical processing 
method more appropriate to produce these glasses as an alternative to the traditional melt-
ing method, because it allows a wider range of SiO2 content and higher purity of the ob-
tained products. [5] 
The SiO2-CaO-P2O5 system is one of the most extensively studied in the field of bioac-
tive sol-gel glasses [6-9]. However, the majority of these bioactive glasses are prepared by 
direct heating of the gels, after allowing gelation to occur, which results in a hard block that 
must be ground and sieved to reach particle sizes at the microscale. Microsized particles of 
bioactive glasses are commonly used, but there are not many works exploring the ad-
vantages of using nanosized particles. 
Nanoparticles have sizes of the order of 10-100 nm in diameter and, unlike bulk ma-
terials, the biological response of these particles is highly dependent on their dimensions 
and specific surface area. [10, 11] Bioactive glass nanoparticles may have a significant func-
tion as well in the genetic control of the cellular response. Additionally, their particular 
characteristics which have anti-inflammatory and proangiogenic potential are ideal for ap-
plications like minimally invasive injectable particles for stable growth of soft tissues. [12, 
13] 
The use of particles within the nanoscale may open new possibilities in the biomedi-
cal area, including in bone repairing, based on the combination of such materials with bi-
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opolymers, as the increased surface area improves the mechanical properties of these new 
biomaterials and provides more nucleation sites for apatite, increasing their bioactive po-
tential, making this kind of composite great candidates for third-generation tissue engineer-
ing. [3, 9, 14-21, 22] 
This study aims to investigate the effects of different compositions (SiO2-CaO-P2O5 
and SiO2-CaO) and thermal treatments on the morphology and in vitro bioactivity of BGNPs. 
As is referred to in the literature, the morphology and size of the bioactive particles can be 
controlled by the rate of the hydrolysis and condensation reactions. [10] The pH was there-
fore also chosen in this work as a parameter to study its influence on the morphology and 
the size of the bioactive glass particles. 
A sol-gel method was previously combined with coprecipitation and applied in this 
work to different formulation systems in order to obtain nanosized particles. [23] The ad-
vantage of combining these materials with biopolymers is also investigated and a composite 
of chitosan and the BGNPs is developed. 
 
 
2. Experimental methods 
 
2.1. BG-NP preparation 
 
To prepare the BG-NPs a protocol based on previous works was followed. [24, 25] 
The procedure for the ternary BG-NP preparation, with the composition SiO2-CaO-P2O5 
(mol%) = 55:40:5, consisted in sequential reagent dissolutions that resulted in hydrolysis and 
polycondensation reactions. The same procedure with the necessary adaptations was fol-
lowed to obtain SiO2:CaO (mol%) = 70:30, in which no P precursor was used. Tetraethyl 
orthosilicate (TEOS, 99.90% pure) was used as the Si precursor, ammonium phosphate diba-
sic as the P precursor, calcium nitrate tetrahydrate (99%) as the Ca precursor, citric acid 
monohydrate (99-100%) to promote hydrolysis, ethanol absolute, ammonium hydroxide 
(maximum of 33% NH3) as the jellifying agent and polyethylene glycol 20 000 (PEG) as the 
surfactant were purchased from Sigma-Aldrich. In some cases the BG-NPs were sintered at 
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700 °C, according to the thermogravimetric and differential thermal analysis (TG/DTA) study 
of dried gels of a similar system performed by Ma et al. [26]  
 
 
2.2. Chitosan/BG-NPs composite preparation 
 
The membranes were obtained dissolving chitosan (0.7 % w/v) and BG-NPs (0.3 % 
w/v) in 2 % v/v acetic acid. The control membranes contain 1 % w/v of chitosan. After evap-
oration for several days, the membranes were neutralized in NaOH 0.1 M, and left to dry. 
 
 
2.3. XRD analysis 
 
X-ray diffraction measurements were performed with a Bruker D8 Discover model 
operated at 40 kV and 40 mA using Cu Kα radiation. The detector was scanned over a range 
of 2θ angles from 15° to 60° at a step size of 0.04° and dwell time of 1 s per step. 
 
 
2.4. FTIR spectroscopy analysis 
 
Fourier-transform infrared (FTIR) spectroscopy analysis was carried out in an IR Pres-
tige 21 Shimadzu spectrometer. The samples were prepared by pressing the BG-NPs with 
KBr into a small disc. The FTIR spectra were recorded from 400 to 4400 cm−1 with the resolu-
tion of 4 cm−1. Before measurements the powders were dried at 100 °C overnight to remove 
any adsorbed molecules. 
 
 
2.5. In vitro bioactivity study 
 
In vitro bioactivity tests were carried out by soaking 10 mg of bioactive glass in 15 ml 
of SBF (simulated body fluid) solution in the case of BG-NPs powders, and 1 cm2 per 50 ml of 
SBF in the case of chitosan/BG-NPs composite for zero (control), one, three, five and seven 
  
 
Chapter IV 133 
 
days at 37 °C. Upon removing from SBF, the samples were rinsed with distilled water and 
left to dry.  
The SBF was prepared by dissolving NaCl, NaHCO3, KCl, K2HPO4
.3H2O, MgCl2
.6H2O 
and Na2SO4 in distilled water and buffered with Tris buffer and HCl to reach a pH value of 
7.4, following the protocol described by Kokubo and Takadama [27]. All materials were pur-
chased from Sigma-Aldrich. 
 
 
2.6. SEM and EDX sample preparation 
 
To study the surface and the morphology of the samples, a NanoSEM-FEI Nova 200 
(FEG/SEM) scanning electron microscope was used. A conductive gold coating was applied 
to the samples. A Pegasus X4M instrument was used to perform the EDX experiments at low 
vacuum and without coating. 
 
 
2.7. Cell viability tests 
 
Cell viability and metabolic activity were determined using the MTS assay. L929 
mouse fibroblasts were seeded in a multi-well plate and nourished with Dulbecco’s modified 
minimum essential medium (D-MEM) supplemented with 10% fetal bovine serum (FBS) and 
1% antibiotic. The plates were incubated at 37 °C with 5% CO2. In the meantime, fluid ex-
tracts were obtained by placing in a falcon tube 0.2 g of sterile BG-NPs per ml of culture 
medium. After 24 h under stirring at 37 °C, the media, with different extracts from each 
sample, were filtered and applied, as the nourishment medium, to the plates containing the 
cells previously seeded. The cultures were then incubated at 37 °C for one, three and seven 
days. The culture media was replaced on the third day. The MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) test was performed to 
determine the cytotoxicity of the BGNPs. 
In this assay, the tetrazolium compound is reduced by the viable cell’s mitochondria 
into a water-soluble brown formazan product. The relative viability (%) of the cells was de-
termined by comparing the obtained results with cells grown without BG-NP extracts that 
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were used as a positive control of cell viability. Latex was considered to be a negative con-
trol of cellular viability. After each time point (one, three and seven days of culture), the 
MTS test was performed to assess the metabolic activity of the cells in contact with the BG-
NP extracts. For this assay, an MTS solution was prepared by using a 1:5 ratio of MTS rea-
gent and D-MEM culture medium (without phenol red or FBS). After removal of the fluid 
extracts and washing with PBS, 100 μl of MTS reagent was added to each sample followed 
by a 3 h incubation period at 37 °C. 
Finally, the cell supernatant of each sample was removed to another plate and their 
optical density (OD) was read at 490 nm on a microplate reader (Synergy HT, Bio-Tek In-
struments). 
The values of optical density are directly proportional to the quantity of formazan 
product and thereby to the number of living cells analyzed. All cytotoxicity tests were con-
ducted by using five replicates.  
 
 
3. Results and discussion 
 
BG-NPs were obtained by the sol–gel method. This is a very straightforward method 
to produce bioactive glasses; nevertheless, it still requires some important steps such as the 
addition of a basic catalyst to promote precipitation of the particulate gel and the reduction 
of the gelation time [28, 29], as well as a heat treatment to incorporate calcium and remove 
organic residues. [10] Therefore, besides the study of the formulation’s influence, the pH 
resulting from the addition of different amounts of NH4OH as the basic catalyst and the dif-
ferences between samples heat-treated and non-heat-treated were also analyzed. 
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3.1. Chemical composition 
 
3.1.1. X-ray diffraction (XRD) 
 
 
 
Fig. IV. 1 XRD spectra of raw and thermally treated BG-NPs produced at different pH and formulations. 
Binary pH 9 (a) 0 °C, (b) 700 °C; binary pH 11.5 (c) 0 °C, (d) 700 °C; ternary pH 9 (e) 0 °C, (f) 700 °C; 
ternary pH 11.5 (g) 0 °C, (h) 700 °C and hydroxyapatite peaks are indicated (*). 
 
 XRD patterns of the studied samples are shown in figure IV.1. As is well known, glass 
is an amorphous inorganic material with no detectable diffraction maxima. Therefore, it is 
expected that the bioactive glass diffractograms will reflect the amorphous nature of this 
material. Indeed, XRD spectra of both the binary and ternary system prepared at pH 11.5 
and after thermal treatment, respectively figures IV.1(d) and (h), exhibit a broad dispersive 
band, indicating the amorphous nature of the bioactive glass. Before being submitted to the 
thermal treatment, the diffractograms present two parasite lines (19° and 24°) reported in 
the literature as being associated with Si. [30] After the thermal treatment process, the lines 
disappear. 
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Hong et al concluded that the crystallinity of bioactive glass ceramic nanoparticles 
obtained with the same preparation conditions could increase with increasing phosphate 
content. [31] However, comparing the diffractograms in figure IV.1 of binary (with no P) and 
ternary (with 5% P) samples obtained at different pH (9 and 11.5) and temperatures (0 and 
700 °C), one can conclude that the major differences in crystallinity arise from the pH of 
preparation. The spectra do not reflect the composition of the system in terms of the pres-
ence or absence of P. However, the pH of preparation seems to be the most important fac-
tor setting the amorphous or crystalline character of the material after the thermal treat-
ment. When working at pH 9, the sintered sample spectrum from both the binary, figures 
IV.1 (a) and (b), and ternary, figures 1(e) and (f), systems reflect the existence of crystalline 
phases, as some diffraction maxima can be observed. Comparing the ternary samples after 
thermal treatment (figures IV. 1(f)—pH 9 and (h)—pH 11.5), the main difference is related 
to the crystallinity. With respect to the ternary sample prepared at pH 9, figure 1(f), the 
thermal treatment process seems to lead to the hydroxyapatite typical diffractogram. The 
main lines are typical phosphate crystal peaks showing the presence of hydroxyapatite, 
which exhibits well-defined diffraction maxima at 2θ = 25.9°, 29° , 31.8°, 32.2°, 32.9°, 34° , 
39.8°, 46.7°, 49.5°, 50.5° and 53.1°. The apatite peaks’ presence can be explained based on 
two different reasons. The first one is that, in the aqueous environment of the sol–gel pro-
cess, precipitation of hydroxyapatite can occur from the amorphous structure of silica-based 
bioactive glasses. [32] However, it could also be the case that the thermal treatment tem-
perature was excessively high and therefore passing the value of minimum stabilization 
temperature that ensures a maximum of bioactivity before the crystallization of the materi-
al. A higher crystallinity has a lower dissolution rate which has a direct detrimental effect on 
bioactivity. [10] On the other hand, the sample prepared at pH 11.5, figure IV. 1(h), presents 
an amorphous spectrum after thermal treatment very similar to the one associated with the 
commercial Bioglass®, as only the characteristic amorphous band at low angles is visible. 
Crystallization of bioactive glasses decreases the level of bioactivity and even turns a bioac-
tive glass into a bioinert material. [31] It appears to be the case of the binary samples pre-
pared at pH 9 (figures IV. 1(a) and (b)), with a considerable amount of peaks with very high 
crystallinity, as the size of the peaks can be related to their crystallinity. These samples are 
the ones exhibiting the lower bioactivity as will be confirmed further in this study. In all 
samples except for the sintered ternary powders prepared at pH 11.5, figure IV. 1(h), the 
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thermal stabilization leads to a more crystalline sample, which may happen due to the small 
size of the particles, which, having a higher specific surface area, also have higher driving 
forces for nucleation in crystals. [10] Samples of the ternary system prepared at pH 11.5, 
figures IV.1. (g) and (h), form a broad band centered at a 2θ value of 30° that corresponds to 
the wollastonite (CaSiO3) phase. Labbaf et al claim that thermal treatment temperatures 
should be the lowest value able to retain the particles in the amorphous state. As a temper-
ature of 700 °C was used, and the amorphous shape was kept, this seems to be the ideal 
stabilization temperature before reaching a wollastonite crystalline phase that would de-
crease the bioactive potential of the BG-NPs. Thermal treatment is always a necessary step 
because it is essential to incorporate calcium at approximately 450 °C, to remove the organ-
ic phase at 500 °C and to reduce silanol groups from the glass surface and nitrate by-
products from the glass network at 600 °C. [10]  
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3.1.2. FTIR measurements 
 
 
 
Fig. IV. 2 Infrared spectra of raw and thermally treated BG-NPs. 
Binary pH 9 (a) 0 °C, (b) 700 °C; binary pH 11.5 (c) 0°C, (d) 700 °C; ternary pH 9 (e) 0 °C, (f) 700 °C and 
ternary pH 11.5 (g) 0 °C, (h) 700 °C. 
 
The FTIR spectra of the produced BG-NPs are presented in figure IV.2. Silicate ab-
sorption bands are observed in all spectra, assigned to the peaks 1085, 800 and 464 cm−1, 
respectively: asymmetric stretching mode, symmetric stretching vibration and rocking vibra-
tion of Si–O–Si [26]. 
In the sintered ternary system sample prepared at pH 9, figure IV.2. (f), the heating 
treatment at 700 °C is shown by two narrow peaks at 580 and 600 cm−1, indicating a P–O 
bending vibration due to the presence of a crystalline calcium phosphate (apatite-like) 
phase [26]. These twin bands merge into a weak band in the case of amorphous glass, fig-
ures IV.2 (e), (g) and (h). 
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This is in accordance with the XRD data. Moreover, the P related peaks do not ap-
pear in the binary spectra, figures IV.2 (a) - (d), since they do not include P in their formula-
tion. In the case of ternary system samples, figures 2(e) - (h), peaks at 1045 and 1090 cm−1 
are also assigned to the P–O bond although masked by the broad silicate band. [31] At 950 
cm−1 one can confirm the Ca presence due to the peak related to Si-O-Ca bonds containing 
non-bridging oxygen [26]. The 1630 cm−1 is assigned to the OH group due to residual H2O 
absorbed in the BG-NP. [33] Bands related to the presence of the calcium precursor 
Ca(NO3)2, 1400-1300 cm
−1 (N=O bend) and 1600-1500 cm−1 (N=O stretch) disappear after 
the thermal treatment, confirming the decomposition of the nitrate Ca(NO3)2 at 700 °C, es-
pecially the vibrations of ionic (NO3)
− at 1380 cm−1. [33] These bands are more evident in the 
binary pH 9 - 0 °C, figure IV.2. (a) and tend to attenuate after thermal treatment. Also in 
figure 2(a), the 1630 cm−1 stretching vibration of the H–O bond, related to water is more 
evident. The 1340 cm−1 sharp peak could also be due to the presence of water as it is as-
signed to OH free groups. The 1460 cm−1 could be assigned to a carbonate absorption band, 
due to the carbonate existing in the lattice of the binary pH 9 BG-NPs, as a result of CO2 dis-
solution from the atmosphere during the sol–gel procedure. [34] After thermal treatment 
this band disappears. 
 
 
3.1.3. Energy dispersive x-ray (EDX) analysis.  
 
Table IV.  1. EDX quantification (at.%). 
 
 Binary Ternary 
 pH 9 pH 11.5 pH 9 pH 11.5 
%At 0˚C 700˚C 0˚C 700˚C 0˚C 700˚C 0˚C 700˚C 
Si 70.24 69.15 82.00 81.53 52.63 55.30 33.46 35.31 
P 0 0 0 0 14.62 15.01 20.40 21.87 
Ca 29.76 30.85 18 18.47 32.75 29.69 46.14 42.81 
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Through energy dispersive x-ray (EDX) analysis, it was possible to quantify the final 
ratios of the binary and ternary compositions in atomic percentage (at.%). The results are 
presented in table IV.1. The measured values present deviations regarding the initial formu-
lations. As can be observed in the table, the particles produced at pH 9 have the right origi-
nal proportions of Si and Ca in the binary case, but in the ternary system only Si is at the 
original percentage and P is three times higher, and consequently Ca is 15% below the origi-
nal percentage. 
At pH 11.5 Si is above the initial value in the binary system (and Ca below). On the 
other hand, in the ternary system, Si is almost 20% below the original set value and Ca re-
mains in the right proportion, P being four times higher. The reason for these differences 
may be the removal of free calcium ions during the washing step. Indeed, in the sol stage, 
almost 100% of Ca dissolves in the pore liquor as calcium nitrate, and it will only deposit in 
the drying step. Therefore, the final composition of bioactive glass can be changed if the 
pore liquor is washed before drying, removing the calcium that was not incorporated in the 
silica or phosphoric gel network. [10, 34] 
This fact would explain the variation in values obtained, as the experimental proce-
dure followed in this work includes a washing step, necessary to remove the ammonia from 
the precipitate. 
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3.2. Surface analysis 
 
 
 
Fig. IV. 3 SEM of raw and thermally treated BG-NPs. 
Binary pH 9 (a) 0°C, (b) 700 °C; binary pH 11.5 (c) 0 °C, (d) 700°C; ternary pH 9 (e) 0 °C, (f) 700 °C and 
ternary pH 11.5 (g) 0 °C, (h) 700 °C. 
 
Surface analysis was performed by scanning electron microscopy (SEM) observation. 
The samples were previously coated with a thin gold layer. The differences in the BG-NPs 
both in size and morphology were analyzed between the different batches of BG-NPs pro-
duced. At pH 9, figures IV. 3(a), (b) and (e), (f), the size of the particles is more heterogene-
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ous, especially in the ternary case, figures IV.3. (e) and (f), where the sizes could vary in the 
range 50–200 nm. The particles produced at pH 11.5, figures IV.3. (c), (d) and (g), (h), have 
sizes below 40 nm. 
Regarding the effect of calcination in the morphologies of the binary and ternary sys-
tems, at pH 9 particles appear to be melted and more aggregated and at pH 11.5, besides 
the aggregation, there is also a decrease in the particles size. This consequence is not evi-
dent in the ternary particles produced under the same conditions. It is known that tempera-
tures higher than 700 °C, in the ternary system, have the effect of melting and sintering the 
particles in large aggregates. [23] A shorter temperature of calcination is thought more suit-
able to apply in binary systems, in order to avoid the fusion of the particles and their densi-
fication due to the sintering effect. 
In all cases the particles are round shaped. Labbaf et al claim that the spherical 
shape is in part due to the use of ammonium hydroxide as catalyst, although the morpholo-
gy and size can be as well controlled by the rate of the hydrolysis and condensation reac-
tions. Even though it is know that, when using a base catalyst to control the condensation 
reaction the particles do not assemble, some agglomeration is observed. However, the cata-
lyst chosen prevents them fusing together during thermal treatment. [10] 
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3.3. Cytotoxicity tests of the BG-NPs 
 
 
 
Fig. IV. 4  Cytotoxicity test results of raw and thermally treated BG-NPs over three time points (one, three and 
seven days). 
Binary pH 9 (a) 0 °C, (b) 700 °C; binary pH 11.5 (c) 0 °C, (d) 700 °C; ternary pH 9 (e) 0 °C, (f) 700 °C; 
ternary pH 11.5 (g) 0 °C, (h) 700 °C and all data were expressed as mean ± standard deviation for n = 
5. 
 
The BG-NP effect on cell metabolic activity was assessed by seeding L929 cells with 
their leachables. Figure IV.4. shows the cell’s viability evaluated by carrying out the MTS 
test. A slight decline in the cellular metabolic activity was verified from the first to the third 
day in all samples, the decrease being more relevant in sample (a). The mentioned decrease 
was followed by a viability increase from day three to day seven. These results suggest that 
the cell’s metabolism is being influenced by the ions present in the leachables, as sample (a) 
showed the presence of more chemical species in FTIR analysis (see figure IV.2.) and, as a 
consequence, it has the most evident decrease in the third day viability. Nevertheless, the 
interactions between the cells and the BG-NP leachables do not affect significantly their 
viability, as it increases again towards the seventh day of culturing. The cell’s behavior 
throughout the study time proves the non-toxicity of the materials produced at different pH 
and also before and after thermal treatment. Therefore, high biocompatibility of the mate-
rials is ensured in all of the studied conditions. 
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3.4. In vitro bioactivity test of the BG-NPs 
 
It is commonly accepted that the bioactivity of glasses relies on their ability to induce 
hydroxyapatite formation in a physiological environment, such as simulated body fluid (SBF) 
that reproduces the human plasma by having similar pH and ionic composition. In this envi-
ronment, the bioactive glasses will release ions and form silanol groups on its surface that 
will act as a nucleating agent for a hydroxyapatite layer. [35] 
Being an interface-driven phenomenon, bioactivity will depend on parameters such 
as surface charge, composition, structure and morphology. [36] In fact, these parameters 
will influence the dissolution rate of the materials, whose ideal ionic concentrations will de-
fine the ability to stimulate cellular proliferation and differentiation. [2] 
 
 
3.4.1. X-ray diffraction (XRD)  
 
 
Fig. IV. 5. XRD spectra of raw and thermally treated BG-NPs produced at different pH and formulations after 
seven days of immersion in SBF. 
Binary pH 9 (a) 0 °C, (b) 700 °C; binary pH 11.5 (c) 0 °C, (d) 700 °C; ternary pH 9 (e) 0 °C, (f) 700 °C; 
ternary pH 11.5 (g) 0 °C, (h) 700 °C and hydroxyapatite peaks are indicated (*). 
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Figure IV.5. shows the XRD spectra of the BG-NPs in all of the studied conditions af-
ter soaking in SBF for seven days. In the non sintered samples of the binary systems, both 
pH 9 and 11.5, figures IV.5. (a) and (c), just one to three of the major diffraction peaks in the 
spectra can be interpreted as hydroxyapatite, as a result of being soaked in SBF after seven 
days. In contrast, the sintered binary samples, figures IV.5. (b) and (d), especially the one 
prepared at pH 11.5, figure IV.5. (d), have several peaks related to hydroxyapatite regarding 
day seven of SBF soaking. 
In the case of the ternary system without thermal treatment, figures IV.5. (e) and (g), 
the particles after seven days present an apatitic layer at their surface, with several peaks of 
the spectrum matching the ones of hydroxyapatite. It is possible to conclude that, in each 
system (binary or ternary), at pH 11.5, figures IV.5. (e)-(h), there are more peaks related to 
hydroxyapatite than in the samples produced at pH 9, figures 5 IV.(a)-(d). Regarding the 
temperature, the heat treatment at 700 °C is conducive to better bioactivity than the non-
heat-treated samples, as the diffraction angles of the peaks after soaking in SBF match the 
reference x-ray spectra of hydroxyapatite. Considering the formulation of the BG-NPs, the 
ternary system exhibits a layer of pure hydroxyapatite after seven days of immersion, when 
treated at 700 °C, at both pHs, figures 5 IV.(f) and (h). One can conclude that the ternary 
formulation has better bioactivity results than the binary one, and that thermal treatment 
has an important role in promoting the mineralization ability, regardless of the pH of prepa-
ration in this study.  
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3.4.2. Scanning electron microscopy (SEM) 
 
 
 
Fig. IV. 6  SEM images of the BG-NPS after seven days in SBF, revealing cauliflower-like apatite clusters on their 
surface. 
(a) binary pH 9 0 °C, (b) 700 °C; ternary pH 9 (c) 0 °C, (d) 700 °C; binary pH 11.5 (e) 0 °C, (f) 700 °C 
and ternary pH 11.5 (g) 0 °C, (h) 700 °C. 
 
Bioactivity can be confirmed by observing the development of a needle-like apatite 
layer, forming cauliflower-like clusters on the surface of the particles, namely hydroxyap-
atite (Ca10(PO4)6−x (HPO4)x (OH)2−x ), the main mineral constituent of bone. [37] 
Observing the images in figure IV.6., obtained in the SEM study of the bioactivity of 
BG-NP powders, one can conclude that the amount of apatitic crystals at the surface of the 
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samples increases when the pH is 11.5 instead of 9, and when the formulation is of a ternary 
system instead of binary. Indeed, after seven days of soaking the samples in SBF, it is possi-
ble to observe that the condition with the richer apatitic films the one corresponding to the 
ternary system produced at pH 11.5 both at 0 °C and sintered at 700 °C, indicating the best 
bioactivity in a qualitative evaluation, figures 6 IV.(g) and (h). The XRD data previously pre-
sented support these conclusions and confirm that the calcified film is related to hydroxy-
apatite. 
 
 
3.4.3. Energy dispersive X-ray analysis (EDX) 
 
 
 
Fig. IV. 7 EDX study of the bioactivity of the BG-NPs prepared in different conditions at zero, one, three, five 
and seven days.  
(a) Binary pH 9 at 0 and 700 °C, (b) ternary pH 9 at 0 and 700 °C, (c) binary pH 11.5 at 0 and 700 °C 
and (d) ternary pH 11.5 at 0 and 700 °C. 
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The results obtained by SEM were also confirmed by EDX analysis that allowed the 
following of the elemental evolution throughout the time period of study. After soaking in 
SBF, the expected behavior of a bioactive material containing Si and Ca (as in the case of BG-
NPs) is the rising of Si accompanied by the decrease of Ca in the first stage, due to the ex-
change of the last elements with H+ and H3O
+ from the environment. After this first step, 
disruption of the glass network occurs by hydrolysis and as Si–O–Si bridges break, during 
which soluble silica is lost to the solution in the form of Si(OH)4 leading to the formation of 
silanol groups (Si–OH) at the BG-NP/solution interface. The OH− groups from silanol will 
attract Ca2+ and PO3−4 from the surrounding media and precipitation occurs. An amorphous 
calcium phosphate layer begins to grow on the surface of the sample, and the Ca and P val-
ues increase. In contrast, Si content decreases proportionally. The incorporation of OH− and 
CO2−3 anions from the solution leads to the final step of mineralization which is the for-
mation of a crystalline hydroxyapatite layer. [38] 
In fact, in all systems as the study proceeds, the Si content decreases and the Ca and 
P increase. The P is taken out from the SBF in the case of the binary systems, see figures 
IV.7. (a) and (c). This strengthens the indication of the development of apatite material onto 
the BG-NP surfaces. 
This behavior varies in time according to the bioactive potential of each sample. In 
the case of the binary and ternary systems prepared at pH 9, figures IV.7. (a) and (b), respec-
tively, the effect of the ion exchange is more significant after the fifth day of the study, 
when Si begins to decrease and the Ca and P values become higher. 
In the binary system produced at pH 11.5, figure IV.7 (c), the apatite begins to devel-
op earlier, after three days of immersion in SBF. In the case of the ternary system (SiO2-CaO-
P2O5) produced at the same pH, the bioactivity character just needs one day to express it-
self, figure IV. 7(d). This last system is then the most bioactive one. 
Regarding the influence of the BG-NP formulation over the bioactive ability of these 
materials, some facts have to be considered. First, the ability to bond with bone has been 
shown to depend largely on the silica (SiO2) content. As the silica content of the glass in-
creases, the dissolution rate of the apatite layer becomes slow and the bone-bonding ability 
of the materials decreases. A glass with content of more than 60 wt% silica has a dramatic 
decrease in its bioactivity. [38] Moreover, the BG-NPs with a higher percentage of Ca are 
expected to be more prone to dissolution than the ones with higher amounts of Si in aque-
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ous environments, since calcium disrupts the silica network, reducing its network connectiv-
ity (mean number of bridging –Si–O–Si– bonds per silicon atom) and therefore its stability in 
solution. [10, 39] Both these facts could justify the reason why samples from binary systems 
have an inferior bioactivity over the ternary ones. One can conclude that, at the lower pH 
(9), the obtained particles are more crystalline which was previously referred to as a draw-
back in setting the bioactive potential, as it lowers the dissolution rate to ineffective values. 
This fact would explain why the ternary system at pH 11.5 is more bioactive than at pH 9. 
In this study, thermal treatment did not have an influence on setting the bioactive 
potential of the BG-NPs. The differences obtained in the atomic percentages throughout the 
days of the study were not significant when the samples had been sintered, regardless of 
the formulation of the particles, although thermal treatment is important to retain the Ca in 
the glass network, which is a crucial element for a successful mineralization. 
 
 
3.5. Chitosan/BG-NP composite development 
 
Composites found in nature contain an inorganic phase, with at least one nanometric 
dimension embedded in an organic matrix, usually assembled in a complex and hierarchical 
structure. [40] Biomimetic osteoconductive nanocomposites may be obtained by combining 
bioactive glass/ceramics with a polymeric matrix. [22] In order to mimic this natural struc-
ture, the most bioactive powders (ternary, pH 11.5, 700 °C) were applied in the develop-
ment of chitosan membranes containing BG-NPs dispersed in the polymer. The membranes 
were obtained by solvent casting of a solution containing chitosan (0.7 wt/vol%) and BG-NPs 
(0.3 wt/vol%). Chitosan is an excellent biocompatible polymer, although, by itself, it is not 
capable of reacting within the physiological fluids in order to develop apatite crystals and 
bond to the bone, figure 8(a). In this study, BG-NPs were applied in the formation of a com-
posite formed by the polymer and the glass powders in order to produce a bioactive compo-
site that allies the remarkable mechanical and processability properties of chitosan to the 
mineralization induction ability of BGNPs. 
The nanosize of the particles allows a large dispersion in the polymer as can be ob-
served in figure IV.8 (b), showing a uniform membrane surface. After seven days of immer-
sion in SBF, a dense apatite layer is formed at the surface of the composite (figure IV.8 (c)). 
  
 
Chapter IV 150 
 
The thickness of the apatitic film can be observed because the polymeric membrane shrinks 
upon drying and the apatite layer breaks (figure IV.8 (d)). This profile view allows us to esti-
mate the reaction layer thickness as 2 μm approximately, having an average thickness of the 
membrane of 47 μm. In contrast, the pure chitosan membrane does not present any bioac-
tive character as, after seven days immersion in SBF, no apatite layer was formed at its sur-
face, proving that this ability is caused by the BG-NPs. It was proved then that one can suc-
cessfully ally the mineralization induction ability of the BG-NPs with the mechanical ad-
vantages of the chitosan biopolymer, producing a nanocomposite with potential applica-
tions in bone tissue engineering or in guided tissue regeneration. 
 
 
 
Fig. IV. 8   SEM images of the membranes before and after SBF immersion. 
(a) pure chitosan membrane after seven days in SBF; (b) composite of 0.7 % w/v chitosan and 0.3 % 
w/v BG-NPS (control = zero days in SBF); (c) composite of 0.7 % w/v chitosan and % w/v BG-NPs 
after seven days in SBF and (d) composite of 0.7 % w/v chitosan and 0.3 % w/v BG-NPS after seven 
days in SBF at a higher magnification. 
 
 
 
 
 
 
  
 
Chapter IV 151 
 
4. Conclusions 
 
In this work, new bioactive glass nanoparticles based on the SiO2–CaO–P2O5 and 
SiO2–CaO systems were prepared using a sol–gel method. Round shaped particles with sizes 
below 50 nm were achieved within the samples produced at pH 11.5. The sol–gel BG-NPs 
obtained in this work, when immersed in SBF, proved the ability to induce mineralization, 
having the desired characteristics of biomaterials used in bone tissue engineering, i.e. bone 
bonding and biodegradability. These two properties are highly desirable at, respectively, 
early and late stages of post-implantation. The best bioactivity results are from by the sam-
ples prepared as a ternary system (SiO2–CaO–P2O5). With the obtained data, one can con-
clude that the thermal treatment at 700 °C improves the bioactivity of the BG-NPs pro-
duced, being more effective when the nanoparticles are prepared at pH 11.5. 
Nanocomposites resulting from the combination of these materials with chitosan 
exhibited bioactive character and may be potentially used in a series of orthopedic applica-
tions, including in membranes for tissue guided regeneration. 
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Chapter IV - Appendix  
 
Wettable arrays onto superhydrophobic surfaces for 
bioactivity testing of inorganic nanoparticles* 
 
 
Abstract 
 
Poly(l-lactic acid) superhydrophobic surfaces prepared by a phase-separation meth-
odology were treated with 30 min exposition of UV/O3 irradiation using hollowed masks in 
order to obtain patterned superhydrophilic squared-shaped areas. These wettable areas 
successfully confined bioactive glass nanoparticles (BG-NPs), by dispensing and drying indi-
vidual droplets of BG-NPs suspensions. The obtained biomimetic chips were used to test the 
in vitro bioactivity of binary (SiO2–CaO) and ternary (SiO2–CaO–P2O5) nanoparticles pro-
duced using sol–gel chemistry by immersing such substrate in simulated body fluid (SBF). 
From SEM and EDX it was possible to conclude that the ternary system promoted an en-
hanced apatite deposition. This work shows the potential of using such flat disposable ma-
trices in combinatory essays to easily evaluate the osteoconductive potential of biomaterials 
using small amounts of different samples. 
 
 
 
 
 
 
 
* This Appendix is based on the following publication:  
Luz, Gisela M.; Leite, Alvaro J.; Neto, Ana I.; Mano, João F., Wettable arrays onto 
superhydrophobic surfaces for bioactivity testing of inorganic nanoparticles,  Materials Let-
ters, 2011, 65 (2), pp: 296-299,   DOI: 10.1016/j.matlet.2010.09.056. 
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1. Introduction 
 
Superhydrophobic surfaces have attracted an increasing interest on worldwide re-
search. [1-4] These surfaces with contact angles higher than 150°, exhibit extreme water 
repellency and have potential applications in a variety of scientific and industrial fields. [5, 6] 
Some natural surfaces, like lotus leaves [7], show superhydrophobic characteristics due to 
the existence of a rough topography of the surface at both the micro and nano scales. Dif-
ferent methodologies have been proposed to produce artificial rough surfaces with similar 
features. [8] Rough surfaces made of poly(l-lactic acid), PLLA, exhibiting a superhydrophobic 
behavior were prepared using a phase-separation method. [6] The aim of this work is to 
demonstrate that such kind of biodegradable superhydrophobic substrates can be used to 
produce innovative chips that are able to act as a practical substrate to perform multiplexing 
tests of biomaterials. In this case the bioactivity studies were focused to address relation-
ships between biomaterial characteristics and osteoconductive potential. The production of 
such chips is based on the fact that the wettability can be increased by exposing the surface 
to UV/O3 radiation. By using adequate masks one can produce patterned superhydrophilic 
spots that can be used to confine different biomaterials. 
Bioactive inorganic nanoparticles have a potential to be applied in a variety of bio-
medical applications, including bone tissue engineering and biomimetic nanocomposites. [9-
12] The chemical composition of such nanoparticles and the processing conditions may in-
fluence their osteoconductive behavior. As many variables may be involved, combinatory 
methodologies should be developed to access biomaterial characteristics/property relation-
ships. In this work bioactive glass nanoparticles based on the ternary and binary systems 
were prepared using protocols previously reported. [13-15] 
We demonstrate that biodegradable superhydrophobic substrates can be used to 
produce disposable chips that are able to easily evaluate important characterization aspects 
such as the in vitro bioactivity of materials. For the proof-of-concept binary and ternary 
formulations of bioactive nanoparticles will be tested to demonstrate the validity of the 
proposed methodology. It is envisaged that this kind of inexpensive chips has the potential 
to be applied to other kind of characterization tests needed in the biomaterial area where 
multiple effects are needed to be explored. 
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2. Materials and methods 
 
2.1. Materials 
 
Tetraethyl orthosilicate (TEOS, 99.90% pure), citric acid monohydrate (99–102%), 
ammonium phosphate dibasic, calcium nitrate tetrahydrate (99%), ethanol absolute, and 
ammonia water (ammonium hydrogen phosphate (98%), maximum of 33% NH3) were pur-
chased from Sigma-Aldrich. The used PLLA has Mn = 69,000 and MW/Mn = 1.734. 
 
 
2.2. PLLA surface preparation 
 
Flat smooth PLLA sheets were processed by compression molding. 
Superhydrophobic PLLA substrates were prepared by spreading a PLLA/dioxane 13% (wt/v) 
solution over pieces of smooth PLLA sheets (10 × 10 mm2); After a few seconds the sub-
strates were immersed in absolute ethanol during 1 h, to induce phase separation. The 
samples were dried in a vacuum oven for 24 h at 40 °C to eliminate all solvent residues. 
When the samples are completely dry, the upper part is removed. The surface of the origi-
nal substrate exhibits in this way the desirable micro/nano-meter rough topography. A 
squared hollowed plastic mask with open regions with a 1 × 1 mm2 size was used to improve 
the wettability in the desired areas by irradiating the surface for 30 min with UV/O3 radia-
tion using a BioForce UV/Ozone ProCleaner device. 
 
 
2.3. BG-NP preparation 
 
To prepare the bioactive glass nanoparticles (BG-NPs) with the composition 
SiO2:CaO:P2O5 (mol.%) = 55:40:5, a protocol based on a previous work was followed [13-15]. 
The same procedure with the necessary adaptations was followed to obtain SiO2:CaO 
(mol.%) = 70:30, where no phosphorous precursor was used. [14] 
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2.4. In vitro bioactivity study 
 
In vitro bioactivity tests were carried out by soaking the 10 × 10 mm2 surfaces in 
50 mL of SBF (simulated body fluid) solution during 0 (control, before SBF immersion), 3 and 
7 days at 37 °C. The samples were then rinsed with distilled water and left to dry. The prepa-
ration of SBF followed the protocol described by Kokubo and Takadama using reagents from 
Sigma-Aldrich. [16] 
 
 
2.5. SEM and EDX 
 
To study the composition and morphology of the surfaces, a NanoSEM-FEI Nova 200 
(FEG/SEM) scanning electron microscope was used. A Pegasus X4M instrument was used to 
perform the EDX experiments. 
 
 
3. Results and discussion 
 
 
Fig. Ap.  1.  The PLLA superhydrophobic surface . 
(a) Change in wettability of the PLLA superhydrophobic surface after 30 min exposition with UV/O3 
irradiation; (b) SEM image of the superhydrophobic surface. 
 
Superhydrophobic PLLA surfaces were successfully prepared with a CA higher than 
150° (Fig. 1 (a)). Such behavior can be explained by the obtained roughness of the surface 
that exhibited a hierarchical structure at both the nano and micro-scales (Fig. Ap. 1(b)). Up-
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on exposure with UV/O3 radiation, the PLLA surface could acquire a superhydrophilic char-
acter (Fig. Ap. 1(a)).  
 
 
 
Fig. Ap.  2.   Preparation of the chips used for the bioactivity testing showing the resulting EDX data for the 
superhydrophobic surface and low magnification SEM image for the areas containing the BG-NP. 
 
Fig. Ap. 2 shows how such superhydrophilic modification was controlled into approx-
imately 1 × 1 mm2 squared regions to produce an array where 1 μl droplets of suspensions 
of the nanoparticles were individually deposited. The droplets were kept confined and sepa-
rated from each other due to the strong difference in the surface tension between the 
superhydrophilic and superhydrophobic regions. After drying the chip, the BG-NPs were 
kept in the superhydrophilic spots. Fig. Ap. 2 shows EDX spectra obtained in the PLLA region 
and a low magnification SEM image which demonstrate the formation of spots with BG-NPs 
on the array. In vitro biomineralization studies in SBF were performed to assess the 
osteoconductive potential of two different formulations of BG-NPs (binary and ternary).  
EDX spectra and SEM micrographs of the superhydrophilic arrays, with the two types 
of BG-NPs soaked in SBF for different incubation periods (0, 3 and 7 days), are present in 
Fig. Ap. 3. The carbon (C) peak corresponds to the substrate (PLLA surface); the oxygen (O) 
peak could be due to the substrate, to both BG-NPs, and to apatite; the phosphorous (P) 
peak could be attributed to ternary BG-NPs and to apatite, but only to apatite in the binary 
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BG-NPs, as this formulation does not contain phosphorus; the calcium (Ca) peak could cor-
respond to both BG-NPs and to apatite. 
 
 
 
Fig. Ap.  3.  Characterization of the chemical elements using EDX and the correspondent SEM micrographs of 
hydrophilic arrays which contained binary or ternary BG-NP soaked in the SBF solution during 0, 3 
and 7 days. 
 
An indication of the development of an apatite precipitate in soaked samples, in 
comparison with non incubated samples, is that the concentrations of Ca and P gradually 
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increase as the concentration of Si decreases due to the dissolution of the BG-NPs. [13, 15] 
Moreover, the SEM images revealed the formation of mineral agglomerates - see Fig. 3. Fur-
thermore EDX showed Ca/P ratios which are closed to the hydroxyapatite stoichiometric 
theoretical value (1.67): 1.72 for binary during 3 days; 1.61 for binary during 7 days; 1.56 for 
ternary during 3 days; and 1.60 for ternary during 7 days. These results confirm the bioac-
tive nature of the BG-NPs. The ratio between the C and P (or Ca) peak intensity could pro-
vide a qualitative indication of the calcification extent in each spot. EDX of binary BG-NPs 
exhibits lower peaks of P and Ca than the ternary, which means that ternary BG-NPs are 
more bioactive than the binary composition. After 7 days of immersion in SBF the hydro-
philic arrays presented a larger amount of apatite than for the 3 day case. This result is visi-
ble in the EDX graphs, where a slight relative increase in P and Ca peaks in both types of BG-
NPs from 3 days to 7 days can be observed. In addition SEM images revealed a more uni-
form apatite layer after 7 days of immersion in SBF. The increase of mineral deposits with 
increased incubation time is related to the longer time available for apatite precipitation. 
 
 
4. Conclusions 
 
This work proposed a new straightforward methodology to test and compare the bi-
oactivity of different BG-NP formulations, by confining reduced amounts of BG-NPs in wet-
table spots organized in an array onto superhydrophobic substrates. The use of such pat-
terned substrates is foreseen for other bioactivity combinatory tests. 
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Chapter V 
 
Nanoengineering of bioactive glass: From hollow to 
dense nanospheres * 
 
 
Abstract 
 
The possibility of engineering bioactive glass (BG) nanoparticles into suitable sizes 
and shapes represents a significant achievement regarding the development of new 
osteoconductive biomaterials for therapeutic strategies to replace or regenerate damaged 
mineralized tissues. Herein it is reported the structural and chemical evolution of sol-gel 
derived bioactive glass nanoparticles for both the binary (SiO2:CaO (mol%) = 70:30) and ter-
nary (SiO2:CaO:P2O5 (mol.%) = 55:40:5) formulations, in order to understand how the parti-
cles formation can be directed. Hollow BG nanospheres were obtained through Ostwald 
ripening. The presence of a non ionic surfactant, poly(ethylene glycol) (PEG), allowed the 
formation of dense BG nanospheres with controllable diameters depending on the molecu-
lar weight of PEG. 
A deep insight into the genesis of BG nanoparticles formation is essential to design 
BG based materials with controlled compositions, morphologies and sizes at the nanoscale, 
in order to improve their performance in orthopaedic applications including bone tissue 
engineering. 
 
 
 
 
 
* This chapter is based on the following publication:  
Luz, Gisela and Mano, J. F, Nanoengineering of bioactive glasses: From hollow to dense 
nanospheres, submitted. 
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1. Introduction 
 
Bioactive glasses are able to regenerate and repair both hard and soft tissue due to 
their osteoconduction, osseointegration and gene regulation properties. [1, 2] Bioactive 
glasses have been extensively studied since their discovery in 1969 by Hench. [3] However, 
the engineering of bioactive glasses at the nanoscale still offers exciting exploration possi-
bilities. 
Sol-gel route together with co-precipitation [4] is the most used methodology to 
produce BG nanoparticles. Several conditions of the sol-gel procedure influence particles 
assembly and growth, namely: reagents used as precursors, pH, addition and concentration 
of dispersants, reagents ratios and addition of catalysers (acids or bases). [5] All these pa-
rameters control the rates of hydrolysis and condensation, affecting final size, structure and 
agglomeration. 
In a previous work [6], BG nanoparticles from both SiO2-CaO (SiCa) and SiO2-CaO-
P2O5 (SiCaP) systems where prepared by sol-gel and characterized. It was concluded that, 
regarding the ternary system, the decrease in the pH of preparation from 11.5 to 9 lead to 
the formation of larger spherical nanoparticles exhibiting less bioactivity.  
These observations were a strong motivation for a further investigation aiming to 
unveil the structural evolution of BG nanoparticles during the sol-gel maturation process. 
Such information could contribute for the design of bioactive glasses with controlled shape, 
dimensions and chemical composition that could elicit desired physiological response, 
namely bioactivity and biocompatibility. In the case of bioactivity, the increase in the surface 
area of nanoparticles will enhance their dissolution rate, which usually correlates to a higher 
bioactive character. Controlling nanoparticles dimensions is also critical regarding toxicity, 
since size is one of the recognition parameters of the immune system. [5, 7] If designed in a 
suitable size and shape both dense and hollow nanospheres can be used in drug delivery, 
since they can easily pass biological barriers taking guest materials with them, whether in 
their voids or matrix releasing the content through nanochannels or simply by gradual disso-
lution of the particles. [5, 8-10]  
In this work, the development of BG nanoparticles from both SiCa and SiCaP formu-
lations at pH 10.5 will be monitored: Samples will be collected on different reaction times, 
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immediately frozen at - 80 ˚C and then freeze-dried in order to fix their structure and prop-
erties. Since PEG is normally used in the production of particles as structure-directing agent, 
a parallel study will be conducted, in which different PEG molecular chains will be added to 
the sol-gel system and the results before and after calcinations will be compared, in order to 
understand how these conditions influence their structural arrangement. 
Targeting of the BG nanoparticles engineering throughout the sol-gel process will fa-
cilitate the accomplishment of actual biotechnology needs, such as avoiding complications 
related with toxicity issues when using biomaterials within living organisms. 
 
 
2. Experimental methods 
 
BG nanoparticles preparation. The procedure to obtain BG nanoparticles with the 
composition SiO2:CaO:P2O5 (mol.%) = 55:40:5 was adapted from a previously reported pro-
tocol. [4] Tetraethyl orthosilicate (TEOS, 99.90% pure), diammonium hydrogen phosphate, 
calcium nitrate tetrahydrate (99%), absolute ethanol, citric acid monohydrate (99%) and 
ammonium water were purchased from Sigma-Aldrich. The mixture of precursor’s solutions 
(7.639 g of calcium nitrate in 120 ml of distilled water, 9.167 g of TEOS in 60 ml of ethanol 
and 30 ml of citric acid 10% (w/v)) was added drop-by-drop to an aqueous solution contain-
ing the phosphorus precursor (1.078 g of diammonium hydrogen phosphate) in 1500 ml of 
distilled water. In the case of the binary system, no phosphorus precursor was used in order 
to achieve the composition SiO2:CaO (mol%) = 70:30.The pH was maintained at 10.5 with 
ammonium water addition. The precipitate obtained was stirred for 48 h and then a resting 
period of 24 h followed. After 96h the precipitate was washed three times with distilled wa-
ter. In order to follow the nanoparticles growth and maturation for both the SiCa and SiCaP 
systems throughout the sol-gel/co-precipitation process, samples were collected after 30 
min (when all the precursors’ solution had reacted), 24h, 48h, 72h and 96h (after the wash-
ing step). In a parallel study, after the 96h washing, 200 ml of an aqueous solution of 
poly(ethylene glycol) 2% (w/v) with Mw of 1500, 8000, 10 000 and 20 000 g/mol was added 
to the precipitate, or in the case of the control 200 ml of distilled water were added and 
then freeze drying followed. Samples of the different conditions were also collected for later 
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characterization. Finally the BG nanoparticles were calcinated at 700 ˚C for 3 h in order to 
achieve the optimal conditions for bioactivity. [11] The effect of calcination was also evalu-
ated. 
 
Scanning electron microscopy (SEM), Scanning Transmitted Electron Microscopy (S-TEM) 
and Energy dispersive X-ray (EDX). The morphology and composition of the BG nanoparti-
cles were examined by a NanoSEM - FEI Nova 200 (FEG/SEM) microscope with and integrat-
ed EDAX - Pegasus X4M (EDS/EBSD) instrument. To perform SEM, a conductive gold coating 
was applied to the samples. For S-TEM observations the particles were dispersed in propa-
nol by ultrasonic bath for 15 min and then transferred to a thin carbon ﬁlm supported on 
TEM copper grids. For EDX, the analyses were conducted at low vacuum and without any 
coating. 
 
X-ray diffraction (XRD). XRD measurements were performed with a Bruker D8 Discover 
model operated at 40 kV and 40 mA using Cu Kα radiation. The detector was scanned over a 
range of 2θ angles from 15˚ to 50˚ at a step size of 0.04˚ and dwell time of 1 s per step. 
 
Zeta (ζ) potential measurements. The electrophoretic mobility of the BG nanoparticles sus-
pensions in ultra pure filtered water was measured at 25˚C with a Malvern Zetasizer device, 
model Nano ZS. The ζ-potential was calculated by the equipment using the Smoluchowski's 
formula. The prepared suspensions of BG nanoparticles collected at different stages of the 
sol-gel process were adjusted to physiological pH 7.4 and then dispersed by ultrasonic bath 
for 15 min prior to each measurement. 
 
 
3. Results and discussion 
 
3.1. Chemical characterization of the BG sol-gel derived nanoparticles 
 
In conventional sol-gel the formed sol is a colloidal silica solution. [12] Sufficient in-
terconnected Si-O-Si bonds need to be formed until they respond cooperatively as colloidal 
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(submicrometer) particles. [12] These species will subsequently later undergo 
polycondensation reactions till they form a network of silica (Si-O-Si bridging bonds) which is 
termed gel. [13] Sol-gel route to produce BG nanoparticles begins with the hydrolysis of Si, 
Ca and P precursors. It is based on the so called Stöber synthesis that consists on the hydrol-
ysis of tetra ethylorthosilicate (TEOS) in ethanolic medium and in the presence of ammoni-
um water. [14] Calcium is introduced by calcium nitrate or calcium chloride. Citric acid is 
used to catalyze hydrolysis. Triethylphosphate (TEP) or diammonium hydrogen phosphate 
are used to add phosphate to the formulation. Ammonium water is required to induce pre-
cipitation, combining therefore, the traditional sol-gel route with co-precipitation methods. 
[4] 
During the sol-gel procedure, some parameters can be changed in order to control 
size and cross-linking density of the nanoparticles, namely the pH, the silicon alkoxide and 
alcohol mixture used, the ratio between water and alkoxide and also ammonia concentra-
tion. [12, 13]  
In a previous work, the effect of pH in the BG nanoparticles preparation was investi-
gated. [11] It was concluded that higher pHs decrease the particles size and increase their 
bioactive potential. Therefore, in this work, pH 10.5 was used, in order to study the for-
mation of BG nanoparticles suprastructures without compromising their bioactivity.  
The addition of PEG with different Mw is also studied in this work. PEG is added in 
the last stage of the procedure, after the washing of ammonia excess with water, and prior 
to the precipitate freezing. 
Freeze-drying was employed to eliminate water instead of a drying step (at 60˚C). 
Freeze drying prevents the agglomeration that occurs in regular drying, caused by the cova-
lent bonding resulting from later condensation reactions. However, freeze drying will only 
eliminate free or physisorbed water (water molecules trapped in the BG nanoparticles struc-
ture). [12] To finalize the sol-gel procedure, calcination is necessary to incorporate calcium 
at 400-450˚C and also to eliminate citric acid at 250˚C and to remove nitrates at 550-600˚C. 
These actions will chemically stabilize the material and assure its biocompatibility. [13, 15-
17] 
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Fig. V.  1.  Schematic of the sol-gel process and visual model of the SiCaP BG nanoparticles formation. 
(a) Silica, calcium and phosphorus precursors mixture. (b) Hydrolisis and condensation reactions 
lead to the formation of particles comprising a silica based network. (c) When the BG precipitate is 
freeze-dryed, the calcium and phosphorus are still not fixed to the network. (d) Calcination at 700˚C 
will lead to the stabilisation of the particles and fixation of calcium and incorporation of phosphorus 
into the now disordered glassy structure. 
 
 
The preparation methodology and the basic structure of BG sol-gel derived nanopar-
ticles are briefly schematized in Fig. V.1. The BG nanoparticles structure comprises covalent 
random networks of silica tetrahedral that share bridging oxygen (Si-O-Si). Calcium works as 
network modifier [18] and it is ionically bonded to the network via non-bridging oxygen 
bonds (Si-O-Ca). To enhance bioactivity of the glasses, phosphorus is also often incorporated 
into their formulation. Although it is not structurally included in the silica network, it forms 
orthophosphates, which are charge balanced by calcium ions. [18]  
The nanoparticles formation at different stages of the sol-gel process was character-
ized by EDX and XRD - see Fig. V.2. 
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Fig. V.  2.  EDX data (in at%) for the different BG-NPs systems. 
(a) SiCa and (c) SiCaP systems and XRD spectra for (b) SiCa and (d) SiCaP at different reaction times 
(30 min, 24 h, 48 h, 72 h, 96 h and calcination at 700˚C). 
 
 
Through EDX analysis it was possible to quantify the compositions in atomic percent-
age (at%) of the binary and ternary samples at the several time points. The first measured 
values after 30 min of sol-gel reaction agree with the initial idealized formulation, SiO2:CaO 
(mol%) = 70:30 in the binary system case - See Fig. V. 2 (a) -  and SiO2:CaO:P2O5 (mol%) = 
55:40:5 in the ternary system case - Fig. V. 2 (c). In the SiCa system the percentages do not 
vary significantly with the reaction time. For the SiCaP formulation, a relative reduction in 
the Si seems to occur. The final disparity of at% regarding the initial content of sol-gel pro-
duced bioactive glasses has been justified by other authors as a consequence of the removal 
of the solubilised calcium nitrate during the washing step. [16, 19] However, the results for 
the SiCaP system shown on Fig. V. 2 (c) indicate that elements ratio evolve during the early 
stages of sol-gel reaction, stabilizing after 72h and are not dependent on the washing step at 
96h. 
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The XRD patterns of the studied samples collected at different time points of the sol-
gel maturation process are shown in Fig. V. 2 (b) and (d). The XRD spectra of the binary 
samples - See Fig. V. 2 (b) - begin with a slightly amorphous character that maintains during 
the first 24 h. After 48 h, some distinct peaks can be observed, and they intensify till 96 h, 
indicating that the sample is becoming more crystalline. These diffraction peaks disappear 
after calcination, and other peaks appear, assigned to a hydroxyapatite phase. Oppositely, 
the ternary system - See Fig. V. 2 (d) - begins with stronger diffraction peak with a large 
amorphous background. The intensity of these peaks begins to decrease after 24 h. The fol-
lowing reaction time, 48 h, exhibits a broad dispersive band, indicating the amorphous na-
ture of the BG, even after calcination at 700 ˚C. The phosphorus presence may be destabiliz-
ing the silica network and increasing its amorphousness.  
Regarding the BG nanoparticles bioactivity, higher crystallinity levels are related to 
lower dissolution rates, representing a direct detrimental effect on bioactivity. [16] The dif-
ferences in the bioactive character of both SiCa and SiCaP systems were already explored 
and characterized in a previous work, [11] where it was concluded that the SiCa system pre-
sents lower bioactivity than the SiCaP one. 
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3.2. Evolution of BG nanoparticles structure during sol-gel/coprecipitation procedure  
 
 
 
Fig. V.  3.  Evolution of the BG nanoparticles through sol-gel reactions. 
The first two columns show S-TEM micrographs of BG nanoparticles of the SiCa and SiCaP systems 
distributed in three different stages overtime. The third column represents schematically the stages 
of hollow nanospheres formation through Ostwald ripening mechanism.  
 
The morphology of the inner structure and the surface of the particles obtained 
were analyzed by S-TEM and SEM respectively - See Fig. V. 3 and 5.  
Regarding the SiCaP system, since the early stages of the sol-gel route, three distinct 
morphologies of BG supraparticles were identified, namely: Morula-like agglomerates of 
nanoparticles, and both dense and hollow spherical supraparticles - See Fig. V. 3 (d-f). Com-
paring all the samples collected at 30 min, 24h, 48h, 72h and 96h of sol-gel reaction, alt-
hough the hollow supraparticles were present in all stages, one can associate the prevalence 
of certain species to three different time intervals. The morula-like agglomerates were iden-
tified solely in the period of 30 min to 24h - See Fig. V. 3 (d) - The dense spherical 
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supraparticles were collected mainly in the period from 24h to 48h - See Fig. V. 3 (e). After 
48h both species were no longer observed and exclusively hollow supraparticles remain till 
the end of 96 h of reaction - See Fig. V. 3 (f).  
Hollow SiCaP nanospheres are the most predominant morphology and were ob-
tained since the first time point of 30 min. Strong contrast between the dark edge and the 
pale center of the particles is a clear evidence of the hollow nature of the BG nanospheres - 
See Fig. V. 3 (f) - having an average diameter of about 150 to 300 nm. These results seem to 
indicate that the initially formed BG glass nanoparticles, from the SiCaP system, self-
assemble into spherical hollow suprastructures in the very first minutes of reaction. Careful 
observation of the S-TEM images indicates that the particles’ shell has a 50 nm thickness, 
approximately the thickness of each individual BG nanoparticles. However, since the reac-
tion system is very large, the process may not be homogenous and some intermediary spe-
cies were observed in later stages, namely the morula-like and the dense spherical 
supraparticles.  
 
 
Fig. V.  4. (a) Sample’s size and (b)  ζ-potential of both binary and ternary systems as a function of sol-gel 
reaction time. 
 
Regarding the SiCaP particles formation, zeta sizer quantification indicates that the 
formed particles mean size is around 300 nm since the first reaction time of 30 min, till 72h 
of reaction time is reached - see Fig. V. 4 (a). After the washing step at 96h, the remaining 
precipitate is composed by slightly larger particles, of about 500 nm.  
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Regarding the SiCa system, after 30 min of reaction till 24h, spherical morula-like 
supraparticles were observed accompanied by smaller nanoparticles basic units - see Fig. 3 
V. (a). The zeta sizer quantification confirms that the samples collected within this period 
contain species with a bimodal distribution comprising sizes around 250 nm and also with 
50 nm, identified in Fig. V. 4 (a) respectively as SiCa 1 and SiCa 2. After 48h all the small par-
ticles (50 nm) seem to vanish, and only the 250 nm particles were detected by the zeta sizer. 
These data are in accordance with the S-TEM images collected - See Fig. V. 3 (b). However, 
after 72h of reaction, the species sizes detected by the zeta sizer begin to increase, till they 
reach a 630 nm dimension after 96 h. The S-TEM image confirms that the initial nanoparti-
cles formed branched clusters and morula-like structures are no longer observed - see Fig. 
V. 3 (c). 
 
 
Fig. V.  5.   SEM images of BG nanoparticles after calcination at 700 ˚C. 
(a) SiCa and (b) SiCaP with detail of broken hollow particles. 
 
The obtained sizes and morphologies are maintained after calcination for both sys-
tems - See SEM images in Fig. V. 5. Due to the surface activity of the particles, collisions may 
occur explaining the fusion of aggregated particles in calabash-like morphologies. [20] In 
addition, a clear evidence of the hollow structure of the SiCaP particles is shown in the detail 
of a broken BG nanoparticle in Fig. V. 5 (b). 
S-TEM images of the collected samples - See Fig. V. 3 (a-f) - demonstrate that self-
assembly of stable hollow nanospheres can spontaneously form in the SiCaP system without 
the need of a template. On the other hand, the SiCa system did not show the presence of 
hollow species in the ultimate stages of the sol-gel procedure. For the SiCa particles, the 
initial stages of the Ostwald ripening are reached; however in stage III a branched cluster 
morphology is preferred, as was already mentioned.  
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In order to infer about the electrostatic interactions that may cause the spontaneous 
self-assembly of the bioactive glass particles, the evolution of the electrokinetic ζ-potential 
was measured during the BG nanoparticles formation - See Fig. V. 4 (b).  
ζ-potential is a physical property that can be attributed to any particle in suspension 
and is defined as the electrical potential difference between the dispersion medium and the 
stationary layer of fluid close to the particle. Therefore, it indicates the degree of repulsion 
between adjacent, similarly charged particles. The zeta potential value is calculated based 
on the electrophoretic mobility of the particles. A ζ-potential above ± 30 mV indicates that 
the particles’ repulsive charges will avoid their agglomeration, assuring their stability when 
dispersed in a solution. [21] 
Although the ζ-potential values are similar for both systems in the first 24h, a diver-
gent evolution of the two systems occurs and the SiCa particles, with values between -30 
and -40, after 48h more stable than the SiCaP ones that vary between -20 and -10mV. These 
values are maintained till the 96h time-point. Upon calcination the SiCaP ζ-potential main-
tains around -10 mV, while the SiCa ζ-potential reaches for -15 mV, indicating that the parti-
cles become more agglomerated due to the sintering effect of calcination.  
ζ-potential profile, together with the chemical and structural evolution of the parti-
cles, may hold an explanation for the differences in the final morphologies obtained. 
In the beginning of the sol-gel process, the aggregation of particles, from both sys-
tems into spherical suprastructures, is caused by a tendency of the particles to minimize 
their surface energy through attractive van der Walls forces. [22, 23] The competition be-
tween electrostatic repulsions and van der Waals attraction will be responsible for the self-
limiting growth process of the suprastructures. [23] However, after 48h the SiCa particles 
begin to present a clear degree of crystallinity - See XRD results on Fig. V. 2 - and their stabil-
ity increases. The particles no longer need to aggregate into spherical suprastructures to 
assure the surface energy minimization. Oppositely, since the phosphorus presence destabi-
lizes the silica network, the SiCaP particles develop increasing amorphous character over-
time. Accordingly, their stability diminishes, and this may be the reason why the particles 
remain organized into spherical aggregates.  
Based on the observation of the intermediary species represented on Fig. V. 3, it is 
believed that these dense spherical aggregates evolve to hollow nanospheres through a 
template-free route that can be explained based on Ostwald ripening mechanisms. 
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Ostwald ripening is a physical process where larger crystals grow at the expense of 
the small ones that have higher solubility. [24] Ostwald ripening also applies for poorly crys-
tallized particles [9], including the amorphous materials resulting from sol-gel process. 
Hence, BG inner particles, being smaller and less dense, easily undergo mass relocation due 
to dissolution. [9] The consumption of the inner particulates leads to the creation of voids. 
Over reaction time, hollow nanospheres are formed. [24-27] Ostwald ripening is prompt to 
occur in sol-gel, due to the presence of a significant number of chemical species necessary 
to generate ionic transport in solution during the ripening process. [26] Ostwald ripening of 
the SiCaP BG nanoparticles is schematically represented in Fig. V. 3 (g-i) - Morula-like 
suprastructures evolve to dense spherical suprastructures that in a last stage form hollow 
nanospheres. 
 
 
3.3. Surfactants influence 
 
The common silica based microparticles sol-gel synthesis relies on the use of an 
organic template, typically an amphiphilic surfactant to influence the final organization of 
suprastructures. [5, 28, 29] Weak noncovalent bonds such as hydrogen bonds and van der 
Waals forces drive the organic/inorganic self-assembly between the surfactants and 
inorganic species. [29] Interactions between the template and sol species may lead to many 
results, namely hollow structures. For BG, a similar mechanism is described for producing 
hollow microspheres, using PEG as template. [30]  
PEG has been widely used as surfactant in the production of biomaterials, namely as 
a structure-directing agent. Moreover, particle size and distribution of silica based nanopar-
ticles depend on the concentration of PEG in dispersion. [31, 32] Hence, PEG is also used to 
control the growth rate of colloids, as this polymer adsorption will decrease further interac-
tions between the colloid surface and the surrounding medium.  Moreover, PEG coating is 
an effective steric stabiliser able to reduce the rate of nanoparticles agglomeration. [33] 
To explore all the possibilities offered by surfactants in controlling the morphologiey 
of particles in solution, the effect of PEG Mw on the BG nanoparticles dispersed in solution 
was investigated. After 96 h of sol-gel reaction, different molecular weight PEG chains 
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(1500, 8000, 10 000 and 20 000 g/mol) were vigorously stirred with the particles for to 2h 
after the washing of SiCaP BG precipitates. 
 
 
 
Fig. V.  6.  PEG chain Mw interactions with SiCaP BG samples. 
(a) and (b) - no PEG added, (d) and (e) - 1500 g/mol, (g) and (h) - 8000 g/mol, (j) and (k) - 10 000 
g/mol, (m) and (n) - 20 000 g/mol, respectively for non calcinated (0˚C) and calcinated (700˚C) BG 
nanoparticles. The third collumn (c), (f), (i), (l) and (o) represents the scheme for each PEG chain 
Mw. 
 
Fig. V. 6 resumes this experiment. Small molecular chains with the Mw of 1500 e 
8000 g/mol added to the BG initial particles resulted in the formation of dense spheres of 
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300 nm and 100-150 nm diameter after calcination at 700 ˚C - see Fig. V. 6 (d) and (e) and 
(g) and (h). High Mw chains addition - see Fig. V. 6 (k) and (n) - resulted in BG hollowed 
supraparticles similar to the ones observed when no PEG was added - See Fig. V. 6 (a) and 
(b). Therefore, PEG chain Mw seems to influence the final diameter and structure of the 
particles obtained and can be used as simple tool to engineer BG nanospheres in order to 
meet the applications needs. Since both hollow and dense supraparticles coexist, further 
studies should be conducted to conclude if these shorter PEG chains act only on the BG indi-
vidual nanoparticles or if hollow spherical supraparticles are destabilized by the PEG addi-
tion and vigorous stir, providing thus more BG nanoparticles subunits. 
Observing Fig. V. 6 (b), (k) and (n), it is possible to conclude that the increase in the 
Mw, maintaining the same concentration, results in a high degree of agglomeration.  
The first column of Fig. V. 6 also shows that before calcination, the particles had 
larger diameters. The size decrease observed may be a consequence of pore diameter re-
duction between the basic subunits during calcination, which can be also useful in increasing 
the compressive strength. [13, 15, 34] Therefore, calcination can be used to engineer small-
er BG nanoparticles. 
The third column of Fig. V. 6 summarizes the model proposed to describe the influ-
ence of PEG’s chain Mw on the formation of dense BG nanospheres. The addition of high 
Mw PEG chains has the same effect on the BG morphology than the absence of PEG. High 
PEG Mw corresponds to high chain lengths. The extended length of the polymer chains justi-
fies the lack of interactions with the particles. On the other hand, low Mw, by having shorter 
length chains, allows interaction between BG particles and PEG chains, resulting in spherical 
dense supraparticles.  
 
 
4. Conclusions 
 
BG nanoparticles prepared by sol-gel from the SiCa (binary) and SiCaP (ternary) sys-
tems were studied in order to understand their structural evolution over reaction time. It 
was found that in the binary system the BG nanoparticles subunits - with sizes around 50 nm 
- aggregate in clusters, while in the ternary system the BG nanoparticles subunits spontane-
ously assemble into hollow spherical supraparticles and their formation can be explained by 
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an Ostwald ripening process in an attractive “one pot” template-free method. The hollow 
supraparticles maintained their shape and integrity even after being calcinated.  
PEG chain’s molecular weight was used to create dense monodispersed supraparti-
cles. This procedure also allows the control of the final size of the particles. Using PEG chains 
with Mw of 1500 g/mol will result in supraparticles with 300 nm diameters. By increasing 
the Mw up to 8000 g/mol, supraparticles with sizes between 100-150 nm are obtained. 
The understanding of which mechanisms are on the basis of particles formation and 
how sizes and morphologies can be controlled is essential to take the next step into BG par-
ticles nanoengineering in order to respond to each specific biomedical demand. 
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Chapter VI  
 
Chitosan/bioactive glass nanoparticles composites for 
biomedical applications* 
 
 
Abstract 
 
Nanocomposites films based on a chitosan blend with bioactive glass nanoparticles 
(BG-NPs) with different formulations, namely SiO2:CaO:P2O5 (mol.%) = 55:40:5 and 
SiO2:CaO:P2O5:MgO (mol.%) = 64:26:5:5 were produced in order to develop systems with 
applicability in Guided Tissue Regeneration.  
The zeta potential of the BG-NPs containing magnesium was found to be lower than 
the other formulation and the corresponding composite with chitosan was the most hydro-
philic.  
The bioactive character of the biomaterials was also assessed in vitro by immersion 
of the materials in SBF, followed by SEM and EDX evaluations. 
SaOs-2 osteoblastic-like cells were seeded on the different nanocomposites and their 
behavior was followed by SEM observations, citotoxicity assessments, DNA quantification 
and ALP analysis. The introduction of the inorganic component in the chitosan matrix had a 
positive effect on the biological response of the membranes. 
The developed nanocomposite films are potential candidates for regenerating dam-
aged bone tissue and could be useful in orthopaedic and maxilo-facial applications. 
 
 
 
 
* This chapter is based on the following publication:  
Chitosan/bioactive glass nanoparticles composites for biomedical applications, Gisela M. 
Luz, João F. Mano; Biomedical Materials 2012, 054104, DOI:10.1088/1748-6041/7/5/054104. 
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1.  Introduction 
 
Surface chemistry and physical properties of bone substitutes used in osteo regen-
eration are of great importance, since they will direct biological responses such as cell adhe-
sion and differentiation. [1] These features are critical for providing the optimal culturing 
environment for bone formation during the early stages of the regenerative process. [2] 
Bioactive glasses are well suited materials for bone tissue regeneration due to their 
chemical interaction with surrounding bone tissue in vivo, which promotes osteointegration 
by the formation of a calcium phosphate layer which is later modified by bone cells. [2, 3] 
Moreover, the ionic release from bioactive glasses may stimulate gene expression, promot-
ing osteoinduction. [4] Some works showed that dopping bioactive glasses with different 
ions can add value to these materials. [5] For instance, magnesium, one of the main substi-
tutes for calcium in biological apatite, [6] when included in the bioactive glasses formula-
tion, can enhance osteoblastic adhesion. [7] 
The advantages of dopping bioactive glasses can be easily extended to the produc-
tion of polymer based bioactive nanocomposites. Polymer based nanocomposites emerged 
from the Nanotechnology field as a promising route to mimic complex natural structures. [8] 
Regarding more specifically the mineralized structures in Nature, including bone itself, much 
effort has been put in the development of reinforced polymeric matrixes with nanosized 
reinforced fillers in order to obtain biomaterials with improved mechanical properties. [9-
12]  
Despite of all the advantages of using BG-NPs in the osteoregeneration field, bioac-
tive glasses dissolution can generate very alkaline pHs when the material has a strong bioac-
tive character, representing an important drawback of such biomaterials. Therefore, the aim 
of this work was to find a balance between bioactivity/ionic release and proper osteoblastic 
stimulation. By combining bioactive glass nanoparticles (BG-NPs) of different compositions, 
namely SiO2:CaO:P2O5 (mol.%) = 55:40:5 and SiO2:CaO:P2O5:MgO (mol.%) = 64:26:5:5, with a 
natural polymer, chitosan, biocompatible and bioactive nanocomposite membranes where 
obtained. The combination of chitosan, a versatile biopolymer for orthopaedic tissue-
engineering [13] with BG-NPs was already proved to result in a bioactive composite as a 
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calcium phosphate layer was formed in vitro upon immersion in a simulated body fluid 
(SBF). [14] 
Since cell adhesion and motility is of major importance in wound healing [15], the os-
teoblastic reaction to chitosan/bioactive glass nanocomposites with different chemical 
compositions was assessed, as well as changes in the surface topography, charge and wet-
tability as they also influenciate osteoblastic attachment and growth by controlling adhesion 
proteins adsorption. [16, 17]   
 
 
2. Experimental methods 
 
BG-NPs preparation. The procedure to obtain BG-NPs with the composition SiO2:CaO:P2O5 
(mol.%) = 55:40:5 was based on a previously reported protocol. [18] Tetraethyl orthosilicate 
(TEOS, 99.90% pure), citric acid monohydrate (99%), calcium nitrate tetrahydrate (99%), 
absolute ethanol and diammonium hydrogen phosphate (98%) were purchased from Sigma-
Aldrich. The mixture of precursor’s solutions (7.639 g of calcium nitrate in 120 mL of distilled 
water, 9.167 g of TEOS in 60 mL of ethanol and 30mL of citric acid 10% (w/v)) was added 
drop-by-drop to an aqueous solution containing the phosphorus precursor (1.078 g of 
diammonium hydrogen phosphate in 1500 mL of distilled water). In the case of the quater-
nary system, some changes were made. Magnesium nitrate hexahydrate from Fluka analyt-
ics was used in order to achieve the composition SiO2:CaO:P2O5:MgO (mol.%) = 64:26:5:5, 
and calcium chloride (Merck) was used as calcium precursor. In both cases, the pH was 
maintained at 11.5 by adding ammonia water. The precipitate obtained was stirred for 48 h, 
and then a resting period of 24 h followed. The precipitate was washed three times with 
distilled water. 200ml of poly(ethylene glycol) 2% (w/v) (Mw 20 000) were added to the pre-
cipitate, and then freeze drying followed. Finally the BG-NPs were heated at 700˚C for 3h in 
order to achieve the optimal conditions of bioactivity. [14] 
 
Membranes preparation. The membranes were obtained by solvent casting, using medium 
molecular weight chitosan (from Sigma-Aldrich). Chitosan was dissolved in an aqueous ace-
tic acid solution 2% (v/v) to a concentration of 1% (w/v) for preparation of the control 
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membranes of pure chitosan labelled CHT. For the composite membranes, the membranes 
were obtained by dissolving Chitosan (0.7% wt) and BG-NPs (0.3% wt) in the acetic acid solu-
tion. The materials containing SiO2:CaO:P2O5 and SiO2:CaO:P2O5:MgO bioactive glass nano-
particles were labeled CHT/SiCaP and CHT/SiCaPMg, respectively. 
After homogenization for 15 min in an ultrasound bath, 80 ml of polymeric solution 
were casted onto 125 mm x 20 mm square petri dishes and allowed to evaporate for 7 days. 
The dried membranes were neutralized by soaking in NaOH 0.1 M for 10 min followed by 
washing in distilled water until pH of 7 was reached in the liquid milieu. Membranes were 
allowed to dry at RT, clipped between 2 frames to obtain straight and smooth surfaces. They 
were then cut to obtain 7 mm diameter circular samples.  
 
In vitro bioactivity study. In vitro bioactivity tests were carried out by immersing circular (7 
mm diameter) chitosan based membranes in 50 mL of simulated body fluid (SFB) solution 
during 0 (control), 1, 3, 5 and 7 days at 37 ˚C. SBF was renewed after the third day, in order 
to assure proper ionic saturation. Upon removal from SBF, the membranes were rinsed with 
distilled water and allowed to dry. The SBF was prepared by dissolving NaCl, NaHCO3, KCl, 
K2HPO4.3H2O, MgCl2.6H2O and Na2SO4 in distilled water and buffered with Tris buffer and 
HCl to reach a pH value of 7.4, following the protocol described by Kokubo and Takadama 
[19]. All chemicals were purchased from Sigma-Aldrich. 
 
Scanning electron microscopy (SEM) and Energy dispersive X-ray (EDX) samples prepara-
tion. To study the surface and the morphology of the samples, a NanoSEM-FEI Nova 200 
(FEG/SEM) scanning electron microscope was used. A conductive gold coating of 10 nm was 
applied to the samples. A Pegasus X4M instrument was used to perform the EDX experi-
ments at low vacuum and without any coating. 
 
Contact angle measurements. The wettability of the surfaces was evaluated using an 
OCA15+ goniometer (DataPhysics, Germany) and the sessile drop method. The volume of 
the applied droplets of glycerol was 3 μL. The mean value was calculated from at least four 
individual measurements on different areas of the surfaces. 
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Cytotoxicity, DNA quantification, ALP analysis and cell attachment tests. Cells from a hu-
man sarcoma osteogenic cell line (SaOs-2) were used to characterize the nanocomposites in 
vitro. The cells were cultured at 37˚C with 5% CO2 and nourished with Dulbecco’s modified 
minimum essential medium (D-MEM) supplemented with 1% antibiotic and 10% FBS. The 
medium was refreshed every 3 days until confluence, when the cells were tripsinized. 
The chitosan based composites were previously sterilized by immersion in 70% (v/v) 
ethanol overnight and then washed twice with sterile phosphate buffered saline (PBS). The 
cells were seeded on the samples (n = 3) at a density of 65 000 cells/cm2, and then the cul-
tures were incubated at 37°C.  
After each time point (1, 3, and 7 days of culture), MTS (3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) test (Promega) was per-
formed to determine the cytotoxicity of the membranes. The relative cellular viability (%) 
was obtained and compared with tissue culture polystyrene (positive control of cell viabil-
ity). Latex was used as negative control of cellular viability. For this assay, a MTS solution 
was prepared by using a 1:5 ratio of MTS reagent and D-MEM culture medium without phe-
nol red or FBS, followed by a 3h incubation period at 37°C. All cytotoxicity tests were con-
ducted by using 3 replicates. Finally, the optical density (OD) was read at 490nm on a 
multiwell microplate reader (Synergy HT, Bio-Tek Instruments).  
To assess proliferation by DNA quantification and ALP activity, samples were also col-
lected on days 1, 3 and 7 after seeding. Samples removed from culture were rinsed twice in 
a PBS solution and transferred into 1.5 mL microtubes containing 1 mL of ultra-pure water. 
In order to assure cell lysis, samples were incubated for 1 h at 37 ˚C in a water-bath and 
stored at least for 1h in a - 80 ˚C freezer. After thawing, samples were sonicated for 15 min. 
A PicoGreen dsDNA quantiﬁcation kit (Invitrogen) was used to determine the prolif-
eration of cells in the nanocomposites. Triplicates were made both for samples and dsDNA 
standards (0-2 µg/ml), followed by incubation of the 96-well white plate (Costar; Becton-
Dickinson) for 10 min in the dark. Fluorescence was read using a microplate ELISA reader 
(BioTek, USA) at an excitation of 485 nm and an emission of 528 nm with bandwidth of 20 
nm. DNA concentration values were obtained from a standard curve. 
In order to detect initial osteogenic differentiation, ALP activity was measured. The 
assay mixture contained, in each well of a 96-well plate (Costar; Becton-Dickinson), 20 μl of 
the sample and 60 μl substrate solution consisting of 0.2% (wt/v) p-nytrophenyl phosphate 
  
 
Chapter VI 192 
 
(Sigma) in a substrate buffer with 1 M diethanolamine HCl (Merck, Germany), pH 9.8. After 
an incubation period of 60 min at 37˚C, 80 μl stop solution [2 M NaOH (Panreac, Spain) plus 
0.2 mM EDTA (Sigma)] was added to each well. Standards were then prepared with p-
nytrophenol (10 μM/ml; Sigma) in order to achieve final concentrations in the range 0-0.3 
μM/ml. Samples and standards were prepared in triplicates. Absorbance was read at 405 
nm and sample concentrations were read from the standard graph. ALP enzymatic activity 
was normalized to total DNA content. 
Finally, also on days 1, 3 and 7 after seeding, cell morphology on the 
nanocomposites was assessed by SEM. The samples were rinsed twice with PBS to remove 
non-adherent or loosely adherent cells and fixed with a solution of 2.5% (v/v) 
glutaraldehyde in 0.1M PBS, for 1h at 4˚C. After removing the fixative, the cells were rinsed 
in PBS and distilled water and dehydrated in a graded series of ethanol solution (50%, 70%, 
90% and 100%) each one repeated twice for 15 min. They were left to dry at air at RT, and 
sputter-coated with gold before SEM observation.  
 
 
3. Results  
 
3.1. Nanoparticles characterization: SEM observations and Zeta-potential measurements 
 
 
 
Fig. VI. 1. SEM images of the BG-NPs: (A) SiO2:CaO:P2O5 and (B) SiO2:CaO:P2O5:MgO system. 
SiO2:CaO:P2O5 nanoparticles (figure VI. 1A) showed a higher level of agglomeration 
than the  SiO2:CaO:P2O5:MgO (figure VI. 1B). The particles containing Mg also appeared to 
have longer diameters (30-60 nm) than the formers (20 nm), although some carefulness is 
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required in these analyses, since the particles were coated with a 10 nm thickness gold lay-
er, adding 20 nm in the final diameter of non agglomerated particles vs agglomerated ones. 
The ζ-potential of chitosan powders, SiO2:CaO:P2O5 and SiO2:CaO:P2O5:MgO nano-
particles were investigated at the physiological pH of 7.4. Measuring the ζ-potential of a 
particle suspended in water, can be very useful since one can predict the stability of a parti-
cle based on its ζ-potential value. ζ-potential is defined as the electrical potential difference 
between the dispersion medium and the stationary layer of fluid close to the particle. There-
fore, it indicates the degree of repulsion between adjacent, similarly charged particles. The 
ζ-potential value is calculated based on the electrophoretic mobility of the particles. The 
magnitude of the ζ- potential gives an indication of the potential stability of the particles in 
suspension. Particles having values above 30 mV or under -30 mV are considered stable. 
[20] Chitosan particles are the most stable particles as they have a ζ-potential of + 35.76 mV. 
They also present positive charge. Both SiO2:CaO:P2O5 and SiO2:CaO:P2O5:MgO nanoparti-
cles present negative ζ- potentials, respectively -8.8 mV and -19.13 mV.  
 
 
3.2. Nanocomposites surface characterization: SEM observations and Contact Angle 
measurements 
 
 
 
Fig. VI. 2. SEM images of the nanocomposites surfaces. The inset images show the profile of glycerol droplets 
dispersed over the membranes. 
(a) Pure chitosan (b) CHT/SiCaP and (c) CHT/SiCaPMg nanocomposite. 
Surface characterization of the nanocomposites was performed by SEM and Contact 
Angle measurements. 
Pure chitosan membranes presented a flat and smooth surface (figure VI.2A) in 
comparison with the nanocomposites containing SiO2:CaO:P2O5 and SiO2:CaO:P2O5:MgO 
nanoparticles (figure VI.2B and C). Some differences in the topography of the membranes 
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can be seen. CHT/SiCaP nanocomposite (figure VI.2B) shows a rough surface with fish scales-
like disposition. In the other hand, CHT/SiCaPMg nanocomposite (figure VI.2C) presented 
smooth grooves. 
 Given that hydrophilicity is one of the physico-chemical properties that govern cell 
attachment, proliferation, and protein expression, the hydrophilicity of the nanocomposites 
was evaluated using contact angle measurements. Figure VI.2 also indicates the contact an-
gles of the different samples with respect to glycerol. All the samples were considered hy-
drophilic. 
Tissue culture polystyrene (TCP) was also studied for comparison purposes (data not 
shown). Pure chitosan membrane showed levels of hydrophilicity similar to TCP (61.9˚±2.7˚). 
The addition of bioactive glasses nanoparticles to the chitosan matrix seems to have a dif-
ferent consequence in the final composite hydrophilicity depending on the formulation of 
the nanoparticles, being the CHT/SiCaPMg membrane the most hydrophilic.  
 
 
3.3. Bioactivity study 
 
 
 
Fig. VI. 3. SEM images of (a) CHT/SiCaP and (b) CHT/SiCaPMg nanocomposite surfaces after 7 days of soaking 
in SBF showing the development of an apatitic film onto the membranes. 
To assess the bioactivity of the nanocomposites, samples were immersed in SBF at 
37 ˚C for different time periods. SEM images show the samples surface after 7 days of im-
mersion in SBF (figure VI.3). Regarding the CHT/SiCaP nanocomposite (figure VI.3A), after 
seven days of immersion in SBF, a dense apatite layer was formed on its surface. The thick-
ness of the apatitic film can be observed since the polymeric membrane shrinks upon drying 
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and the apatite layer breaks. This profile view allows us to estimate the reaction layer thick-
ness as 785 nm approximately, being the average thickness of the membrane of ≈ 50 μm. 
The surface of the CHT/SiCaPMg nanocomposite exhibited a large number of small apatite 
clusters which did not densely cover the entire surface (figure VI.3B). The clusters comprised 
plate shaped particles with 350 nm in length and 10 - 40 nm in thickness.  
As expected, pure chitosan did not present any bioactive character after being im-
mersed in SBF (data not shown), so this ability verified in the nanocomposites is caused only 
due to the presence of the bioactive glass nanoparticles. 
 
 
Fig. VI. 4. EDX spectra concerning the bioactivity study of (a) CHT/SiCaP and (b) CHT/SiCaPMg membranes 
immersed in SBF for different time points (0 - control, 1, 3, 5 and 7 days). 
 
EDX analysis of the nanocomposites was performed in order to analyze changes in 
the surface chemical composition related to the mineralization process - see Figure 4. The 
initial oxide quantification of the BG-NPs was SiO2:CaO:P2O5 (mol.%) = 56.5 : 7.8 : 35.7 for 
the CHT/SiCaP composites and SiO2:CaO:P2O5:MgO (mol.%) = 70 : 18.5 : 3.9 : 7.6 for the 
CHT/SiCaPMg ones. The analyzed compositions present a slight variation regarding the ide-
alized formulation of the BG-NPs used, respectively SiO2:CaO:P2O5 (mol.%) = 55:40:5 and 
SiO2:CaO:P2O5:MgO (mol.%) = 64:26:5:5. The variations are related to dissolution behaviors 
of calcium nitrate that are prone to occur in aqueous environments such as the sol-gel sys-
tem, influencing thereby the final relative composition. [21]  
Regarding the CHT/SiCaP nanocomposite, an amorphous calcium phosphate layer 
begun to grow on the surface of the sample, as was indicated by the Ca and P increasing 
values and Si content decrease. The same behavior can be observed in the CHT/SiCaPMg 
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nanocomposite; however in this sample, also the Mg content decreases over immersing 
time on SBF. The value of Ca/P ratio of the apatite film developed on the surface of the 
nanocomposites was 1.65 and 1.59 at the day 7, respectively to CHT/SiCaP and 
CHT/SiCaPMg nanocomposites.  
 
 
3.4. Biological study of osteoblastic response 
 
3.4.1 Cellular viability 
           
 
 
Fig. VI. 5. Cell viability of the produced samples from MTS tests throughout 7 days of culture as compared with 
the cells cultured in TCP.  
Data are means ±SD (n=3; *=p<0.05). 
 
MTS assay results for the osteoblasts seeded on the samples for 1, 3 and 5 days are 
seen in figure VI.5. Values of optical density were read from the cells seeded in the pure 
chitosan membrane and in the bioactive glass nanocomposites. The values were compared 
with the ones obtained in the cells seeded in tissue culture polystyrene (TCP), which was 
used as a positive control of cell viability. Latex substrates were used as negative control for 
cellular viability, and after 7 days of culture the percentage of cell viability in latex was 
considered to be negligible (<0.5%) - data not shown. All the studied samples showed good 
percentage values of cell viability over cells seeded on TCP. No significant difference in cell 
viability was observed across this experimental group. At day 7, CHT/SiCaP nanocomposite 
was the only sample where the values decreased. Pure chitosan membrane and 
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CHT/SiCaPMg nanocomposite presented similar viability profiles overtime, with 100% of 
cellular viability reached after 7 days of culture.  
 
 
3.4.2. DNA quantification 
 
 
Fig. VI. 6. In vitro double-stranded DNA concentration in the pure chitosan membranes and BG-NPs 
nanocomposites seeded with osteoblasts cultured throughout 7 days. 
 
Concerning cell proliferation results, data obtained from the DNA quantification 
(Figure VI.6) indicated that proliferation of osteoblasts seeded onto nanocomposites 
seemed to increase in all the tested samples. Comparing the samples, both CHT/SiCaP and 
CHT/SiCaPMg nanocomposites showed in general better results towards the pure chitosan 
membrane control.  
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3.4.3. ALP analysis 
 
 
 
Fig. VI. 7. ALP enzymatic activity of cells seeded on the pure chitosan membranes and BG-NPs nanocomposites 
throughout 7 days, and normalized to total DNA content. 
 
Figure VI.7 shows the ALPase enzymatic activity of the osteoblasts seeded on the 
produced nanocomposites. Overall, the ALP activity of the three samples increased all 
through the time points analyzed, being the CHT/SiCaPMg nanocomposite the sample hold-
ing the highest ALP enzymatic activity values till day 3. However, on day 7, CHT/SiCaPMg 
nanocomposite levels decreased, while the levels of the others samples continued to in-
crease. 
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3.4.4. Cell morphology and attachment 
 
 
 
Fig. VI. 8. SEM images of osteoblastic cells after a 7 days seeding on pure chitosan (A) and (B),  CHT/SiCaP 
nanocomposite (C) and (D) and CHT/SiCaPMg nanocomposite (E) and (F) observed at two 
magnifications.  
 
The morphology of the cells after 7 days of culture in the developed materials was 
investigated by SEM. When exposed to the studied substrates chitosan presented well 
spread osteoblasts with developed lamellipodia and various long filopodia - Figure VI.8A and 
8B. In contrast, osteoblasts seeded on CHT/SiCaP nanocomposite showed rounded mor-
phologies with reduced attachment levels - See figure VI.8C and D. Only discrete cytoplas-
matic extensions at the periphery of the cell were observed. The CHT/SiCaPMg nanocompo-
site presented a more flattened cellular morphology, with very developed lamellipodia - See 
Figure VI.8E and F.  
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4. Discussion 
 
The SiO2:CaO:P2O5 (mol.%) = 55:40:5  formulation of BG-NPs is a well studied system 
with proved high bioactivity. [14] The SiO2:CaO:P2O5:MgO(mol.%) = 64:26:5:5  formulation 
was selected since it has lower Ca content and higher Si levels, which are known to decrease 
the bioactive character of materials. [22] Magnesium was included in the formulation in 
order to enhance cellular adhesion [7]. The magnesium content was fixed in 5% since some 
adverse effects of magnesium are reported in literature, namely osteoblastic inhibition by 
toxic causes due to excess of Magnesium. [23]  
Differences between the two formulations also influenced the final arrangement of 
the particles - See figure VI.1. This relation may be associated to the particles ζ-potential. 
The ζ- potential of the SiO2:CaO:P2O5 is slightly negative (-8.8 mV) and the particles are more 
agglomerated. On the other hand, SiO2:CaO:P2O5:MgO nanoparticles presented a ζ-potential 
value of -19.13 mV. Therefore, the lower levels of agglomeration observed are due to the 
higher stability of these particles.  
Nanoparticles agglomeration is very important since it can affect particles dispersion 
in the nanocomposite. Although the polymeric solutions containing the BG-NPs were 
sonicated before casting, differences between the final structures of the nanocomposites 
were observed. Figure VI.2C (CHT/SiCaPMg) shows a smoother surface than figure VI.2B 
(CHT/SiCaP) possibly due to the lower level of nanoparticles agglomeration. 
Regarding the osteoblastic interaction with the composite’s surface, diverse degrees 
of cellular attachment can occur due to the presence of different chemical groups that 
change the material’s surface charge. [24, 25] There is not a clear consensus whether the 
osteoblasts (with a ζ- potential of -6.2 mV at physiological pH) [26] attach and proliferate 
preferably on negative [27] or positively [26] charged surfaces such as chitosan [28-30]. An-
other possibility, already mentioned in other studies [31-32] and also observed in this work, 
is that both positive and negative surface charge can favor osteoblastic growth as long as 
they present a marked surface stability. Indeed, Figure VI.8 suggests that the cells showed 
better attachment signals when seeded on the surfaces with higher stability (based on their 
ζ-potential values), namely CHT and CHT/SiCaPMg. 
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Another important aspect influencing the cellular attachment on a surface is its wet-
tability, since this property will influence the adsorption of important proteins from the cul-
ture medium, such as fibronectin and vitronectin, which will mediate cell response and im-
prove cell attachment. [33-37, 16] Moderate hydrophilicity was presented by the pure chi-
tosan membranes and the CHT/SiCaPMg nanocomposites. These nanocomposites seem to 
be more suitable for protein adsorption. These information are supported by the MTS and 
SEM results, respectively figure VI.5 and 8, and they would explain how a flat positive sub-
strate as chitosan, presents similar percentages of cell viability and analogous cell behaviour 
than a rough, negative substrate as the CHT/SiCaPMg nanocomposites. Moreover, it would 
also be a reasonable explanation on why cells seeded on the CHT/SiCaP nanocomposite, 
with a higher hydrophobic character, and thereby less capable of adsorbing attachment pro-
teins, present a round shape and have less filopodia. 
SaOS-2 line of human osteosarcoma cells was chosen to study the cellular behaviour 
when in contact with the surface of the produced nanocomposites. Although it has been 
stated that osteoblasts presumably recognize grooves as a naturally extracellular matrix 
environment, which is favorable for their attachment, [38] in this study, cellular attachment 
on the pure chitosan membrane (with a very smooth and flattened surface) was quite effi-
cient and cells presented a more flattened morphology and developed more filopodia than 
the cells seeded on the other samples which offered different levels of roughness. These 
results indicate that roughness may not be the only parameter influencing cells fate. 
In order to have a better insight on all the factors affecting the cells behaviour, some 
biological responses were evaluated in vitro. Osteoblastic viability after seeding on the sur-
face of the developed nanocomposites was determined using the MTS assay. Metabolic ac-
tivity of cells can be monitored using the tetrazolium compound (MTS), since it is chemically 
reduced by the mitochondrya of the cells into formazan. Comparing the produced nano-
composites, MTS results (figure VI.5) showed that osteoblasts seeded on the CHT/SiCaPMg 
nanocomposite surface were slightly more viable than they were in the CHT/SiCaP nano-
composite. Differences in bioactive potential of the different nanocomposites can be a pos-
sible explanation to this fact. 
Knowing that the stoichiometric hydroxyapatite theoretical Ca/P value is 1.67, [39] 
and that the values of Ca/P ratio of the apatite film developed on the surface of the 
nanocomposites was 1.65 and 1.59 at day 7 of soaking in SBF, respectively to CHT/SiCaP and 
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CHT/SiCaPMg nanocomposites, this means that the apatite layer resembling more the natu-
ral bone mineral phase is being formed faster in the CHT/SiCaP nanocomposite. This implies 
that the CHT/SiCaP composite is releasing a higher concentration of ions than the 
CHT/SiCaPMg. However, cells respond to the ionic environment, subsequently, very bioac-
tive glasses, due to excessive ion release, can raise the environment pH to values critical to 
cells. [40] These could be a reason for the decrease of cellular viability at day 7, regarding 
the most bioactive nanocomposite (CHT/SiCaP). The SEM results - See figure 3 - also indicate 
that the CHT/SiCaP induced a higher level of apatitic growth. This was the expected result, 
since, as already was referred, CHT/SiCaPMg contains the BG-NPs particles designed to be 
less bioactive as they contain higher levels of silicon and lower levels of calcium. Regarding 
the Mg content, there is no consensus on the role of Mg in respect with the bioactive poten-
tial of the material. It has been stated that this component increases the bioactivity of bio-
active glasses [41] and also that it retards the apatitic layer formation rate. [42, 43]  
The proliferative capacity of osteoblasts was measured using PicoGreen® fluores-
cence assay in order to quantify the amount of double stranded DNA (dsDNA) per sample. 
DNA quantification results (figure VI.6) indicate a slightly different tendency than the ones 
provided by MTS (figure VI.5).  In this case, both CHT/SiCaP and CHT/SiCaPMg present better 
proliferation values than the control, and no decrease in cellular parameters is observed on 
day 7 for CHT/SiCaP. MTS and DNA results comparisons require some carefulness, since con-
flicts between these assays are common as they do not necessarily correlate linearly with 
increasing cell densities. [44]  
SEM observations of cell attachment on the developed nanocomposites - See figure 
VI.8 - can also be very useful, since cellular morphology is an indication of their develop-
ment. Chitosan (Figure VI.8A and B) and CHT/SiCaPMg nanocomposite (Figure VI.8E and F) 
presented well spread osteoblasts with a developed lamellipodia and various long filopodia. 
However, osteoblasts seeded on CHT/SiCaP nanocomposite (Figure VI.8C and D) showed 
rounded morphologies with markedly reduced attachment levels indicated by discrete cyto-
plasmatic extensions at the periphery of the cell. Furthermore, in all cases, filopodia of the 
growing cells showed random protrusion directions, indicating that there is no specific 
alignment to the surfaces roughness. Osteoblasts morphology vary from elongated to cu-
boidal, depending on their matrix deposition activity since cell spreading facilitates os-
teoblast matrix deposition during bone remodelling. [45-47]  
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An ALP activity study was conducted in order to confirm if osteoblastic mineraliza-
tion was occurring. The increase of ALP activity observed in Figure VI.7, regarding all the 
studied samples, is an indication that the nanocomposites were successful in inducing os-
teoblastic differentiation in an early stage. The osteoblastic activity was more intense in the 
CHT/SiCaP nanocomposite till the third day of study, however, only in this sample, on the 
seventh day of study, a decrease on the ALPase enzymatic activity was observed, which is an 
indication of the beginning of the mineralization process between days 3 and 7. [48] SEM 
images of the osteoblasts seeded on the CHT/SiCaPMg nanocomposite (Figure VI.8E) con-
firm the existence of possible mineralization nodules observed at the cells surface. Both 
CHT/SiCaP and CHT/SiCaPMg nanocomposites showed enhanced ALP activity towards the 
pure chitosan membranes on day 1 and 3. This fact may be related to the release of ions 
from the BG-NPs contained in the nanocomposites known to induce osteoblastic differentia-
tion. In the case of CHT/SiCaP, the pH due to the ionic release possibly was excessively high 
after 3 days of cell seeding, compromising subsequently the osteoblastic response. 
 
 
5. Conclusions 
 
In the present study, chitosan nanocomposite membranes were successfully pre-
pared using two distinct bioactive glass nanoparticles systems, namely SiO2:CaO:P2O5 
(mol.%) = 55:40:5 and SiO2:CaO:P2O5:MgO (mol.%) = 64:26:5:5. Bioactive glass nanoparticles 
were proved to be an appropriate choice to develop Guided Tissue regeneration nanocom-
posites, since they have good dispersibility in polymeric matrixes such as chitosan, and also 
due the possibility of adequating the particles properties by adjusting their formulations. 
The CHT/SiCaPMg with moderate bioactive character and higher hydrophilicity was 
found to stimulate a better osteoblastic response towards cellular differentiation and min-
eralization. 
Further studies should provide better understanding of the significance of each ionic 
component in the BG-NPs formulation towards the osteoblastic stimulation process. 
The developed nanocomposites can have potential applications in Guided Tissue Re-
generation, namely in purposes related to the orthopaedic field. 
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Chapter VII  
 
Micropatterning of bioactive glass nanoparticles on 
chitosan membranes for spatial controlled 
biomineralization* 
 
 
Abstract  
 
BG-NPs capable of inducing apatite precipitation upon immersion in SBF were pat-
terned on free-standing chitosan membranes by microcontact printing using a PDMS stamp 
inked in a BG-NPs pad. Formation of the patterns was characterized by SEM. Mineralization 
of the bioactive glass patterns was induced in vitro by soaking the samples in SBF over dif-
ferent time points up to 7 days. The confined apatite deposition in the patterned regions 
with diameters of 50 μm was confirmed by FTIR, EDX analysis, and SEM. In vitro tests con-
firmed the preferential attachment and proliferation of L929 cells to the areas printed with 
BG-NPs of the membranes. This approach permits one to spatially control the properties of 
biomaterials at the microlevel and could be potentially used in guided tissue regeneration 
for skin, vascular, articular, and bone tissue engineering and in cellular cocultures or to de-
velop substrates able to confine cells in regions with controlled geometry at the cell’s length 
scale. 
 
 
 
 
* This chapter is based on the following publication:  
Luz, Gisela M.; Boesel, Luciano; del Campo, Aranzázu; Mano, João F., Micropatterning of 
Bioactive Glass Nanoparticles on Chitosan Membranes for Spatial Controlled 
Biomineralization, Langmuir, 2012, 28 (17), pp: 6970-6977,  DOI: 10.1021/la300667g. 
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1. Introduction 
 
In recent years, the biomaterials field has witnessed the rise of a third generation of 
materials able to stimulate specific cellular responses. [1, 2] Exposed to the right surface 
chemistry and topography, cells can adhere, proliferate, and differentiate. [3-6] Tailoring of 
surfaces morphology can be done along the Z direction by promoting roughness (including 
hierarchical features) or patterning regular motifs. Chemically, the surface can be modified, 
for example, by layer-by-layer constructs, sequential attachment of chemical/biochemical 
elements, and also grafting smart macromolecules. Changes along the X–Y direction enclose 
creation of geometrical domains, regular stripes, or gradients. [3] It has been demonstrated 
that the size of cell-binding domains may have a direct influence in cellular behavior, includ-
ing differentiation, [4] and anisotropic patterns could direct preferential cell alignment. [7] 
Different methods can be applied to engineer culture substrates for guiding cellular 
responses with spatial control. μCP of biologically relevant ligands [8-10] using a soft PDMS 
stamp is the most common technique to generate specific patterns with different and well-
defined chemistries. Patterns of proteins, molecules, polymers, nanoparticles, self-
assembled monolayers, colloids, and metals have been reported. [11-14] Application of this 
patterning technology to cell culture engineering provides new tools for spatially controlled 
tissue engineering. The flexibility of sizes and shapes of the patterns have allowed genera-
tion of patterned cell cocultures that facilitate cell proliferation and differentiation and also 
engineering of tissue constructs. [8, 15] 
Bioactive glass has been demonstrated to have a beneficial effect in bone regenera-
tion, skin, articular regeneration, and angiogenesis applications as it binds to both bone and 
soft tissue. [16] Bioactive glass has been mainly applied in orthopedic and dental areas, 
since it promotes deposition of apatite under physiological conditions. [1, 17, 18] A few 
works have reported the fabrication of substrates with spatial control of biomineralization. 
[19, 20] μCP has not been used for this purpose, though it presents significant advantages 
over the reported methods. (i) It is based on a very simple procedure, easily adjustable to 
different substrates that do not require inherent bioactivity. (ii) No external stimuli are re-
quired to trigger the beginning of mineralization, [20] and (iii) no organic solvents are used 
in the process which would not be an appropriate choice when working with polymers. [19] 
  
 
Chapter VII 211 
 
In addition, the major advantage of applying BG-NPs patterns for tissue culture applications 
is the fact that bioactive glasses are gene-activation materials capable of inducing cellular 
differentiation. [21] Therefore, development of BG-NPs patterns will provide a versatile tool 
for biological studies, since they are inexpensive and also more resistant to temperature, 
storing, and sterilization procedures than the molecular components often used in biology 
research. Moreover, this system would also be very useful in bioactive glass-related studies, 
since their formulation, sizes, and geometry influence their bioactivity and cellular interac-
tions. 
This work describes a methodology to obtain micropatterned bioactive glass nano-
particles (BG-NPs) on chitosan membranes by μCP. Ionic dissolution of Si, Ca, and P gives 
rise to both intracellular and extracellular responses at the interface of the glass with its 
cellular environment which stimulate cells to grow and differentiate, influencing as well 
their biomechanical properties. [1] Instead of producing homogeneous nanocomposites 
with BG-NPs distributed in all their volume another strategy was followed in which the inor-
ganic fraction is deposited over the polymeric membrane. Nanocomposites produced by 
combining BG-NPs and polymers [22] are inspired by mineralized structures found in Na-
ture. [23] 
Moreover, this work aims to achieve spatial control of biomineralization using μCP of 
BG-NPs to generate mineralizable patterns. μCP allows precise control of nanoparticles den-
sity at the surface, thereby controlling ionic release from the BG-NPs and avoiding inefficient 
particles concentration toward mineralization or excessive release of ions that locally 
change the pH of the environment to levels lethal to the cells. This is important when work-
ing at the nanolevel, since unlike bulk materials the high specific surface area of BG-NPs in-
creases their degradability. [12, 24-26] In addition, nanosized particles can cause different 
biological responses in comparison with the ones obtained for larger particles with the same 
chemical composition. One example is the enhancement of cell attachment due to the na-
noparticles higher surface reactivity, which increases protein adsorption. [27, 28] 
Combining both physical and chemical strategies to control cell attachment and apa-
tite deposition, one expects the creation of an innovative, tissue engineering platform that 
could have potential applications in different regeneration fields. 
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2. Experimental Section 
 
BG-NPs Preparation. The procedure to produce BG-NPs with composition SiO2:CaO:P2O5 
(mol %) = 55:40:5 was based on a previously reported protocol. [29] Tetraethyl orthosilicate 
(TEOS, 99.90% pure), diammonium hydrogen phosphate, calcium nitrate tetrahydrate 
(99%), absolute ethanol, citric acid monohydrate (99%), and ammonium hydroxide were 
purchased from Sigma-Aldrich. The mixture of precursor’s solutions (7.639 g of calcium ni-
trate in 120 mL of distilled water, 9.167 g of TEOS in 60 mL of ethanol and 30 mL of citric 
acid 10% (w/v)) was added drop-by-drop to an aqueous solution containing the phosphorus 
precursor (1.078 g of diammonium hydrogen phosphate) in 1500 mL of distilled water. In 
the case of the binary system, no phosphorus precursor was used in order to achieve the 
composition SiO2:CaO (mol %) = 70:30.The pH was maintained at 11.5 with ammonium hy-
droxide addition. The precipitate obtained was stirred for 48 h, and then a resting period of 
24 h followed. The precipitate was washed three times with distilled water. A 200 mL 
amount of an aqueous solution of poly(ethylene glycol) 2% (w/v) with Mw = 20 000 was add-
ed to the precipitate, and then freeze drying followed. Finally, the BG nanoparticles were 
calcinated at 700 °C for 3 h in order to achieve optimal conditions for bioactivity. [30] 
 
PDMS Stamps Preparation. A master containing three different patterned fields was used. 
The geometries were 50 μm diameter cylindrical pillars arranged in a square pattern with 50 
μm spacing, 50 μm diameter cylindrical pillars arranged in a hexagonal pattern with 40 μm 
spacing, and ellipsoidal pillars (50 μm long axes and 30 μm short axes) arranged in a hexag-
onal pattern with 40 μm spacing. Each field was an 8 mm2 square. The master was fabricat-
ed by photolithography using SU-8 photolack. [31] PDMS stamp was prepared by casting a 
10:1 mixture of Sylgard 184 (Dow Corning) prepolymer and cross-linker. The mixture was 
poured over the master and cured at 90 °C for 3 h in a vacuum oven. After cooling, the 
PDMS was peeled off from the lithographic template and cut to suitable sizes. 
 
Membranes Preparation. Membranes were obtained by solvent casting. Medium molecular 
weight chitosan with a degree of deacetylation of 79%, purchased from Sigma-Aldrich, was 
dissolved in an aqueous acetic acid solution 2% (v/v) to a concentration of 1% (w/v). An 80 
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mL amount of chitosan solution was casted onto 15 mm × 20 mm square Petri dishes and 
left for evaporation for 7 days. The dried membranes were neutralized by soaking in NaOH 
0.1 M for 10 min and washed with distilled water until water with a pH of 7 was reached. 
Membranes were left to dry at RT and clipped between 2 frames to obtain straight and 
smooth surfaces. They were then cut in order to obtain 7 mm diameter circles. 
 
Patternings. A 549 μL amount of BG-NPs dispersion with different nanoparticles concentra-
tions in ethanol (between 0.003% and 0.05%) was poured on the surface of a glass slide (9° 
inclination) in a small area of 1 cm × 1.5 cm limited with a hollow rectangular piece fixed to 
the glass slide with dental wax. The dispersion was left to evaporate for 48 h inside a cham-
ber saturated with ethanol. The lift-off was made by pressing the PDMS stamp against the 
dried membrane of BG-NPs that remained in the glass slide (donor substrate) for 10 min at 7 
kPa and RT. Before the “printing” step, the chitosan membrane was treated with a drop of 
acetic acid (0.1 M) spread on its surface with a brush. μCP of the nanoparticles was achieved 
by pressing the BG-NPs-loaded stamp on the chitosan membrane for 30 s under 30 kPa at 
RT. After removing the PDMS, the membrane was washed with ethanol and dried in a vacu-
um oven for 2 h at 40 °C followed by 24 h at 10–2 bar. 
 
In Vitro Mineralization Study. In vitro mineralization tests were carried out by soaking pat-
terned circular (diameter 7 mm) chitosan membranes in 50 mL of simulated body fluid (SFB) 
solution for 0 (control), 1, 3, 5, and 7 days at 37 °C. Upon removal from SBF, the membranes 
were rinsed with distilled water and left to dry. The SBF was prepared by dissolving NaCl, 
NaHCO3, KCl, K2HPO4·3H2O, MgCl2·6H2O, and Na2SO4 in distilled water and buffered with 
tris(hydroxymethyl)aminomethane buffer and HCl to reach a pH value of 7.4, following the 
protocol described by Kokubo and Takadama. [32] All chemicals were purchased from Sig-
ma-Aldrich. 
 
Fourier-Transformed Infrared (FTIR) Spectroscopy Analysis. FTIR spectroscopy analysis of 
the formed hydroxyapatite on the chitosan membranes was carried out in an IR Prestige 21 
Shimadzu Spectrometer. The hydroxyapatite powder was collected by scratching the surface 
of the membranes and pressed with KBr in a small disk. FTIR spectra were recorded from 
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400 to 4400 cm–1 with a resolution of 4 cm–1. Before measurements the powders were dried 
at 100 °C overnight. 
 
Scanning Electron Microscopy (SEM) and Energy-Dispersive X-ray (EDX) Samples Prepara-
tion. A NanoSEM-FEI Nova 200 (FEG/SEM) scanning electron microscope was used to image 
the surface and morphology of the printed membranes. A conductive gold coating with 20 
nm thickness was sputtered to the samples. A Pegasus X4M instrument was used to perform 
the EDX experiments at low vacuum and without coating. 
 
Cytotoxicity and Cell Attachment Tests. L929 mouse fibroblasts line (European collection of 
cell culture-ECACC, UK) was used to test the in vitro biocompatibility of the membranes. 
Chitosan membranes were previously sterilized by immersion in 70% (v/v) ethanol overnight 
and then washed twice with sterile phosphate-buffered saline (PBS). Cells were seeded in 
the samples (n = 3) at a density of 65 000 cells/cm2 nourished with Dulbecco’s modified min-
imum essential medium (D-MEM) supplemented with 10% fetal bovine serum (FBS) and 1% 
antibiotic. Cultures were incubated at 37 °C for 1, 3, and 7 days. After each time point (1, 3, 
and 7 days of culture), MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) test was performed to determine the cytotoxicity of the mem-
branes. The relative cellular viability (%) was determined and compared with tissue culture 
polystyrene (TCPS) (positive control of cell viability). Latex was used as a negative control of 
cellular viability. For this assay, an MTS solution was prepared using a 1:5 ratio of MTS rea-
gent and D-MEM culture medium without phenol red or FBS, followed by a 3 h incubation 
period at 37 °C. All cytotoxicity tests were conducted using 3 replicates. Finally, the optical 
density (OD) was read at 490 nm on a multiwell microplate reader (Synergy HT, Bio-Tek In-
struments). 
At days 1, 3, and 7 after seeding, cell attachment on the membranes was followed by 
SEM. Membranes were rinsed twice with PBS to remove nonadherent or loosely adherent 
cells and fixed with a solution of 2.5% (v/v) glutaraldehyde in 0.1 M PBS for 1 h at 4 °C. After 
removing the fixative, cells were rinsed in PBS and distilled water and dehydrated in a grad-
ed series of ethanol solution (50%, 70%, 90%, and 100%), each one repeated twice for 15 
min. They were left to dry at air at RT and sputter coated with gold before SEM observation. 
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For the fluorescent images, calcein AM was used to stain the cells. A 2 μL amount of 
calcein AM and 1 mL of D-MEM culture medium without phenol red or FBS were added to 
each sample, followed by 10 min of incubation at 37 °C. Live cells stained green due to en-
zymatic conversion of the nonfluorescent cell-permeant calcein AM to fluorescent calcein. 
Fluorescent cells were visualized with the corresponding filters under an inverted micro-
scope (Imager-Z1M). 
 
 
3. Results and Discussion 
 
The procedure employed to load the BG-NPs onto chitosan membranes has been de-
scribed as a “stamp pad” [33] or “stick-and-place” [34] method. The PDMS stamp was 
placed in contact with a glass slide coated with the BG-NPs (donor substrate). The stamp 
picked up the nanoparticles, and these were printed onto the chitosan membrane (receiving 
substrate).  
 
 
Fig. VII.  1. Schematic illustration and photographs of the materials and procedure followed for the µCP. 
(a) Inking of the PDMS stamp in a glass substrate covered with a homogeneous layer of BG-NPs (a1); 
(b) Lift-off of the PDMS stamp carrying the BG-NPs on the base of the features and PDMS stamp (b1); 
(c) Pressing of the PDMS stamp in the chitosan membrane’s surface, and chitosan membrane used as 
printing substrate (c1); (d) Printing of BG-NPs over the chitosan membrane’s surface, and detail of the 
device used to press the stamp against the substrate (d1). Same stamp may be utilized again after 
washing with ethanol in such imprinting procedure. 
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Figure VII.1 represents the different steps of this process. Ethanol was used to pro-
duce the BG-NPs ink as it is known to have a minimal swelling effect on the PDMS stamp. 
[35] PDMS was the selected stamp material since it has enough rigidity to support the topo-
graphic microstructure while it is soft and bendable, allowing conformal contact between 
the stamp and the membrane. [11, 33, 36, 37] 
 
 
 
Fig. VII.  2. Device used to print the µCP patterns. 
The device is mainly composed by two axes. One of the axes (1) is fixed to the base of the device 
and will be the guide of the central piece (3). This central piece will establish the connection 
between the fixed axe and the movable axe (2) where the weights are applied. Fixed axe provides 
stability during the printing process. There are two screws in piece (3). One will fix the central piece 
to the fixed axe, and the other will fix or loosen the position of the movable axe. Different weights 
(4) have a hole in the middle in order to fit in the movable axe. Weight of the axe plus the gray disk 
(5) is exactly 50 g. PDMS stamp (6) is glued to the bottom of the movable axe with a double-sided 
adhesive tape. 
 
Different processing conditions were tested in the production of the patterned 
membranes, namely, the pattern shape and features height, the BG-NPs “ink” concentra-
tion, the pressure applied, and the contact time. Although μCP is usually performed manual-
ly, in this work a homemade transfer device was used in order to have accurate control of 
the pressure applied to the stamp/substrate interface - see Figure VII.2. 
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3.1. Pattern Formation  
 
 
 
 
Fig. VII.  3. SEM images of types of patterns used. 
(a) PDMS stamp and (b) chitosan membrane patterned with 50 μm diameter circles aligned in a 
squared arrangement; (c) PDMS stamp and (d) chitosan membrane patterned with 50 μm diameter 
circles forming a hexagonal pattern; (e) PDMS stamp and (f) chitosan membrane patterned with 
ellipses aligned in a hexagonal arrangement with the higher axis reaching 50 μm. 
 
Three geometries of PDMS stamps were used in this study: 50 μm diameter cylindri-
cal pillars arranged in a square pattern with 50 μm spacing (Figure VII.3a), 50 μm diameter 
cylindrical pillars arranged in a hexagonal pattern with 40 μm spacing (Figure VII.3c), and 
ellipsoidal pillars (50 μm long axes and 30 μm short axes) arranged in a hexagonal pattern 
with 40 μm spacing (Figure VII.3e). SEM images of the corresponding BG-NPs patterns ob-
tained after stamping on the chitosan membranes are shown in Figure VII.3b, d and f. The 
diameter and spacing of the features needed to be optimized for our particular application 
and materials used. Stamps with features with 20, 30, and 40 μm height were tested for 
stamping. The pattern formed by the PDMS stamp with 30 μm height features seemed to 
combine the nondeformability with adequate BG-NPs transfer from the stamp to the mem-
brane and gave the best results using a BG-NPs concentration of 0.03% (w/v). Well-defined 
and nondeformed circles of homogeneously distributed BG-NPs were obtained on the 
membranes. Another reason for choosing this pattern design was to have enough area 
available within the patterned fields to allow cell proliferation but also to have enough 
space between the features to allow good resolution of the pattern and avoid contamina-
tion of BG-NPs outside of the desired areas. 
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The force applied to the stamp during contact with the membrane influences pattern 
formation and reproducibility. [11] Due to the elastomeric and soft nature of the PDMS, 
excess applied vertical pressure during printing causes distortion of the patterns. [11, 37] 
Reproducibility could be greatly improved using a mechanical device that allowed accurate 
control of the applied pressure. The effect of the contact time between the PDMS stamp 
and the BG-NPs membrane substrate was also studied. No important differences in the ob-
tained patterns were found for contact times between 30 s and 10 min. This result agrees 
with previously reported data. [12] When printing the BG-NPs in the chitosan membrane, 
acetic acid was used to treat the membrane and promote covalent binding between the 
polymer and the BG-NPs, since, otherwise, BG-NPs would remain attached to the PDMS 
stamp rather than transfer to the chitosan membrane. Both surface chemistries of the 
stamp and substrate are important in determining transfer efficiency. [37] For the particles 
to transfer onto the substrate, binding to the new surface must be more energetically fa-
vorable than remaining on the stamp. The process of transferring between stamp/ink is 
modeled with a speed-dependent critical energy release rate, which increases with speed 
due to the viscoelastic nature of PDMS. [34] Thus, fast peeling rates are used initially to 
transfer objects from a surface to PDMS, and slow rates are used to transfer these objects 
to a new unpatterned surface. [36] In addition, temperature is also an important parameter 
to consider in patterning systems. However, the rate of stamp removal and the temperature 
during the printing experiment were kept constant for all experiments. 
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3.2. Mineralization Studies  
 
 
 
Fig. VII.  4. (a) SEM images of BG-NPs pattern on chitosan before immersion in SBF. (b) SEM images of the 
patterned chitosan membrane evidencing the calcified clusters after 5 days of soaking in SBF. 
 
Mineralization of the BG-NPs patterns was assessed in vitro by analyzing the ability 
of the patterned membrane to induce precipitation of apatite upon immersion in SBF. The 
patterned membrane before immersion in SBF showed small clusters of BG-NPs randomly 
distributed although well confined in the circular stamped regions - see Figure VII.4a. BG-
NPs tend to agglomerate in clusters of variable sizes. However, individually, these particles 
present rounded shape morphology with sizes around 40 nm. [30] After immersing the en-
tire membrane in SBF for 5 days, well-defined cauliflower-like clusters were detected. These 
were formed by platelets similar to the ones found in the typical structures of 
biomimetically formed apatite - see Figure VII.4b. Mineralization occurred only in the pat-
terned areas where BG-NPs were present proving the confinement of controlled mineralized 
patterns. 
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Fig. VII.  5. (a) EDX spectra and (b) relative compositions of Si, P, and C are given (in atomic percent, atom %) 
from EDX analysis upon the mineralization study of the BG-NPS-patterned chitosan membranes 
soaked in SBF for different time points (0 (control), 1, 3, 5, and 7 days). 
 
EDX analyses of the membrane were performed in order to analyze the change in 
the surface chemical composition related to the mineralization process-see Figure VII.5. A 
slight increase in the fraction of Si in the membrane and a decrease of Ca until day 1 was 
observed. This is attributed to the exchange of Ca ions from the sample and H+ and H3O
+ 
from the SBF solution. After day 1, disruption of the glass network occurs by hydrolysis and 
soluble silica is lost to the solution in the form of Si(OH)4, which leads to formation of silanol 
groups (Si–OH) at the BG-NPs/solution interface. The OH– groups from silanol attract Ca 
from the surrounding media, and precipitation occurs. An amorphous calcium phosphate 
layer begins to grow on the surface of the sample, as can be confirmed by the Ca and P in-
creasing values. In contrast, Si content decreases dramatically. Incorporation of OH– and 
CO3
2– anions from solution until day seven leads to the final step of mineralization which is 
formation of a crystalline apatite layer. [38] 
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The value of the Ca/P ratio of the nonstoichiometric apatitic layer developed on the 
surface of the BG-NPs was 1.63 in day 7. This value is very close to the one attributed to 
stoichiometric hydroxyapatite, 1.67, [39] implying that a hydroxyapatite layer resembling 
the natural bone mineral phase is being formed at the end of 7 days of immersion in SBF. 
 
 
 
Fig. VII.  6. FTIR spectra of the powders scratched from the surface of the patterned membranes after 0 
(control) and 7 days of immersion in SBF. 
 
Evolution of apatite formation was also analyzed using FTIR - see Figure VII.6. The 
spectra presented correspond to the apatite powder scratched from the patterned mem-
branes after 0 and 7 days of immersion in SBF. Silicate absorption bands are observed in all 
spectra, assigned to the bands 1085, 800, and 464 cm–1, respectively: asymmetric stretching 
mode, symmetric stretching vibration, and rocking vibration of Si–O–Si. [40] Silicate-related 
bands are more intense in the control sample, which is in accordance with previous observa-
tions that the Si content decreases after being soaked in SBF. 
Major evidence of hydroxyapatite growth is based on the bands at 600 and 550 cm–1 
related to the P–O bending vibration due to the presence of a crystalline calcium phosphate 
(apatite like) phase. After 7 days in SBF the amorphous band in the control sample at around 
600 cm–1 in SBF evolves to these two bands, evidencing the phosphate groups in the hy-
droxyapatite crystalline conformation. The bands at 1045 and 1090 cm–1 are also assigned 
to the P–O bond, and they increase in the 7 days sample. [41] The band at 874 cm–1 is as-
signed to the acidic phosphate group (HPO4
2–). [42] The presence of Ca is assigned by the 
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band at 950 cm–1 related to Si–O–Ca bonds containing nonbridging oxygen in opposition 
with the bridging oxygens that link two SiO4 tetrahedra. [40, 43] 
Soaking of the BG-NPs in SBF for 7 days was already proved to result in a crystalline 
apatitic layer. [30] In a previous study performed by the authors, XRD data show that the 
amorphous spectra of the BG-NPs, after immersion in SBF for 7 days, resulted in peaks with 
diffraction angles matching the reference X-ray spectra of hydroxyapatite. 
 
 
3.3. Cellular Viability  
 
The cytotoxicity of the patterned chitosan membranes was assessed using a direct 
contact MTS assay - see Figure VII.7. All results for both patterned and unpatterned (pure 
chitosan) membranes of relative viability (%) of the L929 cells were normalized to cell viabil-
ity on TCPS, which was used as a positive control of cell viability. Latex substrates were used 
as a negative control for cellular viability, and after 7 days of culture the percentage of cell 
viability in latex was considered to be negligible (<0.5%). The results revealed that the cells 
seeded on the BG-NPs-patterned membranes exhibited increased cell viability over the cul-
ture time points (1, 3, and 7 days). Moreover, the viability of cells seeded on patterned 
membranes was considerably superior to that observed in plain chitosan membranes. The 
results obtained in the MTS tests prove the important role of the BG-NPs in promoting cellu-
lar viability and are also supported by the morphological observation study. 
Major evidence of hydroxyapatite growth is based on the bands at 600 and 550 cm–1 
related to the P–O bending vibration due to the presence of a crystalline calcium phosphate 
(apatite like) phase. After 7 days in SBF the amorphous band in the control sample at around 
600 cm–1 in SBF evolves to these two bands, evidencing the phosphate groups in the hy-
droxyapatite crystalline conformation. The bands at 1045 and 1090 cm–1 are also assigned 
to the P–O bond, and they increase in the 7 days sample. [41] The band at 874 cm–1 is as-
signed to the acidic phosphate group (HPO4
2–). [42] The presence of Ca is assigned by the 
band at 950 cm–1 related to Si–O–Ca bonds containing nonbridging oxygen in opposition 
with the bridging oxygens that link two SiO4 tetrahedra. [40, 43] 
Soaking of the BG-NPs in SBF for 7 days was already proved to result in a crystalline 
apatitic layer. [30] In a previous study performed by the authors, XRD data show that the 
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amorphous spectra of the BG-NPs, after immersion in SBF for 7 days, resulted in peaks with 
diffraction angles matching the reference X-ray spectra of hydroxyapatite. 
 
 
 
Fig. VII.  7. Cell viability of the produced samples from MTS tests throughout 7 days of culture as compared 
with the cells cultured in TCPS. Data are means ± SD (n = 3; * = p < 0.05). 
 
The cytotoxicity of the patterned chitosan membranes was assessed using a direct 
contact MTS assay - see Figure VII.7. All results for both patterned and unpatterned (pure 
chitosan) membranes of relative viability (%) of the L929 cells were normalized to cell viabil-
ity on TCPS, which was used as a positive control of cell viability. Latex substrates were used 
as a negative control for cellular viability, and after 7 days of culture the percentage of cell 
viability in latex was considered to be negligible (<0.5%). The results revealed that the cells 
seeded on the BG-NPs-patterned membranes exhibited increased cell viability over the cul-
ture time points (1, 3, and 7 days). Moreover, the viability of cells seeded on patterned 
membranes was considerably superior to that observed in plain chitosan membranes. The 
results obtained in the MTS tests prove the important role of the BG-NPs in promoting cellu-
lar viability and are also supported by the morphological observation study. 
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Fig. VII.  8. SEM and Fluorescent images of the cellular patterns. 
(a) Fluorescent images of cell stained with calcein AM after 1 day of culture in plain chitosan and (b) 
BG-NPs patterned membranes; (c) SEM images of 1 day of cell culture in plain chitosan and (d) BG-
NPs patterned membranes; SEM images magnification of 24 h (e), 3 days (f), and 7 days (g) of cell 
culture in BG-NPs patterned membranes; circle of 50 μm of diameter was inserted in the top (right) 
of images b and d for indication purposes. 
 
In order to study cellular morphology and position at the surfaces, L929 cells were 
seeded on the control (plain chitosan membranes) and BG-NPs-patterned membranes at a 
density of 60  000 cell/cm2. Figure VII.8 presents SEM and fluorescence microscopy images 
of the membranes for different culture times: 1, 3, and 7 days. In the patterned membranes 
cells adhered and proliferated mainly in the areas printed with BG-NPs. In addition, the den-
sity of cells on the patterned substrate increased with increasing culture time, always re-
specting the printed BG-NPs pattern. The BG-NPs-confined area proved to be a highly 
bioreactive surface which can promote attachment of living cells. Although cells present a 
flattened morphology, the control membranes of plain chitosan did not favor proliferation 
of cells throughout the time study, compared to the patterned membranes, consistent with 
the MTS results. Cells cultured on the patterned BG-NPs membranes appear to be relatively 
well spread and highly flattened with an increased cell–substrate contact area ratio. For-
mation of pseudopodia was also observed. However, at day 7, cells appear to exhibit a rela-
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tively rounded unspread morphology, probably due only to the lack of space since the MTS 
results proved their viability. In this case cells preferred to adopt a more dense geometry 
and form stacked arrangements over the regions containing BG-NPs rather than migrate and 
attach to pure chitosan regions. The cell stack observed in Figure VII.8G indicates that the 
higher located cells, not able to sense neither the nano- nor the microtopography, prefer 
the environment created by the BG-NPs ionic release rather than migrating to chitosan. 
 
 
4. Conclusions 
 
For the first time μCP has been used to pattern mineralizable elements onto a bio-
material. Chitosan membranes were used and circular motifs containing bioactive glass na-
noparticles were printed on them using previously inked PDMS stamps. The bioactive char-
acter of the BG-NPs spots allowed nucleation and growth of apatite, highly localized in the 
patterned regions of the chitosan membranes. By combining the remarkable properties of 
BG-NPs and the excellent biocompatibility of chitosan with this simple microcontact printing 
approach it was proved that it is possible to control the cellular interactions with a bioactive 
substrate at the microscale level. Successful patterning of fibroblasts is an indication of the 
versatility of the developed system. 
This technology can be extended to studies of patterns with different sizes, geome-
tries, and orientations that are known to influence cell differentiation and also develop cel-
lular cocultures. The approach proposed opens also new routes of developing patterned 
medical membranes with distinct properties in the two sides, able to promote guided tissue 
regeneration in the bone side, while preventing soft tissue growth on the other face. 
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Chapter VIII 
 
Nanotectonics approach to produce hierarchically orga-
nized bioactive glass nanoparticles-based macrospheres * 
 
Abstract 
 
Bioactive particles have been widely used in a series of biomedical applications due 
to their ability to promote bone-bonding and elicit favorable biological responses in thera-
pies associated with the replacement and regeneration of mineralized tissues. In this work 
hierarchical architectures are prepared by an innovative methodology using SiO2-CaO sol-gel 
based nanoparticles. Inspired on colloidal crystals, spherical aggregates were formed on 
biomimetic superhydrophobic surfaces using Bioactive Glass nanoparticles (BG-NPs) able to 
promote bone regeneration. A high ordered organization, a common feature of mineralized 
structures in Nature, was achieved at both nano and microlevels, being the crystallization 
degree of the structures controlled by the evaporation rates taking place at RT or at 4°C. The 
crystallization degree of the structures influenced the Ca/P ratio of the apatitic film formed 
at their surface, after 7 days of immersion in SBF. This allows the regulation of bioactive 
properties and the ability to release potential additives that could be also incorporated in 
such particles with a high efficiency. Such versatile method to produce bioactive particles 
with controlled size and internal structure could open new possibilities in designing new 
spherical devices for orthopaedic applications, including in tissue engineering. 
 
 
* This chapter is based on the following publication:  
Luz, Gisela M.; Mano, João F., Nanotectonics approach to produce hierarchically organized 
bioactive glass nanoparticles-based macrospheres, Nanoscale, 2012, 4 (20), pp: 6293-6297, 
DOI: 10.1039/C2NR31895D. 
1. Introduction 
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Bioactive glasses represent an attractive class of biomaterials in bone Tissue Engi-
neering, since they are able to regenerate both hard and soft tissues due to their 
osteoconduction, osseointegration and gene regulation properties. [1-3] 
Going down the nanoscale, BG-NPs were already successfully synthesized by sol-gel 
methodologies, with controllable sizes and morphologies. [4-6] The demand is now to de-
sign biomimetic hierarchical organizations resembling bone itself using such kind of building 
blocks, which implies a structural control comprising nano, micro and macro level associa-
tions. 
Biomineralization is an inspiring example on how Nature produces tough structures 
based on simple and most of the times brittle units. [7] The robustness of these structures is 
explained by their hierarchically organization and have an important role on defining the 
materials functionality. [8]  
In order to mimic these complex structures, some bottom-up approaches based on 
the assembly of inorganic nanoparticles into higher-order architectures, have been 
used. These strategies are collectively termed nanotectonics. [9] Among the nanotectonic’s 
techniques, template-directed strategies, [10-13] programmed assembly [14-17], colloidal 
crystallography [18-19]  and matrix confinement [20, 21] are the most used when seeking 
the production of biomimetic materials comprising both structural hierarchy and chemical 
functionality.  
Among the available existing techniques to induce self-assembly of colloidal particles 
into ordered arrays, EISA is a very attractive option due to its simplicity and effectiveness. In 
conventional approaches, a colloidal droplet evaporates from a substrate, leaving behind 
solute organized particles that remain attached to the solid surface. [22, 23]  Despite the 
advantages of using EISA to produce ordered structures beginning at the nano level, it has 
been studied majorly to produce 2D ordered colloidal patterns. [22]  
An ingenious way of extending the EISA concept to 3D structures is to pour drops of 
colloidal suspensions on superhydrophobic surfaces. [12] Due to the repulsive interactions 
between aqueous drop and surface, a perfect spherical shape will be maintained while 
spontaneous self-assembly occur simultaneously, leading to the formation of ordered col-
loidal arrays organized in 3D structures.  
Colloidal crystals, the inspiration for this work, are the result of a non-traditional 
crystallization process, where instead of atoms and molecules, spherical nanoparticles will 
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self-assemble into ordered crystal-like structures. Similarly to what happens in colloidal crys-
tallization, non-spherical nanoparticles can also mediate the formation of superstructures 
with a high degree of organization defined as mesocrystals. [24]  
The aim of this work was to create ordered structures by inducing the self-assembly 
of BG-NPs building blocks, through evaporation. Concentrated droplets of aqueous colloidal 
suspensions of BG-NPs were poured on superhydrophobic copper surfaces. Due to the com-
plex roughness and high contact angle of the surfaces, the BG-NPs suspensions assumed a 
spherical shape. Overtime, the BG-NPs were forced to organize into close packed structures 
due to liquid phase evaporation. Different hierarchical levels, namely, nanometric, micro-
metric and macroscopic, were obtained, resembling the mineralized structures that one can 
find in Nature. [8] Moreover, these suprastructures still maintain a high level of porosity, 
making them suitable for biomedical applications. 
 
 
2. Experimental methods 
 
BG-NPs production. The procedure to prepare BG-NPs with the binary composition 
SiO2:CaO (mol.%) = 35:65 was adapted from a previously reported protocol [6, 25]: Tetrae-
thyl orthosilicate (TEOS, 99.90% pure) was mixed with absolute ethanol. Calcium nitrate 
tetrahydrate, and distilled water were also mixed together. Both solutions were mixed for 3 
h after addition of citric acid monohydrate (99%) and then added drop by drop to 1500 mL 
distilled water always mantaining the pH at 11.5 with ammonium water addition. The pre-
cipitate obtained was stirred for 48 h followed by a resting period of 24 h. The precipitate 
was washed three times with distilled water and then freeze-dried. Finally the BG nanopar-
ticles were calcinated at 700 ˚C for 3 h. All the reagents were purchased from Sigma-Aldrich 
except for ammonium hydroxide (33%) that was purchased from Panreac (Spain). 
Superhydrophobic copper surfaces. The superhydrophobic surfaces were prepared using 
commercial plates of copper (Cu). Ammonium hydroxide (33%) was purchased from Panreac 
(Spain) and 1H, 1H, 2H, 2H – perfluorodecyltriethoxysilane (PFDTS, 97%) was purchased 
from Sigma-Aldrich. The surfaces were prepared following a previously described chemical-
based deposition procedure [26]. The Cu substrate was immersed in distilled-water and the 
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pH was adjusted to 9-10 with ammonium hydroxide. After 5 days at 4 °C the surfaces were 
collected, washed with distilled-water and left to dry on air. Finally, the Cu plates were im-
mersed in a PFDTS solution (1% v/v in ethanol) during at least 24 h and then dried in air.  
 
Preparation of the macrospheres. A 5 µL drop of 28 (w/v) % aqueous BG-NPs dispersion 
was poured over a superhydrophobic copper surface, forming an almost spheric drop. The 
evaporation of the liquid phase occurred both at RT and 4 °C forming a BG-NPs based 
macrosphere. 
 
In vitro bioactivity study. In vitro bioactivity tests were carried out by immersing one 
macrosphere in 5 mL of simulated body fluid (SFB) solution during 0 (control) and 7 days at 
37 ˚C. SBF solution was renewed after 3 days in order to assure ionic saturation. Upon re-
moval from SBF, the spheres were rinsed with distilled water and allowed to dry. The SBF 
was prepared by dissolving NaCl, NaHCO3, KCl, K2HPO4.3H2O, MgCl2.6H2O and Na2SO4 in dis-
tilled water and buffered with Tris buffer and HCl to reach a pH value of 7.4, following the 
protocol described by Kokubo and Takadama [27]. All chemicals were purchased from Sig-
ma-Aldrich. 
 
Scanning electron microscopy (SEM) and Energy dispersive X-ray (EDX) samples prepara-
tion. To study the composition and morphology of the samples, a NanoSEM-FEI Nova 200 
(FEG/SEM) scanning electron microscope was used. A conductive gold coating of 10 nm was 
sputtered to the samples. A Pegasus X4M instrument was used to perform the EDX experi-
ments at low vacuum and without any coating. The measures were preformed at least in 
three different areas of each sample. 
 
Staining of the BG-NPs macrospheres with methylene blue dye and calcein AM. To test the 
homogeneity and distribution of an additive, methylene blue dye (2mg per ml of BG-NPs 
suspension) and calcein AM (2µl per ml of BG-NPs suspension) were added, each one to a 
different 5 µL drop of 28 (w/v) % aqueous BG-NPs dispersion and then poured over a 
superhydrophobic copper surface. The evaporation of the liquid phase occurred at RT. In 
both cases, the dried macrospheres were cross-sectioned with a blade. The methylene blue 
dyed macrosphere and cross section were photographed with a digital camera. In the case 
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of the calcein AM stained macrospheres, fluorescent images were obtained with the corre-
sponding filters under an inverted microscope (Imager-Z1M). At high alkaline pHs, as is the 
case of BG-NPs suspensions, the calcein AM fluorescence will work as a Ca2+ indicator, 
thereby attaching to the calcium contained in the bioactive glass nanoparticles formulation.  
 
 
3. Results and discussion 
 
 
Fig. VIII. 1.  Schematics of the procedure followed to prepare the BG-NPs based macrospheres. 
(a) A 5 µL drop of highly concentrated aqueous BG-NPs dispersion was poured over a 
superhydrophobic copper surface (1), forming a perfect spheric drop (2). After evaporation of the 
liquid phase, a BG-NPs based macrosphere was formed. (b) Photograph of a just poured drop of 
BG-NPs dispersion (2) and of a (3) similar drop after 30 min of evaporation at RT; (c) Photograph of 
a dry sphere. 
 
One novelty of this work was the use of a superhydrophobic surface to evaporate 
the BG-NPs dispersion droplets on an environment at controlled temperature; such 
parameter may be used to influence the evaporation rate on the final organization of the 
BG-NPs. Figure 1 summarizes the procedure to obtain the macrospheres. 
The developed technique presents a competitive potential in opposition to more 
complex or agressive approaches to produce dry particles, such as spray-drying or freeze-
drying avoiding both freezing and drying stresses, which can damage sensitive additives 
namely by proteic denaturation. [28, 29]  
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Fig. VIII. 2. Different magnifications of SEM micrographies of the spheres surface which evaporated at RT (a)-
(c); and at 4°C (d)-(f). 
 
The volume of the liquid precursor and it’s concentration in BG-NPs leads to spheres 
diameters of 1.3 mm (fig. VIII.1C) - the size of the final objects could be easily controlled 
with high accuracy by adjusting these two parameters; hydrogel particles processed using 
superhydrophobic platforms were obtained with different sizes by dispensing distinct vol-
umes of the initial liquids. [30]  
The procedure used in this work could be also scalable towards a high-throughput 
production of particles by using a faster and automatic dispensing system, combined with 
an adequate drying procedure. 
The evaporation process leads to a spontaneous assembly of BG-NPs into polycrys-
talline aggregates. The interactions among the BG-NPs were favourable for their packing 
into perfectly symmetrical superstructures, which is characteristic of mesocrystals. The self-
assembly of the particles is merely the result of the evaporation forces and will depend on 
the shape of the nanoparticles, colloidal stabilization and vectorial long-ranged interaction 
potentials. [31] The stability of the structures is dictated by the repulsive electrostatic and 
steric forces between BG-NPs. Although the exact ordering principles guiding the nano-
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subunits highly ordered organization are still not completely understood, tensorial polariza-
tion forces and dipole fields have been discussed. [32-34]  
Each individual BG-NP will act, theoretically as a non-spherical charged object in an 
electrolyte, creating thereby a screened electrostatic potential that is anisotropic at any 
distance. [35] Therefore, mutual ordering of the nanoparticle building units can be induced. 
[31]  
Regarding the sample obtained at RT - see Fig. VIII.2 (a)-(c) - many mesocrystals with 
sizes of about 5 µm were formed due to the particles assembly. However, the organization 
of these crystals in the bulk is incomplete, since although well facetted, they do not present 
connection between all their faces. The most predominant equilibrium shape resulting from 
the self-assembly of the BG-NPs corresponds to a truncated rhombic dodecahedron, pre-
senting 8 hexagonal and 4 squared surfaces - see Fig. VIII.2 (b). Curiously, this is the equilib-
rium shape of bcc metals. [36] The differences of size and shape among the BG-NPs are tol-
erated, and the lattices also comprises structural defects - see figure VIII.2 (c). 
Regarding the results obtained by evaporating at 4 °C - see Fig. VIII.2 (d)-(f) - the ex-
tent of crystallized domains is more obvious, covering almost all of the macrosphere sur-
face. Lamellar organization of the particles layers can be seen when observing the particles 
disposition in detail - see figure VIII.2 (f). 
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Fig. VIII. 3. Data obtained from the in vitro bioactivity tests. 
SEM images showing the apatitic film formed on the surface of the spheres after 7 days of 
immersion in SBF and elemental analysis comparing the samples before and after 7 days of 
immersion in SBF, respectively for samples which evaporated at RT - (a) and (b), and for samples 
which evaporated at 4 °C - (c) and (d). 
 
In order to evaluate the structural influence on the mineralization ability, the sam-
ples were immersed in SBF for 7 days. Figures VIII.3. (a) and (c) show SEM images of the 
apatitic film that grew on the surface of samples obtained at RT and 4 °C, respectively, after 
immersion in SBF for 7 days. The typical cauli-flower-like morphology is evident in both cas-
es; however, for the samples prepared at RT, the apatitic platelets present a more compact 
disposition than the ones on the samples prepared at 4 °C.  
EDX data are shown in Fig. VIII.3 (b) and (d), revealing that the samples constituents 
followed the expected evolution, already observed for BG-NPs when soaked in SBF. [6] The 
Si content dramatically decreases while the P content increases. Regarding the last sample, 
a Si signal is still observed after 7 days in SBF, indicating a slower dissolution process for the 
samples evaporated at 4 °C. In order to complement the results, an elemental quantification 
was performed based on the At % - data not shown - and the Ca/P ratio was calculated for 
each case. The Ca/P ratio obtained for samples evaporated at RT was 1.64 and for samples 
  
 
Chapter VIII 239 
 
evaporated at 4 °C was 1.76. Despite the fact that both values are close to the Ca/P ratio of 
biological apatite, which is 1.67, the difference between values is an indication that the 
preparation conditions of the macrospheres, namely the evaporation ratio, will influence 
the nature of the apatitic film obtained after soaking the samples in SBF. This happens since 
the level of crystallization induced by the evaporation rate of the macrosphere will directly 
affect its dissolution ability, influencing thereby the amount of ions released to the interface 
environment regarding the sample and the SBF. The morphological control of the bioactive 
nanoparticles in the final structure can be a powerful tool to control the ionic release, and 
thus the bioactivity potential in cases where the formulation is so bioactive that its dissolu-
tion needs to be delayed, since bioactivity varies with the BG nanoparticles formulation. [6]  
 
 
 
Fig. VIII. 4. Dyed BG-NPs macrospheres showing an homogeneous distribution of the additives. 
(a) Photograph of methylene blue dyed whole sphere and its cross section placed next to a ruler, 
where each space corresponds to 1 mm; (b) Fluorescence image of the cross-section of a calcein 
AM stained sphere. 
 
3D ordered bioactive systems were already achieved by a different methodology. 
[13] Ordered macroporous carbon templates replicated from silica colloidal crystals were 
combined with a sol-gel process to form a 3D-ordered macroporous structure of hydroxyap-
atite material composed of hollow spheres. However, this methodology includes a sintering 
step to remove the carbon template. A clear advantage of the present strategy used for the 
macrospheres production is related to the possibility of including additives, such as thera-
peutic drugs. Since the macrospheres are produced under mild conditions and no further 
treatments are necessary after the evaporation step, the systems can also contain sensitive 
additives such as growth factors or other unstable proteins. Such substances are combined 
with the BG-NPs in the initial dispersion. One expects that such additives will be uniformly 
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distributed in the particle after complete solvent evaporation. During the processing of the 
particles all the substances present in the initial liquid formulation will be kept in the formed 
object; therefore the proposed methodology assumes a virtually 100% of encapsulation effi-
ciency for non-volatile molecules. However, the inclusion of an additive may influence the 
self-assembly of the BG-NPs; further studies should be performed regarding this issue. Fig. 
VIII. 4. (a) and (b) provide a proof of concept of the referred application, showing in both 
cases the uniform distribution of respectively, methylene blue dye and calcein AM. 
 
 
4. Conclusions 
 
Hierarchical organization of the BG-NPs was achieved spontaneously through a sim-
ple, fast and cost-effective EISA technique performed on a superhydrophobic surface. The 
level of crystalline organization of the macrospheres obtained could be tuned by controlling 
the evaporation-rate of the liquid phase at different temperatures. This will influence the 
ionic dissolution of the spheres when immersed in SBF, presenting thereby a prospect to 
control their bioactivity. 
This technique owns a notorious competitive potential in opposition to more 
complex approaches to produce inorganic macrospheres with biomedical applications, and 
can be extended to the processing of more complex devices including sensitive and 
expensive additives since the whole process occurs at mild processing conditions. 
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Despite the remarkable osteoconductive properties attributed to bioactive glass 
since its discovery, it is still a brittle material. Therefore, its applications are limited by a 
proper engineering of the material’s structure, or by its combination with other materials, 
like polymers.  
In native mineralized tissues, the blend of organic with inorganic phases is frequently 
the key for the remarkable mechanical properties of this class of natural materials.  In Na-
ture, one can find the inorganic phase organized in hierarchical architectures that are bril-
liantly engineered from the nanolevel. Is therefore important to repeat Nature´s steps and 
look at materials already known to have good biocompatibility, but this time at the 
nanoscale. 
Only very recently, Bioactive Glasses, despite their wide use in clinic for bone regen-
eration purposes, begun to be studied at the nanoscale. Therefore, the work developed in 
this PhD represents a new frontier in orthopedic research. 
 After a study of production optimization, the BG-NPs obtained followed two main 
strategies. Firstly BG-NPs were combined with chitosan to condense in one unique system 
the advantages of both mineral and polymeric materials. In a second strategy, the BG-NPs 
were given the conditions to self-assemble so that a hierarchical multilevel organization 
could be achieved. 2D and 3D dimensions were respectively focused in each main method-
ology. 
The control of BG-NPs properties through processing techniques was proven to be 
easily achieved, based on the results herein reported. In the particular case of this work, 
only the sol-gel system was studied when producing the BG-NPs. This methodology was 
found suitable for the main purposes of the research and allowed for the control of the size 
and morphology of the BG-NPs. Their bioactive character was also controlled by adjusting 
both composition and experimental conditions. 
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Regarding 2D applications of the BG-NPs, bioactive nanocomposites were obtained 
by casting chitosan solutions containing the nanoparticles. BG-NPs were also doped with 
magnesium in order to enhance their biological influence. Results showed a positive effect 
on the osteoblastic response.  
In an extension to the previous successful results, microcontact printing technique 
was used to control spatially the mineralization of chitosan membranes. A valuable and pol-
yvalent platform was created to push even further the study of mineralization and cellular 
interactions. 
At the third dimension, a bottom-up approach to produce hierarchically organized 
BG-NPs based structures was used successfully. It was based on superhydrophobic surfaces 
and developed under RT conditions using only water as solvent. The results showed that BG-
NPs are capable of self-assemble into organized multilevel structures. Therefore, self-
assembly proved to be a powerful tool in mimicking mineralized structures. 
Throughout the experimental work, a special emphasis was given to the characteri-
zation techniques that validated, in vitro, the suitability of the developed techniques for 
general bone regeneration purposes. Nevertheless, some other key challenges still remain 
and critical issues need to be overcome to assure full potential clinical use of the materials 
developed on the scope of this PhD.  
As a continuation of the performed work, mechanical tests should evaluate the ade-
quacy of the produced nanocomposites and BG-NPs macrospheres to set their adequacy to 
orthopedic applications. It would also be interesting to explore the self-assembly of BG-NPs 
in the presence of organic components to fully mimetize bone architecture. 
The properties of the BG-NPs were proved to be strongly related to their composi-
tion. Besides the variation of the basic elements ratio, namely Si, Ca and P, other elements 
may be included on the BG-NPs composition. In Chapter VI, the inclusion of Mg in the BG-
NPs showed to positively influence the osteoblastic response to the particles embedded in a 
polymeric membrane. Also other elements, already known to enhance the biological re-
sponse, such as Sr, should be studied regarding the BG-NPs composition. The multitude of 
possible compositional and experimental combinations demands for tools that make these 
studies feasible. The combinatory assays performed in the arrays platforms already reported 
in Chapter IV’s Appendix, are a good solution to expedit these analysis reducing the amount 
of time and of samples normally associated with such meticulous studies. 
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Control over the BG-NPs distribution was achieved at 2D. However, it would be in-
teresting to develop modes of also extending the spatial control of mineralization to 3D 
structures, namely in hydrogels and scaffolds, in order to target the particles potential in a 
wider range of BTE applications. 
Nanoparticles present a higher surface area which is on the base of their increased 
reactivity. However, the risks of working with nanoparticles either in an experimental envi-
ronment or at higher production scale are not yet fully known. Therefore, it is important to 
develop parallel studies aiming to evaluate the BG-NPs health and environmental risks in 
order to establish effective safety parameters.  
Regardless of an eventual toxicity issue, BG-NPs represent a promising system in 
BTE. In the future, the properties of such systems may be greatly improved by adding im-
portant properties such as antibacterial elements, cellular adhesion enhancers, growth fac-
tors, angiogenic stimulators or anti-inflammatory drugs.  
A plethora of different properties makes bioactive glasses so important in bone re-
generation. Furthermore, their characteristics are expanded when one begins to study these 
materials at the nanoscale. The preliminary research presented in this thesis support the 
potential impact of bioactive glass nanoparticles in the orthopedic field. 
 
 
